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Abstract 
 
 Polymer-based drug delivery systems have fantastic potential in 
chemotherapy as they can reduce drug side effects, help in patient compliance 
and provide targeting. Nanoprecipitation is used to encapsulate small drug 
molecules into polymer nanoparticles to form a drug delivery system. 
A major obstacle in polymer-based drug delivery systems reaching the 
clinic is their inability to load sufficient drug molecules. Little is known about 
the processes involved in the encapsulation of drug molecules into these 
delivery systems. An insight into the processes that govern the formation of 
these particles and encapsulation of small drug molecules within them is 
therefore desirable. 
We used molecular dynamics to model nanoprecipitation by simulating 
the dispersion of an acetone drop, containing polymer, into water containing 
drug. To allow sufficient dispersion of acetone a large amount of water is 
required, thus coarse-graining becomes mandatory. However, we maintain 
accuracy for our polymer-drug interactions by using a multiscale force field. 
Atomistic polymer and drug molecules contain coarse-grain virtual sites which 
facilitate interactions with the coarse-grain solvent molecules. We also 
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employed fully atomistic reference simulations via resolution transformation to 
optimise our multiscale force field. 
This thesis details the theory and design behind this model of 
nanoprecipitation including how other techniques produced inferior results. 
Initial simulations with our multiscale model matched an experimental trend 
and were shown to be accurate relative to atomistic reference simulations. 
We also analysed a fully atomistic simulation of nanoprecipitation that 
took several months to complete. This atomistic simulation was used as a 
reference to update the multiscale force field. The updated force field improved 
on some aspects of the simulation but there are still areas that need 
improvement. 
Insight from the simulations provides an understanding of the 
experimental results and trends. The transferability of the model should help in 
designing more efficient polymer-based drug delivery systems in the future. 
We conclude with future work on modelling polymer-based drug 
delivery systems including alternate methods to gain understanding of not only 
drug incorporation but also drug release. 
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Chapter 1 
Introduction 
 
This thesis details the analysis of drug-polymer interactions through 
molecular dynamics simulations. Small drug molecules can be encapsulated 
within polymer nanoparticles through a technique called nanoprecipitation1. 
The resulting drug polymer nanoparticle is referred to as a polymer-based drug 
delivery system. Drug molecules encapsulated within a carrier will be slowly 
released throughout the body. The carrier can also reduce off-target effects of 
the drug and provide targeting to specific o`rgans or tissues in the body. One 
example is the enhanced permeability retention effect where nanoparticles are 
preferentially retained in tumour sites due to leaky vasculature and poor 
lymphatic drainage. For these reasons several drug delivery systems have been 
designed for various existing chemotherapeutics2±6. 
Whilst the potential for polymer drug delivery systems is very high 
there are several hurdles stopping them from entering the clinic. Historically 
the most difficult obstacle for polymer-based drug delivery systems is 
achieving useful levels of drug loading into the nanoparticles7±9. Whilst trial 
and error experimentation with various polymers is possible, there is a lack of 
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understanding of the underlying principles of drug incorporation and polymer 
drug interactions at the molecular level. Molecular dynamics provides a unique 
insight that is unobtainable by experimental methods. Computational 
simulations allow detailed analysis of drug polymer interactions that help 
comprehend experimental results and could potentially aid in the design of 
more efficient polymer-based drug delivery systems. 
In this chapter we will explore the motivation for this work. 
Nanoprecipitation will be explained and we will look at theoretical work that 
has been performed previously to analyse polymer-drug interactions. 
Additionally the experimental work that is the basis for this PhD is evaluated. 
The aims of this thesis will be presented at the end of this chapter. 
 
1.1 Motivation 
Molecular dynamics has been used to simulate the behaviour of 
molecules for several decades. With the steady increase in computational 
power every year, the accuracy and scale of computational simulations 
increases facilitating the exploration of new and larger systems10. Traditionally 
molecular dynamics has been used to model the behaviour of proteins or lipid 
bilayers. Whilst many proteins are relatively small at around 10 nm in 
diameter, nanoparticles are often much larger - around 100-200 nm in 
diameter11,12. With molecular dynamics the size of a system is directly related 
to its speed as an increase in the number of molecules, increases the number of 
interactions to be computed. As such, until recently there has been little work 
using molecular dynamics to model the formation of full-scale polymer 
nanoparticles. 
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When this project was started it was decided that computational power 
had grown sufficiently that simulations on the formation of polymer-based 
drug delivery systems could be attempted. Whilst mesoscale modelling 
techniques may have to be used, the goal was to design a computational model 
of nanoprecipitation. An accurate model has many useful features; firstly it 
could give an understanding of the processes involved in encapsulating drug 
molecules inside polymer nanoparticles. Secondly the model could be used to 
predict the encapsulation efficiency of various drug and polymer combinations. 
A computer model can be easily edited allowing easy exploration of new 
molecules and their interactions13. 
 
1.2 Nanoprecipitation 
Whilst there are several techniques used to prepare polymer-based drug 
delivery systems14; nanoprecipitation is fast, does not require mechanical work 
and generates particles with a relatively narrow size range1. Droplets of a 
water-insoluble polymer in a water-miscible organic solvent are added to a 
large excess of water.  Drug can either be present in the organic polymer 
solution, or the aqueous receiving solution, depending on the drug properties 
(Figure 1.1). 
As each acetone drop hits the water it quickly disperses into the water. 
This exposes the hydrophobic polymer chains within the acetone and results in 
their aggregation with each other. Nearby, drug molecules diffuse through the 
water and will interact with the polymer chains during aggregation. Drug 
molecules that interact strongly with the polymer nanoparticle will be retained 
during subsequent washing steps and are considered encapsulated. 
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Figure 1.1 Cartoon of the process of nanoprecipitation. Polymer dissolved in 
acetone (blue droplet) is added to water in a beaker under constant stirring. As 
acetone disperses the polymer chains aggregate into nanoparticles. If drug 
molecules are present in either solvent they can be encapsulated in the 
nanoparticles as they form. 
Conceptually, nanoprecipitation involves a number of processes that 
will be to some extent interdependent in a complex way. Firstly there is the 
solvent diffusion process, whereby the water-miscible organic solvent 
disperses into bulk water, and water enters into the volume of the original 
droplet. This change in the solvent environment of the (hydrophobic) polymer 
results in other processes; such as change in the polymer chains from an 
extended to a compacted conformation, intramolecular collapse, intramolecular 
aggregation and polymer chain entanglement. At the same time the drug 
molecules will be diffusing into the region in response to their concentration 
gradient, modulated by their affinity for the various species present. This 
makes modelling nanoprecipitation a difficult task as there are so many factors 
to replicate. We will see that much of the current literature ignores some of 
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these processes. If we want to use computational models to help understand 
and predict experimental results all these factors must be considered. 
 
1.3 Theoretical Work 
Computational models are widely used throughout several industries to 
tackle difficult problems such as predicting the weather or traffic flow15,16. A 
model can help understand complex situations and ideas. 
Recently the Nobel Prize for Chemistry was awarded to Karplus, 
Warshel and Levitt for their work on computational models for chemistry17. 
Their models were the first of their kind and looked at the folding of proteins 
and cleavage of glycoside bonds by lysozyme18. These microscopic processes 
are hard to observe with current experimental techniques such as transmission 
electron microscopy. By modelling how these molecules interact we can gain a 
greater understanding of the processes involved. 
40 years after this pioneering work the field of computational chemistry 
has grown tremendously thanks in part due to the increase in computer power 
IROORZLQJ0RRUH¶VODZ10. As computers become more powerful they are able to 
tackle large systems faster and more accurately. Processes that were originally 
unable to be simulated are now being investigated, with polymer drug 
interactions in nanoparticles being a prime example. 
Whilst there is a large amount of work done on molecular dynamics 
with biomacromolecules, its application to polymer-based drug delivery 
systems is more limited. A pub-med VHDUFKIRU³SRO\PHUPROHFXODUG\QDPLFV´
UHWXUQVaUHVXOWVZKLOVW³SURWHLQPROHFXODUG\QDPLFV´UHWXUQVUHVXOWV 
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With this in mind we will look at a selection of relevant models that 
have been created to analyse polymer-drug interactions. It should be noted that 
whilst not all of the studies have looked at recreating nanoprecipitation in 
silico, there are various other ways to gain a greater understanding of polymer-
based drug delivery systems. In general most of the literature on polymer-drug 
nanoparticles tends to not focus on the formation of the particles themselves 
but the polymer-drug interactions that occur within them. 
 
1.3.1 Modelling Nanoprecipitation 
Spaeth et al. used dissipative particle dynamics (DPD) to model Flash 
NanoPrecipitation19. Flash NanoPrecipitation differs from nanoprecipitation as 
the mixture of anti-solvent with solvent is rapid (over a few milliseconds) and 
not drop-wise. The technique has been used to make nanoparticles of 
controllable size with various polymers experimentally. 
However, as with nanoprecipitation there is a lack of understanding of 
the molecular interactions involved during Flash NanoPrecipitation. This study 
by Spaeth et al. attempts to address this by simulating the process using DPD. 
The model was parameterised based on experimental work. The authors found 
an implicit-solvent model using Brownian dynamics to produce incorrect 
aggregation dynamics. Conversely, an explicit solvent approach produced 
reasonable aggregation dynamics. This result is expected as implicit solvation 
treats solvent as a continuous medium instead of explicit solvent molecules. 
Simulating Flash NanoPrecipitation at experimental conditions is 
challenging for several reasons: the concentration of polymer and solute results 
in roughly 200,000 solvent molecules per solute molecule, nanoparticles 
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formed were 100-200 nm in diameter and the mixing time was estimated to be 
a few milliseconds. The authors speculate that to form a single nanoparticle 105 
solute molecules with 109 solvent molecules would need to be simulated over a 
few milliseconds which is beyond the scope of the computational resources 
available. 
Multiple steps were taken to overcome this problem. Firstly a single 
solvent particle was used and its interactions with the solute were changed over 
time to mimic the change in solvent environment that occurs during Flash 
NanoPrecipitation. Solvent molecules were coarse-grained using DPD to 
reduce the degrees of freedom in the simulation. To further reduce the number 
of solvent molecules, the solute and polymer concentrations were 10-20 fold 
greater than experimental conditions. Finally the simulations were only run for 
200 µs, far less than the few milliseconds required. Whilst there are several 
caveats involved here they were all necessary to simulate Flash 
NanoPrecipitation. However, these changes must be factored into the 
discussion of any results generated by a model that is sufficiently different 
from experimental conditions. 
DPD is a mesoscale modelling technique that uses repulsive forces 
between particles, with a random force and a frictional force as a thermostat to 
sample the NVT ensemble. Each molecule in the system is coarse-grained into 
particles 1 nm in diameter. For polystyrene, 1 CG particle represents two 
monomers of the polymer. 
For the simulations, both polystyrene-b-poly(ethylene glycol) (PS10-b-
PEG68) and the antifungal itraconazole were placed in a periodic box with 
solvent particles. By simplifying the molecules used in DPD a large timestep of 
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0.36 ps is used for the 200 µs simulations. DPD produces accelerated dynamics 
compared with molecular dynamics so the simulation times were rescaled 
accordingly. 
First the authors analysed the effect of mixing time by increasing the 
duration for the solvent interactions to fully change from instantaneous (0 µs) 
to 200 µs. As expected shorter mixing times caused nanoparticles to form more 
rapidly. Additionally a short mixing time reduced the amount of polymer and 
solute molecules in each nanoparticle formed. 
Solute-polymer interactions were adjusted such that they were either 
favourable or unfavourable. Unfavourable interactions led to the formation of 
empty micelles with the solute forming aggregates separately. By the end of 
the simulation a large solute aggregate formed with only a few polymer 
molecules stabilising it. Favourable solute-polymer interactions allowed 
polymer micelles to form with solute incorporated in the process. The solute-
polymer ratio was increased resulting in a steady increase in the number of 
solutes per nanoparticle up to a ratio of 4:1. This also produced larger 
nanoparticles due to the increase in solute content. 
The polymer used in this study contains both a hydrophilic PEG block 
and a hydrophobic PS block. As the length of the PEG block increased the 
number of solutes per nanoparticle decreased whether the solute interactions 
were favourable or unfavourable. This was due to a decrease in particle size 
with an increase of PEG block. With a smaller particle size there is less space 
for solute in each nanoparticle. With an increase in the PS block length the 
number of solutes per nanoparticle does not change significantly. 
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When solute polymer interactions are favourable the solute clusters 
over the first 15 µs of the simulation and polymer micelles form around the 
solute clusters (Figure 1.2). There is equal mixing of the polystyrene particles 
with the solute particles at the centre of the micelles. When the solute polymer 
interactions are unfavourable, solute is still encapsulated within the micelles 
but the solute is phase separated from the PS block of the copolymer. 
 
Figure 1.2 Snapshots taken from a system with favourable solute-polymer 
interaction at time points 12.5 µs, 17.5 µs, 25 µs and 100 µs. Solute bead 
(blue), PS block (red), PEG block (transparent grey). Taken from Ref19. 
The authors conclude that their results should only serve as an 
indication of the Flash NanoPrecipitation of PS-PEG as the simulation 
FRQGLWLRQV DUH QRW LGHQWLFDO WR H[SHULPHQW 6WLOO ³D PDVVLYH LQYHVWPHQW LQ
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FRPSXWLQJ WLPH´ ZDV UHTXLUHG VXJJHVWLQJ WKDW D VLPXODWLRQ DW H[SHULPHQWDO
FRQFHQWUDWLRQVLV³VWLOOHOXVLYH´ 
The only other computational study of nanoprecipitation is by Capretto 
et al. detailing the use of computational fluid dynamics (CFD) on nanoparticle 
formation through microfluidics20. Microreactors are able to produce 
nanoparticles through nanoprecipitation of a narrow size range which is 
desirable for drug delivery purposes (Figure 1.3). As with the previous paper 
the aim of this study was to gain a better understanding of nanoparticle 
formation using computational modelling. 
 
Figure 1.3 Schematic of a microreactor used for nanoprecipitation. Taken from 
Ref20. 
For this study the polymer used was Pluronic F127 
(HO(C2H4O)a(C3H6O)b(C2H4O)aH) ZLWK WKH K\GURSKRELF GUXJ ȕ±carotene. 
0LFURIOXLGLFV GLIIHUV IURP ³GURS-ZLVH´ QDQRSUHFLSLWDWLRQ DV WKH VROYHQW DQG 
anti-solvent are mixed under continuous flow (1 ml/hour). For CFD a two 
dimensional model was used to simulate a polymer stream with adjacent water 
streams. This model has the benefit of being similar in scale to experimental 
conditions. The model was validated by comparison with experimental data 
using the width of the focused stream.  
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CFD was able to demonstrate how nanoparticles formed. First 
PHWDVWDEOH PLFHOOHV IRUP VHSDUDWHO\ IURP PHWDVWDEOH ȕ±carotene clusters. 
)XUWKHUGRZQVWUHDPWKHFULWLFDOZDWHUFRQFHQWUDWLRQIRUȕ±carotene is reached 
and the insoluble portion of the polymer micelles act as a nucleation point 
FDXVLQJWKHLUVXEVHTXHQWHQFDSVXODWLRQ7KHWLPHEHWZHHQȕ±carotene reaching 
LWV&:&DQG WKHSRO\PHUPLFHOOHV UHDFKLQJ WKH&:&LVGHILQHGDVĲ*. Using 
CFD to obtain this parameter helps in forming stable nanoparticle batches 
without forming unwanted empty particle aggregates. 
Both of these studies on nanoprecipitation have used models that lack 
atomistic detail of the molecules involved. This is understandable due to the 
computational demands of more accurate models. However, it is expected that 
in the future, advances in molecular dynamics and computational power will 
enable more accurate modelling of nanoprecipitation. 
 
1.3.2 Nanoparticle Encapsulation Efficiency 
Subashini et al. investigated drug uptake with various polymers using 
molecular dynamics21. Three drugs of varying water solubility were assessed 
with six polymers containing various functional groups. Nanoparticles were 
prepared by placing each drug adjacent to each polymer (decamers or 
hexamers). Topologies were generated by PRODRG whose accuracy has been 
questioned in the past22. Partial charges generated are often inaccurate and 
resulting in incorrect dynamics for small molecules. Simulations were carried 
out in periodic boxes solvated with water for 300 ps. 
Molecular dynamics (MD) is one of the most common computational 
PHWKRGVIRUVLPXODWLQJPROHFXODU LQWHUDFWLRQV1HZWRQ¶VHTXDWLRQVRIPRWLRQ
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are used to calculate forces between particles based on a force field. The force 
field dictates how attractive or repulsive the interactions are based on van der 
Waals and Coulombic forces. Compared with DPD, MD is more computational 
intensive but generally more accurate. However, MD is often limited to small 
systems due to the computational demand. 
An interaction energy for the polymer and drug was calculated based on 
the difference in the total energy of a system containing the polymer and drug 
together and the polymer and drug separately. Hydrogen bonds were also 
calculated between the polymer and drug molecules. Hydrogen bonds showed 
a negative correlation with interaction energy and experimental drug uptake.  
 
Figure 1.4 The chemical structure of Gantrez AN119 (A), Gliclazide (B) and 
Silymarin (C). 
Gantrez AN119 (Figure 1.4A) formed no hydrogen bonds with 
gliclazide (Figure 1.4B)  and silymarin (Figure 1.4C)  yet achieved the highest 
drug uptake. For doxorubicin Gantrez AN119 had the second lowest amount of 
hydrogen bonds with the highest uptake indicating that hydrogen bonds do not 
influence drug uptake by the polymer.  
A 
B C 
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The authors end by correlating drug uptake obtained experimentally 
with interaction energies from their simulations. A positive trend is observed 
indicating that interaction energies between a single drug and a single polymer 
could help predict the compatibility of a drug polymer pairing. 
Luo et al. used MD and DPD to simulate drug loading and release of 
FDPSWRWKHFLQ &37 IURP D SRO\ȕ-amino ester) (PAE) poly(ethyl glycol) 
(PEG) copolymer23 (Figure 1.5). PAE is protonated at low pH to trigger 
disassembly of PAE-PEG nanoparticles. 
 
Figure 1.5 Chemical structures of the molecules involved in this study. Taken 
from Ref23. 
Molecular dynamics simulations were performed on separate binary 
mixtures of protonated and un-protonated PAE, PEG, CPT and water. Potential 
energies were generated from the last 1.5ns of a 5ns molecular dynamics 
simulation. Flory-Huggins parameters were calculated from the potential 
energies of each binary component mixture. The Flory-Huggins parameter 
gives an indication of the miscibility of two components and can be used to 
generate force constants for DPD simulations. 
Mixtures of the polymer with CPT at 10 mg/ml and 1 mg/ml 
respectively were created and simulated in water for up to 1260ns at which 
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point stable polymeric micelles formed. Initially CPT is adsorbed on to 
polymer clusters but after 360ns these clusters grow into bigger micelles where 
CPT is found both in the core and on the surface. Encapsulation efficiencies 
obtained were different from experiment as there was no change in 
encapsulation with a change in drug concentration whilst experimentally a 
decrease was observed. The authors attribute this to the small size of this 
system which is not sufficiently large to directly compare with experimental 
results. 
At an 8 times higher concentration the polymer forms a vesicle with 
CPT loaded into the hydrophobic layer (Figure 1.6). An increase in 
nanoparticle size is also seen experimentally with an increase in CPT 
concentration. However, the increase observed in the simulation is less 
pronounced. Again this is attributed to the insufficient box size which is 
limited due to computational resources. 
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Figure 1.6 Snapshot taken at 900ns into a high concentration simulation of 
PAE-PEG with CPT. A vesicle forms with a hydrophobic layer of PAE (green) 
and hydrophilic PEG (purple). Orange spheres are camptothecin. Taken from 
Ref23. 
To simulate drug release the particle types for PAE were switched to 
those for its protonated form PAEH. In the simulation the micelles swell in size 
and the PAEH chains move out into the surrounding water. This causes release 
of CPT but the dynamics of DPD are accelerated as described previously and 
the 18ns time frame for CPT release observed is therefore not entirely accurate. 
However, DPD simulations still provide an insight into how CPT could be 
released from these particles. 
DPD has also been used by Nie et al. to simulate a four-arm star 
triblock polymer encapsulating doxorubicin24. A star shaped polymer is a 
dendritic polymer designed to improve the stability of micelles formed. The 
SRO\PHU SRO\İ-caprolactone)-b-poly(2-(diethylamino)ethyl methacrylate)-b-
poly(poly-(ethylene glycol) methyl ether methacrylate) (4AS-PCL-b-PDEAE-
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MA-b-PPEGMA)) is also pH sensitive enabling triggered drug release from 
micelles through the protonation of a diethyl amino moiety. 
The polymer was coarse-grained using around 7-8 non-hydrogen atoms 
for each CG particle. Doxorubicin (DOX) was modelled as five separate 
particles of three different types. To simulate a change in pH a protonated 
version of the diethyl amino particle (DEAH) was also generated. The number 
of DEAH particles in the polymer correlated with the overall pH of the system. 
Beads had a volume of 18.2 nm3 (1.63 nm diameter) and their interaction 
parameters were based on solubility parameters generated from molecular 
dynamics simulations. 
 
Figure 1.7 Cross-section views of (a) blank micelle, (b) schematic of blank 
micelle, (c) DOX loaded micelle. PCL (blue), DEA (pink/red), PEG (green). 
Taken from Ref24. 
Simulations in water revealed that the star polymer formed micelles 
after 20,000 steps of simulation. The micelle had a PCL hydrophobic core with 
hydrophilic PEG making up the shell and pH sensitive DEA in the core and 
shell of the micelle (Figure 1.7). When loaded with DOX, the drug is found in 
WKH 3&/ FRUH DQG DOVR LQ WKH ³S+ VHQVLWLYH PHVRVSKHUH´ 7KLV LV XVHIXO DV
protonation of this region should cause rapid release of drug bound here. 
Simulations on blank micelles revealed that protonation of DEA causes this 
block of the polymer to move to the exterior of the micelle and interact with 
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surrounding water. At early stages of protonation i.e. weakly acidic 
environments, the movement of DEAH is less pronounced as the exterior PEG 
shell of the micelle resists. However, the movement of one block of DEAH 
causes a compound effect on the other protonated blocks causing a complete 
rearrangement of the micelle. 
Whilst DEA protonation causes DOX to be exposed to water, none 
leave the micelle during the simulation. The authors claim this is due to a weak 
GLIIXVLRQHIIHFWFDXVHGE\WKH³VWLOOVWDWH´RIWKHDTXHRXVPHGLXP7KHIORZRI
water molecules found experimentally will promote drug release from 
protonated micelles. The release of drug from nanoparticles is typically over a 
much longer time frame than drug loading so this result is expected. 
Alternative techniques must be used in order to analyse drug release from 
nanoparticles such as umbrella sampling. 
Ahmad et al. used coarse-grain molecular dynamics (CGMD) and DPD 
simulations for two separate systems25. The encapsulation of prednisolone, 
paracetamol and isoniazid within poly(lactic acid) (PLA) was performed using 
DPD. Particle interactions for DPD were based on Flory-Huggins interaction 
parameters calculated using the additive group contribution technique. For this 
technique the structure of a molecule is split into simple functional groups and 
each group is assigned a parameter based on its chemistry. For multiple 
molecules in a system, this allows the calculation of thermodynamic properties 
such as solubility. The values obtained through this method were in reasonable 
agreement with existing literature values. 
This study found that an increase in molecular weight of PLA increased 
the encapsulation of prednisolone; however values were different from 
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experimental data. With paracetamol, a less hydrophobic drug, data for an 
increase in drug concentration was in good agreement with experiment. For the 
hydrophilic drug isoniazid encapsulation was expected to be poor with 
hydrophobic PLA. However, the simulation reveals zero encapsulation of 
isoniazid in PLA at low drug concentrations. The authors argue that this may 
be because coarse-graining multiple molecules into single beads makes it 
difficult to observe extremely low drug loading. 
To simulate isoniazid release from PLA the drugs were forced into the 
polymer nanoparticles by adjusting their interaction parameters. Upon 
switching the parameters back, release of the drug from the nanoparticle was 
rapid ~96ns; however experimentally this release occurs over a much longer 
time frame. The authors conclude that DPD is insufficient to model 
encapsulation of water soluble drugs such as isoniazid. Additionally DPD was 
unable to model the properties of their next polymer quaternary ammonium 
palmitoyl glycol chitosan (GCPQ) specifically an ionic functional group. 
GCPQ was instead modelled using MD with the MARTINI CG force 
field. The MARTINI force field models four non-hydrogen atoms as a single 
coarse-grain (CG) bead. The mapping used for DPD is much larger than 4 to 1 
so in theory CGMD is more accurate. 
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Figure 1.8 (A) Snapshot of propofol (yellow/pink) encapsulated within a 
GCPQ micelle. Chitosan (orange), glycol (red), quaternary ammonium (blue), 
palmitoyl (green). Structures of GCPQ (B) and propofol (C) with circles 
designating the atoms that make up the CG beads used in the model. Taken 
from Ref25. 
Micelles of eight GCPQ chains formed with a hydrophobic core of 
palmitoyl and ethylene glycol/quaternary ammonium groups at the surface. 
After the formation of the micelles, propofol molecules were introduced to the 
simulation to observe their encapsulation by the micelles. Experimentally 
encapsulation is done via probe sonication in water. Propofol partitions 
between the hydrophilic surface and hydrophobic core. This presumably due to 
hydrogen bonding between the hydroxyl group of propofol and the chitosan 
groups on GCPQ (Figure 1.8). A smaller micelle of GCPQ encapsulated more 
propofol than a larger one. Both of these findings and the encapsulation 
efficiency of the micelles was in agreement with experimental data. 
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This work shows that CGMD using the MARTINI force field is a more 
accurate technique for simulating polymer-based drug delivery systems than 
DPD. Whilst DPD showed disparity with experimental data, CGMD was able 
to confirm several experimental results. This could be due to the method of 
parameterisation (through the group contribution method) and/or a loss in 
accuracy due to modelling several molecules as a single bead with DPD. 
Woodhead et al. used a different method to simulate drug encapsulation 
in block copolymers26. Discontinuous molecular dynamics (DMD) involves 
modelling particle interactions using square-well potentials instead of Lennard-
Jones potentials. This removes the need for discrete time steps and saves 
computational time, allowing the simulation of large systems over long time 
periods. The copolymer is dived into 12 spheres (4 solvent-phobic and 8 
solvent-philic). Drug and solvent molecules were modelled as single spheres. 
As with previous studies on modelling polymer-drug encapsulation, the solute 
and polymer volume fraction used was higher than experimental values to save 
computational time. The authors claim that simulations with smaller volume 
fractions took too long to equilibrate presumably due to a lack of interactions 
between the molecules in the system. 
An increase in polymer volume fraction was found to increase solute 
encapsulation efficiency due to an increase in the number of micelles in the 
system. By increasing the polymer-polymer interactions in the model the 
encapsulation efficiency decreased and in addition the number of surface 
bound solute particles increased. This is due to polymer-polymer interactions 
creating a barrier blocking solute entry into the core of the micelles. 
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In agreement with a study by Kumar and Prud-homme on the 
thermodynamics of drug encapsulation into micelles27, the authors found that 
as drug loading increases, the free energy required to load a drug into the 
nanoparticle increases. This result explains why it is challenging to attain high 
levels of encapsulation efficiency into polymer nanoparticles. 
 
 
Figure 1.9 Solute encapsulation is measured over time for pre-assembled 
micelles and micelles that form in co-association with solute. The interaction 
between polymer solvent-SKRELFKHDGSDUWLFOHVİhh) was set at 1.2 and 1.5 for 
comparison purposes. Taken from Ref26. 
Interestingly this study also explores differences in loading solute into 
micelles as they form as opposed to pre-formed micelles. Previous simulations 
were run on pre-formed micelles, when solute was introduced as the micelles 
formed there was no difference in the results obtained for encapsulation 
efficiency with an increase in polymer-polymer interactions. However, when 
solute encapsulation was measured over time at two different polymer-polymer 
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interaction values, pre-formed micelles were able to encapsulate more solute 
than micelles that formed in the presence of the solute (Figure 1.9). 
With strong polymer-polymer interactions the barrier for solute entry 
into the micelles is high so solute encapsulation is low. With weaker polymer-
polymer interactions the environment provided by the micelle is favourable for 
the solute and so encapsulation is high. When the micelles are still forming 
solute encapsulation is lower because this environment does not yet exist for 
the solute. 
This result is very important when considering other literature in this 
field that does not consider the formation of polymer nanoparticles when 
analysing drug encapsulation efficiency23,24. The formation of nanoparticles 
may play an important role in the encapsulation of a solute for a variety of 
reasons. By simulating drug encapsulation into pre-formed particles you may 
miss significant interactions between the solute and polymer. 
In conclusion the authors suggest that to increase encapsulation 
efficiency within polymer nanoparticles a decrease in the polymer 
hydrophobicity may be required. Nanoparticles formed with drug mainly 
bound to the surface of the particle have poor release profiles and this may be 
due to strong hydrophobic interactions between polymer chains. 
Loverde et al. explored the effects of nanoparticle shape on delivery 
using CGMD28. Worm-like nanocarriers have been shown to increase the 
amount of drug delivered to tumours over spherical micelles. The aim of this 
study was to simulate the loading of Taxol (paclitaxel) into worm-like and 
spherical micelles. 
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Figure 1.10 Snapshot of a worm-like micelle. Part of the micelle is sectioned to 
reveal the internal structure. Taken from Ref28. 
The CG topologies for the polymer and drug were based on atomistic 
simulations. Both worm and spherical micelles form in water, with Taxol 
encapsulated at the interface between the hydrophobic PCL core and 
hydrophilic PEG shell. The free energy profile for Taxol was calculated from 
the core of the micelle to the exterior. The free energy calculated was lower for 
the worm micelle compared with a spherical one. Taxol interacts strongly with 
the PEG chains of the micelle as a drop in the free energy profile occurs when 
Taxol enters the shell of the micelle. 
The authors were also able to match an experimental phase diagram for 
the polymer nanostructures with their simulations. The transition from bilayer 
to worm to sphere is due to a change in the hydrophilic fraction of the 
copolymer. 
Long simulations approaching µs were able to demonstrate that worm 
micelles, containing Taxol at experimental encapsulation levels, were stable. 
Whilst Taxol aggregates in water due to its insolubility, in the PCL core of the 
micelle it is more soluble. However, increases in the loading of Taxol shift the 
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drug to the interface between the PCL core and PEG shell increasing the burst 
release of drug from the micelle. 
This is in agreement with the previous study as increased loading into 
these micelles appears to have a detrimental effect. Experimentally the goal is 
to achieve the highest loading possible, yet the results from modelling and 
thermodynamic calculations reveal that a) it may not be possible and b) it may 
not be desirable. 
Tanis et al. were able to use fully atomistic MD to simulate ibuprofen 
interactions with a third-generation poly(amidoamine) dendrimer29. 
Experimentally the maximum number of drug molecules per dendrimer did not 
exceed the number of primary amine groups on the dendrimer, 32. Models 
were created to replicate these experimental conditions including dendrimers 
with 4 different protonation states to mimic changes in pH. 
At basic and neutral pH, density distributions from the centre of mass 
of the dendrimer show that ibuprofen binds throughout the dendrimer. In acidic 
conditions there is no stable drug/dendrimer complex formed, consistent with 
experimental data. When the drug is ionized it is predominately found at the 
surface of the dendrimer in contact with surrounding counter ions. The 
simulations also confirmed that the number of primary amines corresponds to 
the number of ibuprofen molecules bound at pH above the pKa of 4.9. 
Analysis of hydrogen bonds via radial distribution function (RDF) 
revealed that ibuprofen forms H-bonds with the dendrimers amine/amide at 
basic/neutral pH respectively. This result is consistent with the previous 
observation that ibuprofen binds throughout the dendrimer at this pH range as 
amine/amide groups are present at all generation shells in the dendrimer. A 
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lack of H-bonds between the polymer and ionized ibuprofen suggests that an 
alternative interaction causes drug encapsulation at higher pH. Hydrophobic 
interactions were ruled out due the presence of drug at the exterior of the 
molecule not the hydrophobic interior. It is assumed that electrostatic pairing 
between the two molecules is a possible reason for drug encapsulation. 
 
1.3.3 Single Drug Interactions 
Patel et al. looked at nonpolar and polar interaction between PEO-b-
PCL and the hydrophobic chemotherapeutic cucurbitacin30. MD was used to 
calculate Flory-Huggins interaction parameters for binary mixtures of the drug 
with different ratio block copolymers. Simulations involved single drug 
molecules with single polymer chains (3750 Da in size). 
With an increase in the PCL/PEO ratio the Flory-Huggins interaction 
parameter for the drug decreased. This indicates an increase in solubility of the 
drug with the polymer in agreement with experimental data. The total non-
bonded energy for the drug decreases considerably when the PCL/PEO ratio 
increases indicating increased stability via non-bonded interactions. 
Additionally the number of hydrogen bonds increases as the PCL/PEO ratio 
increases. This is due to the majority of hydrogen bonds forming with the PCL 
block of the polymer. 
 
Figure 1.11 Chemical structures of (A) Curcubitacin B and (B) Curcubitacin I. 
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Experimentally the release rate of cucurbitacin B from PEO-b-PCL is 
slower than with curcubitacin I (Figure 1.11). H-bond analysis revealed that 
there is a more substantial increase in H-bonds for CuB with an increase in 
PCL/PEO ratio than for CuI. This may explain the experimental results. 
However, this study is in contrast to the work described previously by 
Subashini et al. on Gantrez AN119. They found that hydrogen bonds had no 
role in increasing drug encapsulation with various polymers. On the contrary 
an increase in hydrogen bonds showed a decrease in encapsulation efficiency 
for the drugs tested. Both these results indicate that any data on H-bonds must 
be carefully construed and additional polymer-drug interactions must be 
considered before using H-bond analysis to interpret experimental data. 
Costache et al. used a combination of MD and docking calculations to 
predict polymer-drug interactions in tyrosine derived triblock copolymer 
nanospheres31. Docking calculations normally used for small molecular 
interactions in protein binding sites are difficult to use for polymers due to their 
dynamic nature and lack of obvious binding sites. 
The triblock polymer is of the ABA form with A-blocks of PEG at the 
exterior of the nanospheres and B-blocks of desaminotyrosyl-tyrosine octyl 
esters (DTO) in the core. Four drugs were analysed: curcumin, paclitaxel, 
vitamin D3 and camptothecin (CPT). CPT in particular showed poor loading 
with the nanospheres which the authors were interested in exploring 
computationally. 
Polymers used were half the length of those used experimentally due to 
computational limitations. Nanospheres of four polymer chains were formed in 
water in the absence of drug molecules. Nanospheres formed were an order of 
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magnitude smaller than those formed experimentally. Chains of the polymer 
were placed close to each other and left to aggregate. 
Only the hydrophobic DTO core of the nanospheres was used for 
docking to save computational time. It was assumed (and confirmed by 
simulation) that the hydrophobic B-blocks were mainly involved in drug 
interactions. Blind docking was applied to the entire core of the nanospheres as 
no specific binding site was known. 
The most hydrophobic drug vitamin D3 showed the highest binding 
affinity. Overall the binding affinities generated for the three drug molecules 
were in agreement with an experimental trend in drug loading. Interestingly, 
the AlogP values for paclitaxel and curcumin were similar (3.2 and 3.6 
respectively) but their binding affinities and drug loading differed. This 
suggests that for this drug polymer pairing, drug hydrophobicity is not 
indicative of its potential drug loading. 
The increased binding affinity for curcumin over paclitaxel was 
explained through analysis of the lowest energy docking conformations. 
&XUFXPLQ¶V VWUXFWXUH DOORZV IRU LGHDO DOLJQPHQWZLWK WKH'72EORFNV LQ WKH 
SRO\PHUZKLOVWSDFOLWD[HO IRUPHG OHVVʌ-ʌVWDFNLQJ LQWHUDFWLRQV DQGK\GURJHQ
ERQGV'HVSLWHKDYLQJQRʌ-ʌLQWHUDFWLRQVDQGDVLQJOHK\GURJHQERQGYLWDPLQ
D3 showed the highest binding affinity possibly due to its high flexibility 
allowing it to form multiple hydrophobic interactions with the polymer. 
Paclitaxel is far less flexible and this may also contribute to its low binding 
affinity (Figure 1.12). 
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Figure 1.12 Chemical structures of curcumin (A), paclitaxel (B) and Vitamin 
D3 (C). 
These results may help explain the previous dilemma with a correlation 
between hydrogen bonds and encapsulation efficiency. Whilst hydrogen bonds 
may not be necessary for encapsulation, the flexibility of a drug molecule 
appears to be an important factor. 
Camptothecin (CPT), another rigid mildly hydrophobic drug, showed 
poor encapsulation experimentally yet the docking calculations showed high 
binding affinity. This result is explained in terms of how their methodology 
ZRUNV&37SUHIHUUHGDSDUWLFXODU³KRWVSRW´RQWKH'72SRO\PHUDQGLQWKLV
position affinity was high. The authors speculate that once this hot spot is 
occupied then the binding affinity for CPT would decrease drastically. 
For this study docking studies were in good agreement with an 
experimental trend for three of the four drugs tested. The results for CPT 
revealed that simple binding affinities are not always indicative of 
experimental encapsulation efficiencies. To improve this docking technique a 
scoring function could improve its ability to screen multiple drug molecules. 
Refinement of the technique with a larger data set is suggested. 
Maiti et al. also used docking in a study using a pH sensitive 
poly(amidoamine) (PAMAM) dendrimer32. The docking and release of four 
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drug molecules; salicylic acid (Sal), L-alanine (Ala), primidone (Prim) and 
phenylbutazone (Pbz) was investigated. Drugs were first blind docked into the 
centre of the dendrimers. The drug molecules were then pulled away from the 
centre of mass of the dendrimer using steered molecular dynamics.  Steered 
MD involves applying a force to the drug molecule pulling it away from the 
polymer over a specified vector. Umbrella sampling is performed at several 
windows along this vector for each drug. The weighted histogram analysis 
method19 (WHAM) was used to calculate a potential of mean force (PMF) 
from the umbrella sampling simulations. 
 
Figure 1.13 PMFs calculated over a distance from the dendrimer centre of 
mass. PAMAM dendrimer (G5), G5NP (PAMAM non-protonated). Taken 
from Ref32. 
For the protonated dendrimers (G5), soluble Sal and Ala showed the 
lowest free energy barrier when compared with insoluble Pbz and Prim Figure 
1.13). Ala shows the lowest barrier indicating it will be released form the 
dendrimer with the most ease. Experimental data suggests that electrostatic 
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interactions drive encapsulation of drugs within the dendrimer core. For the 
hydrophobic drugs Pbz and Prim, Pbz has a negative charge forming 
electrostatic interactions with the dendrimer core. This results in Pbz having a 
significantly higher energy barrier than Prim although both are relatively 
hydrophobic. 
The low free energy barrier for Ala and Sal not only suggests that drug 
is released easily from the dendrimer but also that drug loading would be 
relatively common in solution. However, experimentally there is low 
encapsulation efficiency with these drug molecules. This is due to a lack of 
nonpolar groups in their structures making fewer hydrophobic van der Waals 
interactions with the polymer. Stronger nonpolar interactions for Prim and Pbz 
increase their energy barrier and encapsulation within the dendrimer. 
Hydrogen bonds between the drug and polymer were also calculated. 
There was no correlation between number of hydrogen bonds and an increase 
in the free energy barrier for release. Ala forms the most hydrogen bonds but 
has the lowest free energy barrier. 
Non-protonated forms of the pH sensitive dendrimer were also tested 
(G5NP). A substantial decrease in the free energy barrier for both Sal and Pbz 
is seen when the dendrimer is non-protonated. This result suggests that release 
of Pbz can occur easily upon deprotonation of the dendrimer due to the 
decrease in the free energy barrier for release. 
As this case is also true for salicylic acid the authors speculate that drug 
loading into dendrimers will be difficult at low pH values when the polymer is 
protonated. Protonation of the dendrimer decreases its electrostatic interactions 
with the ligands resulting in a decrease in the free energy barrier. Therefore the 
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authors suggest that encapsulation in PAMAM dendrimers should be carried 
out at high pH values. When the drug complex enters the blood stream the 
reduction in pH will causes strong binding between the polymer and drug 
causing controlled release of the drug. 
This study reveals that both docking and umbrella sampling are valid 
methods to analyse polymer drug interactions. Drug release rates are often non-
trivial to calculate through conventional molecular dynamics simulations due 
to the lengthy time scales required. Umbrella sampling allows fast and accurate 
analysis of free energy barriers which give an indication of drug release rates. 
Samanta et al. analysed the interactions of a single curcumin molecule 
with a PEO-PPO-PEO block copolymer33. The topology of curcumin was 
parameterised in water, methanol and 1-octanol. Curcumin was simulated in 
the presence of monomers of PEO and PPO (DME and DMP respectively). 
The drug formed stronger interactions with the more hydrophobic DMP 
monomer over DME. In the presence of a single polymer chain, again 
curcumin interacted favourably with the hydrophobic PPO section of the 
polymer. 
Fluorescence emission spectra on PEO-PPO-PEO micelles indicated 
that curcumin is encapsulated within the hydrophobic core. In a simulation of a 
single curcumin molecule with eight polymer chains, curcumin is encapsulated 
within an aggregate of only four polymer chains. The spatial distribution of 
PEO and PPO around curcumin is shown in Figure 1.14. Hydrophobic PPO 
makes more contact with the drug molecule than hydrophilic PEO. Whilst 
these interactions are not in a micelle, the authors hypothesise that this drug-
polymer aggregate could be the first step towards forming a larger micelle. 
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Whilst this work offers an insight into how these molecules interact, the 
simulation is far from experimental concentrations. Without including all the 
reagents at relevant concentrations that are present when preparing these 
delivery systems experimentally the results of these simulations may not be 
particularly relevant. However, computational resources are a big limitation to 
larger scale simulation as such fully atomistic simulations may not be ideal. 
 
 
Figure 1.14 The spatial distribution of PEO (blue) and PPO (green) around 
curcumin is calculated. Taken from Ref33. 
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1.4 Multiscale Modelling 
When modelling polymer-based drug delivery systems the use of a 
mesoscale model is commonplace in addition to using concentrations that are 
greater than those used experimentally. To model even a single nanoparticle 
several simplifications must be made. 
Rossi et al. described an atomic simulation of polymeric material alone 
UHTXLULQJ³VLPXODWLRQVRIWHQVRUKXQGUHds of microseconds and a length scale 
RI WHQV RI QDQRPHWHUV´34. These simulations are only feasible on the most 
powerful supercomputers in the world. As such it is necessary to simplify a 
model whilst minimising the loss in accuracy of polymer-drug interactions. 
 
Figure 1.15 A summary of mesoscale simulations; atomistic being the most 
accurate and DPD the most simplistic yet fastest. Taken from Ref35. 
Mesoscale methods (Figure 1.15) allow the simulation of large systems 
of multiple polymer chains. This is useful as they come closer to simulating 
realistic events. However, coarse-grain (CG) models lack atomistic detail; as 
such they a) limit our ability to draw on our understanding of the basic 
chemistry of intermolecular interactions to explain and predict behaviour and 
b) limit the metrics that can be extracted from such simulations for comparison 
with experimental observables, such as spectroscopic properties. 
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Ideally a computational model will use an accurate all-atom (AA) force 
field for key interactions and sacrifice accuracy by using a CG force field for 
less important interactions in the simulation. For nanoparticle simulations this 
allows the simulation of larger systems with detailed interactions between the 
polymer and drug molecules. 
One example of a multiscale model is the adaptive resolution scheme 
QDPHG$G5HV6IURP.XUW.UHPHU¶VJURXS36. This permits the use of two force 
fields by having a transition region whereby molecules passing through this 
region are converted from atomistic to coarse-grain molecules and vice versa. 
For example atomistic water can reside in the middle of a simulation box and 
water interacts using an atomistic force field. However, when a molecule drifts 
away from the centre of the box it passes through the transition region where 
its CG representation is gradually enabled and its AA representation is 
disabled. This allows it to interact with CG water already present in the 
periphery of the box (Figure 1.16). 
Overall this allows the use of a CG model for the less significant parts 
of the system whilst retaining high accuracy atomistic interactions at the centre. 
This multiscale approach is not unlike the quantum mechanics/molecular 
mechanics (QM/MM) multiscale models originally developed by Warshel and 
Levitt in 197637 for which they won the Nobel Prize in 2013 with Martin 
Karplus17. 
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Figure 1.16 A diagram showing how AdResS (adaptive resolution scheme) 
works. Water is shown in its CG and AA representations at the top. In the 
middle and at the ends are transition regions where the CG and AA 
representations interchange. Taken from Ref36. 
The downside is that these schemes are tricky to implement and for 
water a 1:1 mapping is required for the AA to CG transition. As such the speed 
up obtained is not as significant as if a 4:1 water mapping was used such as in 
the MARTINI CG force field. However, a 4:1 mapping is not possible using 
AdResS as it would require constraining four water molecules to a single CG 
bead. 
Another multiscale model was developed in 2011 by Rzepiela et al.38 
Their technique involved combining CG and AA force fields in the same 
simulation without using an adaptive scheme. Using GROMACS, CG virtual 
sites on atomistic molecules enable CG interactions with CG particles using a 
CG force field. AA molecules are still free to interact with each other using the 
GROMOS96 AA force field. 
They assessed multiple CG force fields, some of which were based 
upon atomistic simulations using force matching and iterative Boltzmann 
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inversion. These techniques allow the conversion of atomistic dynamics into 
potentials for CG interactions. Overall the study found the MARTINI CG force 
field to be the superior force field for their system of liquid butane (Figure 
1.17). 
 
 
Figure 1.17 Atomistic butane (yellow) has CG virtual sites (red) to allow it to 
interact with the surrounding CG butane molecules (grey). Taken from Ref38. 
More recently this multiscale force field was used to simulate more 
complex molecules. Wassenaar et al. described the simulation of ubiquitin and 
D WUDQVPHPEUDQH Į±helix using a mixture of the GROMOS and MARTINI 
force fields39. They compared their multiscale simulations to atomistic 
simulations and found that the multiscale force field was acceptable for apolar 
side chains, more so than polar ones. This is due to a difficulty in simulating 
electrostatic interactions using a mixture of these two force fields. The CG 
force field lacks detailed polar interactions and as such was unable to 
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reproduce a potential of mean force similar to the one observed using that 
atomistic force field with single point charge water. They discuss how the 
relative dielectric permittivity in GROMACS must be adjusted to maintain the 
correct strength of electrostatic interactions for the molecules in the simulation. 
For a polymer system these polar interactions found with protein side 
chains are often not present. Overall most polymer chains are often neutral 
making them more appropriate candidates for use with this multiscale force 
field. 
 
1.5 Poly(glycerol adipate) 
The theoretical work that will be explored in this thesis is based upon 
experimental work performed over the past ten years on poly(glycerol adipate) 
(PGA) and its derivatives. The data from this work has influenced the design of 
the computational models outlined in this thesis. Therefore it is prudent that 
this work is discussed in detail before the theoretical work is discussed. 
In 2005 Kallinteri et al. published a method to synthesise poly(glycerol 
adipate) (PGA), a hydrolysable polyester containing pendant hydroxyl groups 
for functionalisation12. The aim was to design a polymer that was non-toxic, 
did not require surfactants for nanoparticle formation and showed high drug 
incorporation levels. This polymer is also readily functionalised allowing a 
plethora of derivatives to be created with a variety of physicochemical 
properties and thus the potential to improve encapsulation efficiency and drug 
loading.  These possibilities were investigated with the drug dexamethasone 
phosphate (DXMP). DXMP was chosen due to its multiple side effects that 
could be alleviated via targeted delivery in a nanoparticle. Additionally the 
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steroid ring on DXMP is lipophilic and could show strong interactions with a 
hydrophobic polymer. 
Nanoprecipitation was used to prepare nanoparticles of size 150-250nm 
in the absence of surfactant. When prepared in the presence of DXMP the 
particle size increased up to 300nm. The zeta potential of the particles also 
increased indicating that the surface of the particles was more charged with 
drug bound. 
 
Figure 1.18 Chemical structures of PGA and two functionalised PGA 
polymers. The structure of the chemotherapeutic DXMP is also shown. 
PGA was made in three sizes 2, 6 and 12 kDa and functionalised 40, 80 
and 100% with a C8 or C18 acyl chain on the pendant hydroxyl group. A 6 
kDa polymer corresponds to a degree of polymerisation of 30 for PGA (Figure 
1.18). For both C8PGA and C18PGA an increase in molecular weight showed 
an increase in encapsulation efficiency. For C8-PGA as acylation was 
increased the encapsulation efficiency of DXMP also increased, with a large 
increase from 80 to 100% acylation. However, for C18-PGA, encapsulation 
efficiency increased until 80% acylation for 6 and 12 kDa polymers. At 100% 
acylation for C18-PGA a sharp decrease in encapsulation efficiency was seen 
(Figure 1.19). The authors suggested that this decrease was due to a lack of 
Dexamethasone phosphate (DXMP) 
Poly(glycerol adipate) (PGA100) 
 
R = H 
PGA20-co-C18PGA80 
 
(80%) R = 
C18PGA100 
 
(100%) R = 
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aqueous space for the drug within the nanoparticles or decreased interactions 
with DXMP due to a lack of free hydroxyl groups on the 100% acylated 
polymer.  
 
Figure 1.19 Effect of % acylation and PGA backbone molecular weight on 
DXMP encapsulation efficiency for a C18 acyl chain. Taken from Ref12. 
Whilst an increase in acylation increased the encapsulation efficiency 
of PGA it can impair its ability to form nanoparticles. For PGA20-co-C8PGA80 
(2, 6 and 12 kDa) and C18PGA100 (2 kDa) polymers could not form particles 
and PGA20-co-C18PGA80 (12 kDa) was also unable to form particles instead 
forming an aggregate on the walls of the stirred vessel. The authors speculate 
that this is due to a lack of hydroxyl groups reducing the stabilization of the 
particles promoting aggregation. However, some of these polymers could form 
particles in the presence of DXMP. C18PGA100 was able to form particles with 
DXMP at all three molecular weights. This may be due to the high lipophilicity 
Peak 
Polymer 
M. W. 
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of these polymers promoting particle formation with DXMP stabilising the 
structure. 
They conclude that with PGA20-co-C8PGA80 (6kDa) they were able to 
achieve a high encapsulation efficiency compared with other polyesters in the 
literature. 
Puri et al. published further work on PGA nanoparticles with DXMP 
and another water soluble chemotherapeutic, cytarabine (CYT)11. Similar 
polymers were used to make particles as in the previous paper. A decrease in 
particle size was seen upon loading of either CYT or DXMP into PGA or 
C8PGA nanoparticles. It is hypothesised that this may be due to a change in the 
aggregation number of polymer molecules or an increased density due to the 
presence of drug in the particles. 
Particles made with CYT were generally larger in diameter than those 
with DXMP which again could be attributed to stronger interactions with 
DXMP increasing the density of the particles. An increase of 6 mV in the zeta 
potential was observed only for DXMP not CYT presumably due to the 
negative charge on the phosphate group of DXMP. 
The length of the acyl chain on PGA was varied to see its effect on drug 
incorporation. From C2 to C6 there was insufficient polymer hydrophobicity 
whilst C8 was sufficient. At C10 uncontrolled aggregation of the polymer 
occurred resulting in C8PGA being used for this study. Aggregation was also 
seen by Kallinteri et al. for some highly acylated polymers. 
For C8PGA the drug loading and encapsulation efficiency was greater 
for DXMP than for CYT at all acylation percentages. However, with PGA 
backbone there was no difference between the two polymers. The authors 
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surmise that the increased hydrophobicity of C8PGA over PGA alone increases 
the drug loading with DXMP due to its lipophilic steroid ring. Highly polar 
CYT is unable to make strong interactions with the acyl chains on C8PGA as 
such shows low encapsulation efficiency. In agreement with the previous 
paper, an increase was seen in both loading and encapsulation efficiency for a 
12 kDa polymer backbone over 2 and 6 kDa polymers. 
Analysis of drug release revealed that for DXMP an increase in 
acylation decreased the release rate. For C8PGA100 drug was steadily released 
over 15 days up to a cumulative release of ~70%. PGA backbone showed a 
burst release of the drug with ~40% release at a rate indicating that it was 
essentially unbound to the particles. (Figure 1.20). 
 
Figure 1.20 DXMP release from PGA polymers at various acylation % at 37oC 
in water over 25 days. Taken from Ref11. 
For CYT 100% acylation showed burst release comparable to free drug. 
PGA backbone and low acylation PGA showed a more controlled release of 
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CYTA over the 25 days tested. However, around 50% of the release occurred 
over the first few days for these polymers. The difference in loading and 
release for these two drugs is interesting given their water solubility at 300 
mg/ml for CYT and 500 mg/ml for DXMP. 
It is surmised that high drug loading can be indicative of a fast drug 
release rate due to drug predominately being bound at the surface of the 
particles. This is not the case for PGA with DXMP as high acylation % not 
only yielded high drug loading and encapsulation efficiency but also the 
superlative drug release profile. However, this result is likely unique to this 
drug-polymer combination. 
Orafai et al. took a different approach to analysing the encapsulation 
efficiency of PGA using contact angles29 (Figure 1.21). A polymer film is 
created on the surface of a microscope slide and liquids are dropped on to the 
surface. The contact angle the liquid makes with the surface enables surface 
free energies to be calculated. Contact angles have the advantage of being able 
to test several polymers in quick succession. 
Surface free energy is the sum of several parameters including London 
dispersion forces and Keesom polar forces. Identical surface free energies may 
differ in their parameters. For this study diiodomethane and water were 
employed for their differences in polarity and potentially the parameters that 
make up their surface free energies. 
 
67 
 
 
Figure 1.21 A contact angle can be measure for a drop of solvent on a surface 
coated with polymer. Taken from Ref40. 
For the polar solvent water, the contact angle increased with increasing 
acylation up to 40% presumably due to the increase in hydrophobicity. 100% 
acylation showed a decrease in contact angle from ~70o to ~56o. For 
Diiodomethane contact angles were more varied but 40% acylation showed the 
largest contact angle. The total surface free energies calculated were lowest for 
PGA60-co-C8PGA40 leading them to conclude that it is the best candidate for 
nanoparticle formulations. PGA60-co-C8PGA40 also showed the lowest 
dispersion force around half of that calculated for the other polymers. Whilst 
its Keesom polar forces are comparable to C8PGA100 the low dispersion forces 
give PGA60-co-C8PGA40 the lowest total surface free energy. 
2UDIDL¶V UHVXOWVDUH LQ DJUHHPHQWZLWKSUHYLRXVZRUNRQ3*$:KLOVW
an increase in acylation does increase the affinity of PGA for other molecules, 
full acylation of the polymer can have a detrimental effect on its interaction 
with other molecules. We will explore how acylation of PGA affects drug 
interactions using molecular dynamics later on in this thesis. 
Tawfeek et al. synthesised PGA pentadecalactone (PGA-co-PDL) 
microparticles through spraydrying41. PGA-co-PDL is a block copolymer and 
differs from the structure of the PGA derivatives described previously as PDL 
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is added as a separate block not onto the pendant hydroxyl groups of PGA. 
However, the addition of PDL to PGA increases the polymers hydrophobicity 
in a similar way to the addition of acyl chains to PGA. Additionally arginine 
and leucine were incorporated into the microparticles to increase drug loading 
and encapsulation efficiency with the hydrophilic drug sodium fluorescein. 
PGA-co-PDL with 1.5% arginine showed the highest encapsulation 
efficiency and loading. Although loading and encapsulation for all polymers 
tested was low presumably due to the hydrophilic nature of sodium fluorescein 
not being compatible with the hydrophobic polymer. However, PGA-co-PDL 
1.5% Leu was chosen for release studies due to its optimal aerosolisation 
performance. When compared with PGA-co-PDL alone, the presence of 
leucine reduced the cumulative release of sodium fluorescein over time. When 
compared with PLGA, PGA-co-PDL showed a more controlled release of the 
drug over the first 10 hours tested. 
It is unfortunate that this study did not consider variable sizes of the 
PDL block in the copolymer. However, they did reveal that the addition of the 
amino acid leucine or arginine increased the polymers affinity for a hydrophilic 
drug. There is potential to incorporate amino acids into PGA nanoparticles to 
also increase their encapsulation efficiency and drug loading for hydrophilic 
drugs such as cytarabine. 
 
1.6 Thesis Aims 
The main aim of this work is to recreate nanoprecipitation in a 
computer. A computational model has several advantages; a) changes to the 
polymer can be made with great precision, b) one gains atomistic detail of how 
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all of the molecules behave during nanoparticle formation, c) detailed metrics 
can be used to analyse these interactions in more detail. 
As a test case the chemotherapeutic dexamethasone phosphate (DXMP) 
and polymers based on poly(glycerol adipate) (PGA) are used as there is a 
large amount of experimental data on these molecules11,12. This experimental 
data will be used to check the accuracy of the simulations and will serve as a 
reference that the simulations will attempt to replicate. By keeping 
concentrations and simulation components as similar as possible to 
experimental conditions we hope to mimic the experimental data. 
This thesis will be a story of the design and creation of a multiscale 
model to simulate polymer nanoprecipitation. Different models are described 
and the decision to use a multiscale model using CG virtual sites is explained. 
To confirm the accuracy of the multiscale model, resolution 
transformation is be used to generate atomistic reference simulations for 
comparison. Additionally a fully atomistic model of nanoprecipitation is 
analysed and this is used to further optimise the multiscale force field. 
Once optimised, the multiscale nanoprecipitation simulations are 
analysed in detail to get a better understanding of the experimental results. 
These insights will aid in not only the design of future polymer-based drug 
delivery systems, but how functionalization of PGA affects its interaction with 
DXMP in general. 
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Chapter 2 
Methodology 
 
 Whilst the results of this thesis are purely theoretical, polymer synthesis 
and nanoparticle preparation was also performed. The design and synthesis of 
PGA and its functionalised derivatives has relevance for understanding the 
overall approach to this work. PGA is a highly tuneable polymer, but we will 
only explore one type of functionalisation. Nevertheless, the modelling 
approach is in theory applicable to any type of polymer-based drug delivery 
system. 
 
2.1 Experimental Work 
2.1.1 Polymer Synthesis 
Poly(glycerol adipate) (PGA) was prepared in batches as per Kallinteri 
et al.12 The method is based on the enzyme-catalysed poly-condensation 
reaction between glycerol and divinyl adipate (Figure 2.22). A dry 250mL 
round bottomed flask was charged with divinyl adipate (9.91g, 0.05mol), 
glycerol (4.6g, 0.05mol) and 15 mL THF. The reactants were stirred for 30 
minutes to equilibrate at 50oC. Novozyme 435 (1g) was then added to the 
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mixture and then stirred for 24 hours at 200rpm with a mechanical stirrer. An 
open top condenser was fitted to enable release of acetaldehyde during the 
reaction. 
 
Figure 2.22 Synthesis of PGA by poly-condensation reaction of glycerol and 
divinyl adipate. 
The product was filtered to remove the enzyme (which was fixed to a 
resin) and washed with more THF. A rotary evaporator (80 oC) and 
subsequently a vacuum oven (100 oC) were used to remove any excess solvent. 
The polymer was analysed by GPC and it revealed a highly poly-
disperse polymer (PD = 26.15). Whilst this value was large for this batch, 
subsequent batches made of PGA in the laboratory were closer to a PD of 4-6. 
The peak Mw measured by GPC was nearly 9kDa and this is roughly 
equivalent to a 45 unit polymer (or 45mer). This value varies between batches 
with the largest in length being 50-60mers. 
PGA can be functionalised with various pendant groups. One example 
is the addition of a stearate chain via an acid chloride reaction (Figure 2.24). 
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Functionalisation occurs randomly throughout the polymer to form a random 
copolymer. 
 
Figure 2.23  GPC plot showing a highly poly disperse polymer with a Mw of 
nearly 9kDa. This polymer was used for the nanoprecipitation experiments. 
 
Figure 2.24 Functionalisation of PGA with a stearate chain via an acid chloride 
reaction. 
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Polymeric nanoparticles were prepared from the dry polymer using 
nanoprecipitation (interfacial deposition)1. Polymer dissolved in acetone 
(10mg/mL) was added drop-wise to 7mL of water under constant stirring to 
obtain nanoparticles. To encapsulate DXMP in the nanoparticles, drug was 
dissolved in the water at 5mg/mL.  
 
Figure 2.25 In nanoprecipitation polymer dissolved in acetone is added drop-
wise to water containing hydrophilic drug molecules. 
2.1.2 Polymer Designations 
The unmodified polymer is designated simply as PGA100. Acylation of 
the pendant hydroxyl group with stearyl moieties is designated by C18PGA 
with a subscript to denote the percentage of monomers modified. For example 
PGA20-b-C18PGA80 is PGA with 80% of the monomers modified with the C18 
acyl chain. 
 
Acetone + Polymer 
Water + Drug 
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2.2 Theoretical Work 
2.2.1 Molecular Dynamics 
Molecular dynamics (MD) is a technique used to simulate molecules 
and theiU LQWHUDFWLRQV $ FRPSXWHU LV XVHG WR VROYH 1HZWRQ¶V HTXDWLRQV RI
motion for a system of interacting atoms. Forces on a single atom are computed 
from the negative derivate of the interaction potential with every neighbouring 
atom (Equation 2.1). This process is iterative and forces are computed in time 
steps usually around 1-2 femtoseconds. 
                                                      ? ൌ െ ? ?ሺ ?ሻ               (2.1) 
A leap-frog algorithm is used to accelerate the atoms by integrating 
equations of motion depending on the positions of the atoms at time t and 
velocities at time  ? െଵଶ ? ?. This algorithm is time reversible meaning you can 
reverse the direction of the integration to arrive at the starting position of the 
atoms. 
                                    ? ቀ ? ൅ଵଶ ? ?ቁ ൌ  ? ቀ ? െଵଶ ? ?ቁ ൅ ௱௧௠  ?ሺ ?ሻ            (2.2) 
                                     ?ሺ ? ൅  ? ?ሻ ൌ  ?ሺ ?ሻ ൅  ? ? ? ቀ ? ൅ଵଶ ? ?ቁ                        (2.3) 
At user-chosen time intervals, the position and velocity of the atoms are 
written to a trajectory file which can be read by the user to observe the 
dynamics of the molecules over the simulation. If the potential energy surface 
is accurate then this enables a detailed observation of how molecules interact. 
The time taken to compute the forces at each time step is dependent on 
the size of the simulation. Larger simulations require more powerful computers 
and so currently molecular dynamics is limited based on the computational 
power available. 
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Whilst MD has been very fruitful in scientific research, it has several 
caveats. It is classical and as such cannot compute events such as reactions 
between molecules that require quantum mechanics. The potential energy 
surface of an atom is based on the force field chosen for the simulation. There 
are several force fields available and each of these are optimised for different 
molecules. A force field may require further optimisation depending on the 
molecules in the system. 
To avoid computing long-range forces in a simulation, interactions are 
truncated at a specified distance called the cut-off. This reduces the amount of 
forces calculated speeding up the simulation. Van der Waals forces at long 
range are often very small so can be safely ignored. To prevent complete 
truncation of the forces at the cut-off a shift function can be used to generate 
continuous forces. This removes noise generated as the potential is shifted to 0 
as it approaches the cut-off. 
Whilst a cut-off can be used for coulomb interactions (Equation 2.4) it 
is not ideal as long-range electrostatics are required to prevent accumulation of 
charges at the cut-off boundary. The solution is to use Ewald summation to 
split Coulomb interactions into short-range and long-range contributions. 
Short-range contributions are calculated in real-space using standard cut-offs 
and a screening function to decay the charges to 0 at the cut-off. Long-range 
contributions are calculated in reciprocal space using Fourier transform to 
subtract the added screening functions. This allows two finite sums to calculate 
a potentially infinite sum. 
                                      ?  ൫ ?௜௝൯ ൌ ଵସగఌబ ൬௤೔௤ೕఌೝ௥೔ೕ൰              (2.4) 
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A neighbour list is used to avoid calculating distances between all pairs 
of particles at every time step. This list denotes all the nearest neighbouring 
particles and only these particles are considered for the van der Waals and 
Coulomb interactions. The neighbour list is updated during the simulation just 
not at every time step. 
Simulations are typically run within a box of specified size. To 
minimise edge effects in such a system periodic boundary conditions are used. 
The box is replicated in all dimensions such that there are effectively no 
boundaries to the system. Atoms that pass through a boundary are translocated 
to the opposing boundary. This gives the system bulk like properties as 
molecules are not confined to a specific space. The non-bonded cut-off of the 
simulation must be less than or equal to half the length of the simulation box to 
prevent molecules from interacting with multiple copies of other molecules. 
Temperature and pressure during the system are maintained through a 
thermostat and barostat respectively. The thermostat is able couple the kinetics 
of the system to an external heat bath at a given temperature. Variations in 
temperature are slowly adjusted by rescaling the velocities of the particles. The 
EDURVWDWEHKDYHVLQDVLPLODUZD\XVLQJD³SUHVVXUHEDWK´7KHFRRUGLQDWHVDQG
box size are adjusted at certain steps in the simulation to match the bath. 
 
2.2.2 Interaction Potential 
In all-atom (AA) molecular dynamics atoms are represented as single 
spherical particles with a van der Waals potential surrounding them. The 6-12 
Lennard Jones potential models atoms as hard spheres (Figure 2.26). The 
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potential models the repulsive Pauli exclusion principle at short distances 
between atoms and attractive van der Waals forces at larger distances. 
7KH VKDSH RI WKH SRWHQWLDO FDQ EH FKDQJHGE\ YDU\LQJ WKH HSVLORQ İ
DQGVLJPDıYDOXHVLQ(TXDWLRQ7KHVHYDOXHVDUHVHWEDVHGRQWKHIRUFH
field used and the atom types assigned to the molecules in a given system. 
When optimising a force field for a specific molecule the Lennard Jones 
potential can be altered to make atoms more attractive and repulsive based on 
the epsilon and sigma values used. 
 
 
Figure 2.26 A plot of a 6-12 Lennard Jones potential. 
                                           ?ሺ ?ሻ ൌ  ? ? ൤ቀఙ௥ቁଵଶ െ ቀఙ௥ቁ଺൨              (2.5) 
The partial charges on the atoms of a molecule are calculated through 
quantum mechanical (QM) methods. The distribution of charge is determined 
through QM calculations as a cloud around the molecule and partial charges 
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are assigned to the atoms based on their positions. In theory charge in a 
molecule would be dependent on the environment and conformation of the 
molecule but in molecular dynamics charges are fixed. Whilst it is possible to 
update the charges on a molecule during a simulation this is very 
computationally expensive and would significantly slow the simulation. 
Bonds between the atoms are represented as harmonic oscillators. The 
minimum of the harmonic potential is assigned by the user based on the length 
of the bond (Figure 2.27). Angles, proper and improper dihedrals also use 
harmonic oscillators. 
 
Figure 2.27 A graph of a harmonic oscillator used for bond lengths in 
molecular dynamics. The given bond length (r0) is maintained due to the 
increase in potential energy upon bond compression or extension. 
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To avoid doubling of bonded and non-bonded forces for nearby atoms, 
a neighbour exclusion cut-off is set to three. This ensures that a given atom will 
not have non-bonded interactions with the nearest three atoms it is connected to 
through bonds. 
 
2.2.3 Coarse-Grain Molecular Dynamics 
Coarse-graining is a technique used to reduce the degrees of freedom in 
a simulation. By reducing the amount of forces computed at each time step the 
time taken for the simulation is reduced. To achieve this groups of atoms in a 
molecule are represented as single beads. This requires a specialised CG force 
field such as the MARTINI force field. The MARTINI force field was 
optimised using experimental water-octanol partition coefficients42. 
A CG force field aims to reproduce the properties of a reference 
system. The MARTINI force field aims to conserve free energy but other 
techniques such as iterative Boltzmann inversion can reproduce the radial 
distribution of molecules in a system. 
However it is difficult to match multiple aspects of a reference system, 
as such CG MD is often different to AA MD as the molecules are inherently 
different. Each CG molecule must be carefully parameterised for a given 
system. 
 
2.2.4 Nanoprecipitation Model 
Our aim was to model the time evolution of a system that began as a 
spherical drop of an acetone solution containing PGA polymer within a large 
box of water containing dexamethasone phosphate (DXMP). We calculated 
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that a suitable fully atomistic model, that contained all the relevant species at 
the experimental concentrations, would consist of a 12nm diameter droplet, 
containing ~16,000 molecules of acetone and two molecules of a PGA100 
30mer (or one molecule of PGA20-b-C18PGA80 30mer), at the centre of a 60 
nm sided box of ~7 million molecules of water and ~1000 molecules of 
DXMP. In total this would be ~21 million atoms.  This system is large for our 
computational resources and yet is at a concentration that contains just a single 
PGA20-b-C18PGA80 polymer. To include more polymer molecules we would 
need more solvent and a larger box of water to surround it. 
 
Figure 2.28 (A-C) The dispersion of acetone in a periodic box of water. 
To address these issues we took advantage of the facility in the MD 
code GROMACS43 to use multiscale, dual-resolution, modelling methods. 
Water and acetone were modelled purely coarse-grained, using the Martini 
model and parameters (Figure 2.28). PGA and DXMP were modelled at both 
atomistic and coarse-grained levels, using the virtual sites approach (explained 
later in the Methods). Thus in our simulations all solute-solute interactions 
were treated fully atomistically, but solute-solvent and solvent-solvent 
interactions were treated in a coarse grained way. We also decreased the 
amount of acetone present in the system whilst increasing the polymer 
concentration. This allows us to observe how multiple polymer chains interact 
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together to form a nanoparticle on a reasonable time scale (around 5 days using 
192 MPI processes). The concentration of the drug in water is comparable to 
experiment at 3.22mg/ml. Overall, we were able to reduce the number of 
particles in the simulation system to ~1 million for two PGA20-b-C18PGA80, 
C18PGA100 chains or three PGA100 chains with 500 molecules of DXMP. 
 
2.3 Simulation Setup 
2.3.1 Molecular Dynamics 
To run a simulation a coordinate file and topology file is required for 
each type of molecule in the system. The coordinate file describes the position 
of every atom within the molecule in 3D space. The topology file contains the 
atom types of every atom in the molecule, their charges and their bonded 
interactions. Atom types define the Lennard-Jones potential for the VDW 
forces in the simulation and are specific to the force field used. 
For the polymer structures, first monomers of PGA and C18PGA were 
created in Avogadro44. These files were converted into PREP files and 
combined into coordinate files for polymer chains containing 30 monomers 
using Ambertools tleap45. The topology files were created by submitting the 
PGA and C18PGA monomers to the Automated Topology Builder server 
(ATB)46. The ATB uses quantum mechanics (QM) calculations to calculate the 
partial charges, atom types and bonded interactions for the molecule submitted. 
PM3 optimisation is used initially followed by B3LYP/6-31G* in implicit 
water. This generates partial charges for the atoms in the molecule. Bonded 
interactions are assigned based on atom types generated and the optimised 
bond lengths and angles from the QM calculation. The topology files for each 
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monomer were combined to form a whole topology for the 30mer polymer. 
PGA contained 30 PGA monomers, PGA20-b-C18PGA80 contained 4 PGA 
monomers with 26 C18-PGA monomers evenly distributed throughout the 
polymer and C18PGA100 contained 30 C18-PGA monomers. These atomistic 
models were compatible with the GROMOS 53a6 force field. 
'H[DPHWKDVRQH SKRVSKDWH¶V FRRUGLQDWH ILOHZDV FUHDWHG LQ$YRJDGUR
The resulting PDB was submitted to the ATB to generate its topology file 
compatible with GROMOS 53a6. 
For atomistic solvent, a single point charge (spc) water model was used 
and a model for acetone was taken from the ATB which was also compatible 
with the GROMOS 53a6 force field. This acetone model was later adjusted 
based on the WS model47 of acetone. 
 
Figure 2.29 Molecules used in this work including their chemical structures 
and their in silico representations. 
x y 
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For the coarse-grained solvent two equilibrated boxes of water and 
acetone at 300 Kelvin and 1 bar pressure were used. As per the standard 
MARTINI approach, four water molecules were represented by a single water 
bead and a single acetone molecule was represented by a single acetone bead. 
 
2.3.2 Multiscale Force Field 
A multiscale representation containing both atomistic and coarse-
grained structures was used for the polymer and drug molecules. The coarse-
grain virtual sites on the atomistic molecules were created using VOTCA48. A 
mapping file in .xml format was written which specifies the positions for the 
CG virtual sites at the centre of mass of the atoms they represent. Virtual sites 
are integrated into the topology file by specifying the atoms the CG virtual 
sites correspond to. During the simulation, forces on the CG virtual sites are 
imparted onto their corresponding atoms. As such the coarse-grain solvent can 
interact with the atomistic solute molecules. 
For the force field file: atomistic non-bonded parameters and pair types 
from the GROMOS 53a6 force field were combined with CG non-bonded 
Lennard Jones potentials from the MARTINI force field v2.2. CG beads lack 
partial charges and therefore, unless fully charged, they interact solely through 
van der Waals forces. This allows one to adjust the Lennard Jones potential for 
these forces to optimise the multiscale force field. Whilst the atomistic 
parameters were untouched, the CG parameters were adjusted during the 
optimisation process by validation against a fully atomistic model. 
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Figure 2.30 Interactions involved in the multiscale force field. AA interactions 
are labelled in green whilst CG interactions are in red. Note there are no CG 
interactions between the CG virtual sites on the AA molecules to prevent 
doubling with AA interactions already present. 
 
2.3.3 Simulation Setup 
First the acetone drop was created using the GROMACS genbox insert 
command to place polymer molecules (3 for PGA, 2 for PGA20-b-C18PGA80 
and C18PGA100) randomly within a 9nm sided periodic box. This box was 
solvated using genbox with a pre-equilibrated box of CG acetone. genbox 
solvate command fills the box with molecules and removes any that clash with 
the molecules already present in the box. 
 This acetone/polymer box was placed at the centre of a 50nm sided 
periodic box and 500 DXMP molecules were added randomly throughout using 
genbox. After solvation with CG water, 1000 sodium counter ions were 
introduced with genion by replacing random CG water beads in the box to keep 
the volume consistent. 
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Energy minimisation was performed for 10,000 steps using the steepest 
descents method. NVT equilibration was performed for 500ps with the v-
rescale thermostat to achieve 310K temperature. Subsequent NPT equilibration 
for 2ns with the Berendsen barostat brought the system to 1 bar pressure. 
Production MD was run in triplicate using a leap-frog integrator for 
80ns with coordinates saved for the trajectory file every 100ps. Simulations 
used periodic boundary conditions with coulomb and VDW interactions shifted 
between 0 and the 1.2nm cut-off. Bonds were constrained using the LINCS 
algorithm to allow for a 2fs time step. 
For fully atomistic simulations the same method was used but with 
atomistic solvent. Additionally the Particle Mesh Ewald method was used for 
coulomb interactions to preserve long range electrostatic interactions between 
partial charges in the atomistic molecules. 
 
2.4 Analysis 
2.4.1 Resolution Transformation 
As part of the simulation validation procedure we wanted to sample the 
80ns nanoprecitation at three time points where we could convert the 
multiscale model to a fully atomistic model for a comparison between the two 
forcefields. At 30, 50 and 80ns, 11nm sided subsections of the 50nm sided box 
multiscale systems were converted back to fully atomistic representations. We 
XVHG WKH ³EDFNZDUG´ S\WKRQ VFULSW49 to reintroduce atomistic detail to our 
coarse-grain solvent. First atomistic molecules (one for acetone and four for 
water) are swapped for the coarse-grain beads. Steepest descent energy 
minimisation was run for 150 steps without non-bonded interactions followed 
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by another 150 steps with non-bonded interactions turned on. Next MD 
simulations were run at increasing time steps from 0.2fs to 2fs. The resulting 
atomistic coordinate file was combined with the polymer, drug molecules 
(without their coarse-grain virtual sites) and ions to create a fully atomistic 
subsystem. 
 
Figure 2.31 Resolution transformation procedure. (A) An 11nm sided  
box is drawn around the polymer at a time point in the 80ns multiscale 
simulation. CG solvent in this box is subjected to resolution transformation. 
(B) During resolution transformation atomistic acetone (blue/red) is inserted in 
place of CG acetone beads (white). 
2.4.2 Comparative Analysis of Multiscale and 
Atomistic Simulations 
Subsystems from the resolution transformation were subjected to 5ns of 
production MD after minimisation and equilibration using the GROMOS 53a6 
force field. For comparison, each 11nm sided subsection was also simulated for 
5ns using the multiscale force field (simulations conditions identical to those 
described in 2.2.3). 
The performance of the multiscale simulation vis-a-vis the atomistic 
³JROGVWDQGDUG´0'ZDVDQDO\VHGZLWK UHJDUG WR WZRNH\SDUDPHWHUV)LUVWO\
A B
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the time evolution of the total radius of gyration of the polymer clusters in the 
two simulations was compared using g_gyrate. Secondly the average 
orientation of the adsorbed DXMP molecules with respect to the polymer 
nanoparticle was evaluated. For this we measured the difference in the distance 
of the head phosphate and tail oxygen atoms of DXMP to the PGA centre of 
mass over the course of the simulation using g_dist (Figure 2.32). This was 
repeated for five different, randomly-chosen, drug molecules and averaged.  
 
Figure 2.32 A cartoon depicting the calculation of the difference in the distance 
ǻGLVWDQFHIURPWZRDWRPVDWRSSRVLWHHQGVRI';03WRWKHFHQWUHRIPDVV
of the polymer nanoparticle. 
2.4.3 Drug Loading and Encapsulation Efficiency 
Experimentally, polymer-based drug delivery systems were analysed 
for their ability to encapsulate drug molecules. There are a variety of 
experimental techniques used to discern the amount of drug that is 
encapsulated. For our simulations we have the luxury of being able to see 
ǻ distance 
Polymer 
centre of mass 
Tail 
oxygen 
Head 
phosphate 
88 
 
exactly how many drug molecules are in contact with the polymer nanoparticle 
when it has formed. 
The two most commonly used metrics for measuring drug 
encapsulation are encapsulation efficiency (EE) (Equation 2.6) and drug 
loading (DL) (Equation 2.7). Encapsulation efficiency will give an indication 
as to the amount of drug that was present in solution ends up encapsulated in 
the polymer nanoparticle. This value depends on the amount of drug present at 
the start of the simulation. If a small amount of drug was present in solution 
and it eventually all gets encapsulated on the surface of the polymer the EE is 
100%. This value is equivalent to the reaction efficiency used in chemical 
synthesis and so is related more to the manufacturing cost of a formulation. It 
does not give an accurate indication of the encapsulation ability of a polymer. 
The alternative parameter DL is an indication of the total capacity for a 
polymer nanoparticle to encapsulate drug molecules. Ideally this value should 
be as large as possible to get the optimal delivery of drug from the polymer 
nanoparticle. However, DL is often very low for polymer-based drug delivery 
systems. EE for a polymer could be 100% yet the DL may still be low 
depending on the amount of drug present in solution at the start. 
                    ൌ ୑ୟୱୱ୭୤ୢ୰୳୥୧୬୬ୟ୬୭୮ୟ୰୲୧ୡ୪ୣ୘୭୲ୟ୪୫ୟୱୱ୭୤ୢ୰୳୥୳ୱୣୢ               (2.6) 
                            ൌ ୑ୟୱୱ୭୤ୢ୰୳୥୧୬୬ୟ୬୭୮ୟ୰୲୧ୡ୪ୣ୘୭୲ୟ୪୫ୟୱୱ୭୤୬ୟ୬୭୮ୟ୰୲୧ୡ୪ୣ                          (2.7) 
A drug was considered bound to the nanoparticle if it made contact with 
the surface of the polymer nanoparticle. Although some drug molecules do not 
make full contact with the nanoparticle surface once simulated in pure water 
(to mimic a washing step) they become fully adsorbed to the nanoparticle 
surface. 
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Chapter 3 
Designing a Model to Study 
Polymer Drug Interactions 
 
The aim of this PhD was to analyse the interactions between drug and 
polymer molecules in a nanoparticle drug delivery system. Some initial 
questions were asked: What interactions cause the drug to be encapsulated in 
the polymer nanoparticle?  Are drugs buried within or stuck on the surface? 
What functional groups on the drug or polymer are crucial to achieve high 
encapsulation efficiency of the drug within the nanoparticle? 
Molecular dynamics simulations provide an opportunity to answer these 
questions. The objective being that if it is possible to recreate nanoparticle 
formation in a computer, you can then analyse how the polymer and drugs 
interact in detail. From this you can begin to answer some of the questions 
listed above. 
Initially the intention was to recreate existing data in an effort to 
ascertain if a computer simulation was capable of mimicking experimental 
conditions. If successful the system could be freely changed to explore the 
behaviour of new polymers and drugs. 
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An optimal simulation would involve using an accurate atomistic force 
field to model how thousands of drug and polymer molecules interact at 
concentrations relevant to the experimental conditions. However, molecular 
dynamics involves computing the interactions of every atom in a system, so as 
the number of atoms increases the speed of the simulation decreases. This 
problem is usually overcome by using more powerful resources for the 
simulations such as supercomputers and even specialised computers like 
Anton50. An alternative is to use a simplified model that allows simulation of 
more basic molecules that behaves similarly to a fully atomistic model. Users 
must make compromises and adjustments to a system to ensure the most 
accurate simulation is run with the resources available. 
 
3.1 An Acetone Drop Nanoprecipitation Model 
The process of nanoprecipitation requires acetone to disperse within 
water therefore changing the solvent environment around the polymer chains 
causing them to aggregate into a nanoparticle. 
Initially, the assumption was made that acetone was not critical to 
polymer aggregation and a simulation in pure water would be sufficient for 
assembling polymer nanoparticles. However, our simulations revealed that in 
pure water hydrophobic poly(glycerol adipate) chains collapse in on 
themselves over a few nanoseconds of simulation time. Small single polymer 
chain aggregates form first and these cluster into a larger nanoparticle when 
they collide with each other (Figure 3.33). In this case intramolecular polymer 
interactions take precedence over intermolecular polymer interactions. 
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When in acetone the polymer is soluble and does not aggregate. It was 
hypothesised that during nanoprecipitation the dispersion of acetone in water 
would create a gradient that would change over time, gradually exposing the 
polymer to the surrounding water. This would allow polymer chains to interact 
with each other before ultimately aggregating and forming a nanoparticle. 
 
 
Figure 3.33 Snapshot taken from the end of a simulation of five 50mers of 
PGA100 in pure water. Each polymer chain is shown in a different colour to 
emphasize the lack of polymer chain entanglement. 
A new simulation was performed this time including acetone. Polymer 
chains were modelled as dispersed within a small box of acetone and this was 
placed in a large box of water. As the simulation was run, water diffused into 
the polymer-containing region causing gradual formation of a nanoparticle. 
Whilst the polymer is slowly exposed to water in this simulation the speed of 
intramolecular polymer collapse is reduced and the amount of intermolecular 
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entanglement is increased. Overall this produced a more entangled polymer 
nanoparticle as hypothesised.  
This acetone drop model was designed VXFK WKDW D VLQJOH ³GURS´ RI
acetone can fully disperse into a large box of water. Unfortunately, this 
simulation is far from optimal as a large amount of simulation time is spent on 
solvent interactions. For a simulation that was designed to analyse polymer 
drug interactions this is far from ideal. However, the dispersion of an acetone 
drop in water most closely resembles the experimental conditions for 
nanoprecipitation and it is for this reason we chose to pursue this system 
further. 
A fully atomistic system, that contained all the relevant species at the 
experimental concentrations, consists of a 12nm diameter acetone drop 
containing ~16,000 molecules of acetone and two molecules of poly(glycerol 
adipate) (PGA100) 30mer, one molecule of PGA20-co-C18PGA80 30mer or 
C18PGA100 30mer. This droplet would be placed at the centre of a 60 nm sided 
box of ~7 million molecules of water and ~1000 molecules of dexamethasone 
phosphate (DXMP). In total this would be ~21 million atoms in order to 
simulate the formation of a nanoparticle of one or two polymer chains 
depending on the polymer used. 
Simulating a system of this size using the resources available at the 
time of starting this PhD was not advisable as it would have taken several 
months to complete a single simulation. As stated previously it is common 
practice when dealing with such large systems to adopt a mesoscale modelling 
technique such as coarse-grained (CG) molecular dynamics or dissipative 
particle dynamics (DPD). A more simplified representation of the molecules in 
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the system reduces the computational requirements of the system and allows 
the simulation to be run. 
For our system we initially chose a coarse-grained approach using the 
MARTINI force field. This involves converting every four non-hydrogen 
atoms in a molecule into a single CG bead. For water this involves converting 
four water molecules into a single bead; 4 to 1 mapping. The MARTINI force 
field is designed so that the interactions between these beads are based on the 
atoms they represent. 
Overall for our acetone drop model this provides a four-fold reduction 
in the number of water molecules thus greatly reducing computational load. As 
our system is comprised predominately of water, coarse-graining is extremely 
favourable. Acetone can also be coarse-grained to provide an additional speed 
up. 
However, coarse-graining has several caveats: the CG model lacks 
explicit electrostatic interactions present for the all-atom (AA) molecules. 
Instead these are implicitly included in the parameterisation of the van der 
Waals interactions between CG beads. Secondly the CG beads are much 
smoother than their AA counterparts. This speeds up their dynamics causing a 
timescale discrepancy between a CG and AA simulation. The MARTINI force 
field quotes a speed up of between 3-8 times42. 
 
3.2 Coarse-Grained Solvent 
For the dispersion of acetone in water during our nanoprecipitation 
simulation, our goal was to match the AA dynamics as closely as possible. AA 
dynamics are more likely to accurately mimic experimental conditions as all 
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the atoms of a molecule are represented. Thus, if the CG acetone dispersed at a 
faster rate than it does atomistically, we hypothesised this would have an 
adverse effect on the nanoprecipitation of the polymer chains during our 
simulation. 
An initial step in optimising our system involved using AA simulations 
as a ³gold-standard´UHIHUHQFH to which we could match the dynamics using a 
CG force field. Two systems, one AA and one CG, were created of equal molar 
ratio containing a single drop of acetone molecules in a box of water. 
The diffusion constant of acetone was measured over a 5ns simulation. 
The CG non-bonded parameters for acetone were adjusted such that the 
diffusion constant of acetone matched the AA acetone diffusion constant 
(Figure 3.34). The diffusion constant for CG acetone was adjusted from 
1.367x10-5 cm2/s to 2.213x10-5 cm2/s (the AA diffusion constant was 
2.113x10-5 cm2/s) for a 0.0357 molar ratio of acetone in water. 
Mean squared displacement over time for the corrected force field is 
almost identical to atomistic simulation (Figure 3.34). Displacement over time 
will affect the speed of acetone dispersion from the acetone drop in water. By 
matching the atomistic simulation we ensure that the acetone dispersion in our 
acetone drop nanoprecipitation model is as close to experimental conditions as 
possible. 
The dispersion of 512 molecules of acetone in water using an AA force 
field and a corrected CG force field is shown in Figure 3.35. A small box of 
acetone molecules disperses into a larger box of water. The dispersion rate of 
acetone in water is similar for both force fields used indicating that the new CG 
parameters match the AA acetone dispersion rate. 
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Figure 3.34 The mean square displacement of acetone in water over 5ns using 
the GROMOS 53a6 AA force field (red), MARTINI force field (green) and a 
corrected CG force field (blue). 
 
 
Figure 3.35 Two separate simulations of acetone dispersing in water using two 
different force fields: AA (red) and CG (blue). Water is not shown for clarity. 
 
Mean Squared Displacement (nm2) 
Corrected 
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3.3 Coarse-Grained Polymer 
To coarse-grain the polymer, the same 4 to 1 (AA to CG) mapping was 
used. The MARTINI force field has guidelines for allocating specific bead 
types to each CG bead in a molecule based on the atoms they represent. The 
mapping process is non-trivial and subject to user scrutiny. Mapping schemes 
can be very different but all try to represent the same molecule. Work by 
Kremer et al.51 has shown how small changes in the mapping scheme of a 
polymer can affect non-bonded and bonded interactions. 
For bonded interactions the MARTINI force field recommends a 
0.47nm bond length with a force constant of 1250 KJ mol-1 for all CG bonds. 
Similarly angles are at 180o with a force constant of 25 KJ mol-1. Using this 
topology, simulations of CG PGA100 were run in pure CG water and pure CG 
acetone separately. In water the polymer formed an ordered crystalline 
structure and in acetone the polymer was insoluble. Both of these simulations 
differed from the AA reference simulations at the same concentrations where 
the polymer formed a more disordered spherical shape in water (Figure 3.36) 
and was soluble in acetone (not shown). 
When using the MARTINI force field for a CG polymer the 
intramolecular interactions are too strong. This causes the polymer to adopt an 
ordered crystal-like structure as certain beads form tight interactions with each 
other. In contrast the atomistic force field generates a more disordered structure 
for the polymer aggregates. This difference in the CG representation could be 
due to the lack of detail in the CG structure or incorrect CG interaction 
parameters. 
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Figure 3.36 Snapshots taken from simulations of PGA100 in water. Polymers 
are represented as lines with different colours for the CG beads in the structure. 
The AA structures were mapped to CG representations at the end of the 
simulation for a clearer comparison. 
 
3.3.1 Improving the CG interactions 
The priority for this work was to ensure that polymer and drug 
interactions were as accurate as possible. It was important to ensure that CG 
interactions between these molecules resembled the AA interactions as closely 
as possible. One technique to improve coarse-grain models is to use AA 
simulations as a starting point for developing CG interaction potentials. 
 
Figure 3.37 CG mapping scheme used for PGA100. Every 3-4 non hydrogen 
atoms are mapped to a single CG bead. 
This was done by using tabulated potentials for non-bonded interactions 
based on the dynamics of an AA reference simulation. For PGA100 in water an 
O
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AA simulation was run first and the resulting trajectory was mapped to a 
coarse-grain mapped trajectory using the mapping scheme shown in Figure 
3.37.  
The positions of the CG beads in the CG mapped trajectory are 
analysed by their radial distribution functions (RDF) (Figure 3.38). AA 
reference RDFs are generated for every non-bonded interaction in the system. 
The four beads in each monomer of the polymer were labelled A, B, C and D 
and RDFs generated were A-A, A-B, A-C, A-D, B-B, B-C etc. The aim was to 
match these AA reference RDFs using a CG force field made from tabulated 
potentials. 
 
Figure 3.38 The RDF of a blue bead to green beads. Seven green beads are 
located at a distance r from the central blue bead. 
To run the CG simulation, the first step was to create bonded 
interactions between the beads in the polymer. A short simulation was run of a 
PGA100 20mer in a vacuum with all non-bonded interactions disabled. This 
allows the bonded interactions in the AA molecule to fully explore their entire 
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conformational space. The AA trajectory was converted to a CG mapped 
trajectory and a Boltzmann distribution was obtained for all the bonds and 
angles beads in the polymer. The versatile object orientated tookit for coarse-
graining applications (VOTCA) enabled the use of Boltzmann inversion to 
convert these distributions into bond and angle harmonic potentials for the CG 
molecule. 
 
Figure 3.39 CG potentials required for PGA100: Non-bonded (green), Bonds 
(black), Angles (red). 
A similar technique was used to derive the non-bonded tabulated 
potentials for every bead pairing of the CG polymer. Using VOTCA again, 
RDFs from the AA reference simulation were subjected to Boltzmann 
inversion to generate an initial guess for the tabulated potentials. These 
potentials coupled with the bonded potentials allowed an initial CG simulation 
of PGA100 in CG water (Figure 3.39). When the simulation ended, RDFs were 
calculated from the simulation and compared with the original AA reference 
RDFs from the CG mapped trajectory of AA PGA100 in AA water.  
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A comparison was made and a new set of tabulated potentials were 
generated and tested with another CG simulation. In this way the non-bonded 
potentials were iteratively refined until the RDFs match. This is the process of 
iterative Boltzmann inversion (IBI) (Figure 3.40). 
 
Figure 3.40 During iterative Boltzmann inversion RDFs from a CG simulation 
of PGA100 in water are plotted at different cycles during the process. The CG 
RDFs begin to converge to the AA reference RDF until a refined CG potential 
was obtained after 25 cycles. 
Although the RDFs do not perfectly match, the potential is refined 
enough for the RDFs to be much closer than the initial guess. The inability to 
match the RDFs was due to the large amount of RDFs involved. Changing the 
tabulated potential for one interaction can have a knock on effect on the 
interactions of another bead pairing. The dynamic nature of the polymer 
nanoparticle used for IBI results in large fluctuations in the RDF during each 
cycle. 
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3.3.2 A new CG model 
 
Figure 3.41 CG structure of a PGA100 nanoparticle in water using the CG 
potentials obtained with VOTCA. The structure more closely resembles the 
AA structure seen in Figure 3.36. 
Upon repeating the CG simulation of PGA100 in water using the refined 
CG potentials, the nanoparticle structure is more disordered and less crystalline 
(Figure 3.41) more closely matching the AA structure shown in Figure 3.36. 
 
Figure 3.42 Plots for the solvent accessible surface area (SASA) of PGA100 
over 40ns. The new CG tabulated potentials offered good agreement with the 
AA simulation compared with the MARTINI force field. 
Figure 3.42 shows how the solvent accessible surface area (SASA) of 
the polymer changes over a 40ns simulation. A virtual probe was used to 
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measure the surface area of the polymer aggregates as they form in water 
during the simulation. The larger surface area found with the MARTINI force 
field was due to the crystalline aggregates formed. The aggregates formed 
using the refined CG potentials matched the SASA of the AA simulations more 
closely.  
The improvements to the CG model are more clearly demonstrated in 
Figure 3.43 where the MARTINI force field caused 250 monomers of PGA100 
in water to aggregate into a bilayer. This again indicates that interactions 
between similar beads in the PGA100 monomer are too strong. Using the new 
CG potentials from VOTCA a disordered aggregate formed in a similar manner 
to the polymer nanoparticles formed in water. 
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Figure 3.43 Two simulations of 250 monomers of PGA100 in water using the 
MARTINI force field and the VOTCA refined CG force field. The MARTINI 
force field generates a bilayer like construct whereas the VOTCA force field 
generates a spherical nanoparticle. 
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3.4 Coarse-Grained Drug 
For an aggregate such as the one formed by PGA100 in water, IBI is a 
good method to parameterise the CG model as the structure remains similar 
through each cycle allowing optimisation of the tabulated potentials. However, 
for a molecule that is soluble in water such as DXMP, IBI is not possible as the 
RDFs for the CG beads change drastically. Additionally for drug and polymer 
molecules there is no obvious reference AA simulation that will enable IBI to 
work. One idea is to simulate melts of polymer and drug molecules. However, 
these simulations do not represent the conditions which will be used for the 
acetone drop nanoprecipitation simulation. 
Additionally, the number of RDFs required to converge is increased as 
CG DXMP contains nine beads. 36 tabulated potentials must be simultaneously 
refined to try and match the same number of AA reference RDFs. 
This is also a problem for drug polymer interactions. Therefore other 
techniques were attempted to obtain tabulated potentials such as umbrella 
sampling. However, it is difficult to obtain accurate potentials for a single drug 
molecule with a large polymer chain which contains multiple conformations 
and functional groups. 
For these reasons a fully CG model for nanoprecipitation is extremely 
difficult to create. There is potential to modify the MARTINI force field such 
that it matches small scale AA simulations, but this is a non-trivial empirical 
process that would create a force field specific to one polymer and drug 
combination. Ideally the force field used in this work should be compatible 
with any polymer and drug combination with minimal optimisation required. 
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3.5 Multiscale Modelling 
As CG simulations are inaccurate for our needs and AA simulations are 
unfeasible, a force field that uses aspects from both scales should have the 
correct balance between accuracy and speed required. 
 
Figure 3.44 Multiscale model used for DXMP (A) and PGA (B). The 
transparent CG beads are virtual sites that are positioned at the centre of mass 
of the atoms they represent. The atomistic molecules interact with surrounding 
CG solvent molecules through these virtual sites using the MARTINI CG force 
field. 
A multiscale or hybrid CG/AA model involves the mixing of two force 
fields. This enables some molecules in a system to be at an AA level of detail 
whilst other molecules are coarse-grained. AA molecules interact with 
themselves and other AA molecules through an AA force field like a standard 
simulation. In a similar vein CG molecules also interact with themselves and 
other CG molecules using the MARTINI force field. However, in order for AA 
molecules to interact with CG molecules, CG virtual sites are created on all of 
the AA molecules in the system (Figure 3.44). 
CG virtual sites are mapped onto the AA molecules in the same way an 
AA molecule is converted to a CG molecule. The CG virtual sites are linked to 
the atoms they are mapped from. Forces acting on the CG virtual sites from 
other CG molecules are passed onto the underlying atoms in the AA molecule. 
In this way CG molecules can interact with AA molecules in the system and 
vice versa. 
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For our nanoprecipitation simulation, multiscale modelling allows the 
use of CG solvent with AA polymer and drug molecules. As the majority of the 
system consists of solvent molecules, coarse-graining the solvent provides an 
increase in the speed of the simulation due to a decrease in degrees of freedom 
for the solvent molecules. Solute molecules (drug and polymer) are kept 
atomistic to preserve the accurate interactions obtained through the use of an 
AA force field. 
The interactions between the solute molecules in the system are the 
most important and so these need to be kept at the highest resolution possible. 
Conversely, the solvent interactions are less important, specifically the inter-
molecular interactions in bulk water. Using a CG force field for these 
interactions provides a large speed up to the simulation whilst hopefully having 
a minor effect on the solute interactions. 
 
3.6 Multiscale Model Optimisations 
Combining two force fields that have been separately parameterised 
over several years is a non-trivial exercise. It is critical that any multiscale 
simulation is fully optimised to ensure that the dynamics are as accurate as 
possible. Again fully AA reference simulations can be used to determine the 
optimal dynamics of a system. From these reference simulations the multiscale 
force field can be optimised. 
 
3.6.1 Polymer-Drug Interactions 
In GROMACS tKHUHODWLYHGLHOHFWULFFRQVWDQWİr, sets the screening for 
the electrostatic interactions in the system. Electrostatic forces play a vital role 
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in the interaction between AA molecules in the system. However, the CG 
molecules and CG virtual sites on the AA molecules have no electrostatic 
interactions. At low values of İr there is little screening of electrostatic 
interactions and vice versa. 
GROMOS96 v53a6 uses an İr of 1 (the default value) as the force field 
does not require screening of electrostatics. The MARTINI force field uses an 
İr of 15 as its basic electrostatics are only integer charges (+1, -1, 0 etc.). CG 
beads are only charged if the underlying atoms would collectively have an 
integer charge. To balance these large charges with the van der Waals forces in 
the system a large dielectric screening constant is used. 
For our system a major problem is that CG water has no electrostatic 
interactions with the highly charged DXMP molecules. It should be noted that 
the CG virtual sites on DXMP carry no charge but the atoms themselves are 
charged. Therefore the double negative charge on the phosphate group of 
DXMP interacts through the AA force field. This charge has strong 
electrostatic interactions to nearby positive charges. 
Whilst AA water is polar and contains a partial positive charge on its 
hydrogen atoms, CG water is a representation of four whole water molecules 
whose overall charge is neutral. In a multiscale simulation, CG water is unable 
to partially neutralise the negatively charged DXMP phosphate group. With 
low values of İr, negatively charged DXMP molecules are strongly drawn to 
positive charges in the system. They either tightly bind to sodium counter ions 
or bury themselves in the AA polymer molecules (Figure 3.45). 
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Figure 3.45 Snapshot taken during a 20ns multiscale simulation of DXMP 
(green/orange) with PGA100 (blue/red) in CG water. Black dashed lines show 
the distance between charged oxygen atoms on the phosphate of DXMP to 
hydroxyl groups on PGA100. The CG water molecules are not shown for clarity. 
Using an AA force field polar water molecules provide counter charge 
to the DXMP phosphate groups. For the multiscale force field we increased the 
İr, to reduce the strength of electrostatic interactions, referencing the 
orientation of DXMP. This matches the AA reference simulation in which the 
relatively hydrophobic steroid portion interacts with the polymer while the 
phosphate group remains exposed to the solvent (Figure 3.46).  
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Figure 3.46 Snapshot taken at the end of a 20ns multiscale simulation of 
DXMP with PGA100 in AA water. There is counter charge present for the 
DXMP molecule and so it adopts a different orientation with respect to the 
polymer. Only water atoms in close proximity to the DXMP phosphate group 
are shown for clarity. 
An İr of 6 was found to be optimal for DXMP with PGA100. Ideally the 
İr should be kept as low as possible to ensure that the AA interactions in the 
system are not affected as they are initially optimised to a value of 1. An İr of 6 
is quite high due the large charge present on DXMP. For a system with 
uncharged drug molecules iW LVK\SRWKHVLVHGWKDWD ORZHUYDOXHRIİr could be 
used. 
Whilst DQİr of 6 is required to reduce the electrostatic interactions of 
DXMP¶V SKRVSKDWH JURXS, this value is not compatible for the polymer or 
solvent molecules which are initially parameterised to different values for İr. 
As such, adjustments to the CG interactions in the force field were required. 
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$Wİr = 6, the electrostatic interactions that keep the polymer aggregated 
in water are weakened as they are optimised for a lower value of İr. To address 
this, the interaction between the CG water molecules and the CG virtual sites 
on the polymer was made more repulsive by adjusting their Lennard Jones 
potentials within the force field. The radius of gyration of the polymer 
nanoparticle is used to compare with the AA reference simulation (Figure 
3.47). 
 
Figure 3.47 The radius of gyration for PGA100 in water using an AA force field 
(red) is compared with the multiscale force field at İr = 6 (green). 
Simulations in pure water for 20ns comparing both force fields reveals 
the orientation of the drug molecules and the aggregation of the polymer chains 
are in good agreement (Figure 3.48). 
Time (ps) 
Rg (nm) 
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Figure 3.48 Snapshots comparing the final atomistic structure with a corrected 
multiscale (hybrid) force field. Water is not shown for clarity. PGA100 
(blue/red), DXMP (green/orange). 
 
3.6.2 DXMP Orientation 
To further analyse the effect of the relative dielectric constant, the 
orientation of DXMP was analysed over a short 5ns simulation using different 
values of İr (Figure 3.49). 
 
Figure 3.49 The orientation of DXMP in relation to a PGA nanoparticle in 
water was analysed over four different 5ns simulations. AA UHGPXOWLVFDOHİr  JUHHQPXOWLVFDOHİr  EOXHPXOWLVFDOHİr = 15) (pink). 
Time (ps)
ȴDistance
(nm)
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7KHGLIIHUHQFHLQWKHGLVWDQFHVǻGLVWDQFHRIWKHSKRVSKRUXVDWRPDQG
the oxygen atom attached to the steroid A ring of DXMP to the centre of mass 
of the polymer nanoparticle was analysed over a 5ns simulation in water (see 
Methods). 
In the AA reference simulation (Figure 3.49 red line) the phosphate end 
of DXMP interacted favourably with counter ions and polar water molecules 
surrounding the polymer nanoparticle. This resulted in the phosphate end of 
DXMP being further from the centre of mass of the polymer than its opposite 
oxygen end. The oxygen end of the molecule is more hydrophobic and was 
associated with the surface of the polymer nanoparticle. In this orientation the 
ǻGLVWDQFH LV D SRVLWLYH YDOXH )RU WKH $$ UHIHUHQFH WKH ǻGLVWDQFH averaged 
around 1nm for five DXMP molecules during a 5ns simulation. 
For an İr of 1 (Figure 3.49 blue line) the electrostatic interactions are 
not screened, therefore the phosphate end of DXMP turned from its initial 
position to face in towards the polymer surface (as is seen in Figure 3.45) 
GHFUHDVLQJ WKH ǻGLVWDQFH %\ WKH HQG RI WKH VLPXODWLRQ WKH ǻGLVWDQFH was 
negative indicating that the orientation of DXMP had almost fully reversed. 
At İr = 15 (Figure 3.49 pink line) the electrostatic interaction are too 
weak and the interactions AA interactions the system were affected. Although 
WKH ǻGLVWDQFH UHPDLQV SRVLWLYH WKH YDOXH fluctuated due to a change in the 
aggregation of the polymer. With decreased electrostatic interactions the 
polymer was no longer able to maintain is aggregated state and began to 
unravel. This affected the metric as the centre of mass of the polymer 
nanoparticle changed and fluctuated during the simulation. As the polymer 
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unravelled its interactions with DXMP also changed DIIHFWLQJ WKH ǻGLVWDQFH
metric. 
For İr = 6 (Figure 3.49 green line) the correct balance of electrostatic 
and van der Waals forces was seen such WKDW WKHǻGLVWDQFHremained close to 
1nm matching the reference AA simulation. 
 
3.6.3 Drug Solvent Interactions 
To parameterise the interaction between DXMP and the two types of 
solvent molecule involved in our nanoprecipitation model, a partition 
simulation was created. A single molecule of DXMP was placed at the 
interface between acetone and water solvent in a cuboid box. Simulations of 
10ns were run to analyse the partitioning of DXMP in the two solvents before 
they fully mixed. 
An AA reference simulation revealed that the phosphate group on 
DXMP stayed in the aqueous phase whilst the rest of the molecule was in the 
acetone phase. This was presumably due to the charged phosphate group 
having strong electrostatic interactions with the polar water molecules. The rest 
of DXMP is steroidal and hydrophobic so it had stronger interactions with the 
acetone phase and did not enter into the aqueous phase. 
A multiscale simulation was run of the same system using CG solvent. 
With an İr of 6 the solvent interactions with DXMP were adjusted such that it 
partitioned in the two solvents similarly to the AA reference simulation (Figure 
3.50). 
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Figure 3.50 Snapshots taken at the end of 10ns simulations showing the 
partitioning of DXMP in acetone/water. With an AA force field (left) and 
multiscale (right). Water (red dots), acetone (blue dots). 
 
3.7 Conclusion 
This chapter serves as an overview of a number of techniques that can 
be used to simulate drug polymer interactions. There are of course many other 
methods that have not been attempted such as simulating only part of the 
polymer nanoparticle or using coarser dynamics such as DPD. 
The choice of a multiscale model for simulating polymer 
nanoprecipitation was driven by the ability to choose the levels of resolution 
for separate molecules in the simulation. Our focus is on the polymer drug 
interactions and a multiscale model provides a method to marry accurate AA 
interactions with coarser solvent interactions. 
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By using small scale AA simulations as references it is possible to 
optimise a multiscale force field for any given molecule with relative ease. 
DXMP is a tricky case as its large charge presents some major problems when 
combining two force fields. However, we have shown that it is possible to 
overcome these problems through the design of metrics and analytical 
techniques to ensure the multiscale dynamics closely resemble AA reference 
simulations. 
It is hypothesised that uncharged drug molecules would be easier to 
optimise for this multiscale force field. Additionally a low value of İr could be 
used such that there would be less optimisation necessary for AA interactions. 
Nevertheless, DXMP is an interesting case example and demonstrates that with 
efficient optimisation a multiscale force field can be used to simulate polymer 
drug interactions. 
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Chapter 4 
Incorporation of DXMP into 
PGA Nanoparticles: Multiscale 
Model 
 
The aim of this chapter was to simulate the process of DXMP being 
incorporated into PGA nanoparticles using a multiscale force field. Simulating 
polymers and drugs which have been used experimentally allows us to verify 
the accuracy of our model. Experimental data has shown that encapsulation 
efficiency of DXMP into PGA nanoparticles is highest for PGA20-co-
C18PGA80 when compared with PGA100 and C18PGA100. Our model should be 
able to reproduce this experimental trend if it is an accurate representation of 
how these molecules behave. If the experimental data correlates with the 
simulations then we can analyse the reason for the experimental trend at the 
molecular level. By revealing key interactions between the molecules we will 
gain a better understanding of drug-polymer compatibility and help create 
better polymer-based drug delivery systems in the future. 
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The multiscale force field detailed in the previous chapter involves 
using CG solvent molecules in place of AA molecules to decrease the degrees 
of freedom in the simulation. As molecular dynamics involves the calculation 
of interactions between every particle in a given system, reducing the number 
of particles decreases the time taken to simulate nanoprecipitation. By using 
CG solvent in place of AA solvent the total amount of interacting particles in 
the system decreases from over 21 million to ~2 million. However, this is still a 
significantly large number of molecules to simulate. 
One major drawback from using the multiscale force field is that the 
time step of the simulation is low (2 fs) as atomistic molecules are still present 
in the simulation. Although the majority of our simulation is single CG 
particles (water and acetone) we must accommodate the small part of our 
simulation that is atomistic. Simulating nearly 2 million molecules at this time 
step on our computational resources was still too slow. Additionally the 
simulation still only contained a single molecule of PGA20-co-C18PGA80 
30mer. 
To better observe the formation of a nanoparticle containing multiple 
polymer chains the concentration of the polymer molecules was doubled. In 
addition the number of acetone molecules was halved to allow for a smaller 
box with substantially less water. Although the polymer concentration in our 
system is now not identical to the experimental conditions, the aim was to 
observe differences between the polymers in our simulations not compare 
directly with experimental data. As was seen in Chapter 1, changing the 
concentrations of components in a simulation is common practice due to 
computational limitations. In the future with more computational resources 
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there will be the potential to run larger scale simulations at the correct 
concentrations. 
The modelled concentration of drug in water was kept comparable to 
experiment at 3.22mg/ml. Overall; we were able to reduce the number of 
particles in the simulation system to 1,054,063 for two PGA20-co-C18PGA80 or 
C18PGA100 chains and 1,053,653 for three PGA100 chains with 500 molecules 
of DXMP. 
 
4.1 Simulation of PGA100 nanoprecipitation in the 
presence of DXMP 
We first explored the nanoprecipitation of the parent, un-substituted, 
PGA100 over an 80ns multiscale simulation. This simulation time ensured full 
dispersion of the acetone into the surrounding water and that the aggregation of 
the polymer nanoparticle was complete (the metrics used to confirm this are 
discussed later). The polymer molecules in the acetone drop at the beginning of 
the simulation were initially well dispersed and in chain-extended 
conformations (Figure 4.51B). As the acetone dispersed into the surrounding 
water, the relatively hydrophobic polymer chains moved towards the centre of 
the shrinking drop. Because the rate of diffusion of the polymer chains was 
slower than that of the solvents, they experienced an increasingly polar 
environment and polymer-polymer interactions became more pronounced. This 
produced both intramolecular collapse of individual polymer chains and 
stronger, more entangled, intermolecular interactions. 
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Figure 4.51 Snapshots taken during the 80ns multiscale simulation of PGA100 
with DXMP. A: 5ns (with acetone shown), B: 5ns, C: 30ns, D: 50ns, E: 80ns 
(with acetone shown), F: 80ns. DXMP (red/blue), PGA (white), acetone (blue). 
Water and CG virtual sites not shown for clarity. 
DXMP is soluble in water and diffused around the simulation box. The 
acetone drop shrank in size during the simulation yet remained relatively 
spherical. DXMP has amphiphilic properties so preferentially interacted at the 
acetone water interphase. 
The more hydrophobic region of DXMP is its steroid nucleus that 
prefers to reside inside in the acetone drop rather than in water. The more 
hydrophilic part of the molecule, the phosphate head group, remains in the 
aqueous phase due to interactions with polar water and ions. This amphiphilic 
nature of DXMP was also seen in Chapter 3 when optimising the drug solvent 
interactions. 
Some DXMP molecules that are in close proximity to the acetone drop 
at the start of the simulation were able to interact quickly with the polymer 
chains (Figure 4.51B). During the rest of the simulation other DXMP 
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molecules positioned at the surface of the shrinking acetone drop were pulled 
onto the surface of the polymer nanoparticle as it assembled. Eventually 
enough acetone dispersed to cause full aggregation of the polymer chains; at 
this point a proportion of DXMP molecules become encapsulated in the 
nascent nanoparticle (Figure 4.51). 
During the simulation DXMP molecules orientated in a favourable 
position as the most hydrophobic part of the molecule was positioned to 
interact with the surface of the relatively hydrophobic polymer nanoparticle. 
This left the phosphate head group of DXMP to interact preferentially with 
surrounding water and counter ions (Figure 4.52). 
 
Figure 4.52 Snapshot taken from a simulation of PGA100 with DXMP. DXMP 
molecules position themselves at the surface of the acetone drop in a specific 
orientation. 
Whilst the polymer chains are in an extended confirmation in the 
acetone drop they have interactions with DXMP molecules at the surface of the 
acetone drop. This could help draw more drug molecules onto the surface of 
121 
 
the acetone drop also increasing the amount of drug encapsulated in the 
assembling nanoparticle. These interactions could be specific to this drug-
polymer combination as the amphiphilic nature of DXMP and the solubility of 
PGA100 both enable this to happen. 
In practical formulation experiments, DXMP-loaded nanoparticles were 
found to display a 20% larger zeta potential than non-loaded polymer 
nanoparticles5. This finding is one indication that the simulation is consistent 
with experimental data and suggests the orientation of DXMP seen in these 
simulations ± i.e. with the exposed phosphate groups at the surface of the 
nanoparticles, is a plausible explanation for the experimentally observed 
negative zeta potentials for DXMP containing nanoparticles. 
Once the acetone is fully dispersed a few acetone molecules are still 
present at the surface of the nascent nanoparticle next to the DXMP molecules 
also present at the surface (Figure 4.51E-F). Experimentally acetone is allowed 
to evaporate and it is assumed that all of the acetone evaporates from the water 
eventually. We are limited to simulating only short time frames so it is not 
known if these acetone molecules remain on the surface of the particles or not. 
This simulation emphasizes the importance of having acetone present in 
the model. Modelling a single solvent type whose characteristics were 
µPRUSKHG¶IURPDFHWRQHWRZDWer over the course of the simulation, in a manner 
similar to Spaeth at al, produced structures similar to those seen in simulations 
of pure water (see Chapter 3). The dispersion and subsequent shrinkage of 
acetone drop brings polymer chains together and promotes their entanglement 
into a nanoparticle. 
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Furthermore DXMP behaves differently in the presence of a shrinking 
acetone drop as already described. With a single solvent particle there is no 
opportunity for DXMP to interact with the surface of an acetone drop. DXMP 
interaction with acetone drop may drive its encapsulation into PGA100 due to 
the shrinkage of the acetone drop. Without acetone, drug molecules would 
have to drift into the vicinity of the aggregating polymer nanoparticle. 
 
4.2 Simulation of PGA20-co-C18PGA80 
nanoprecipitation in the presence of DXMP 
 
Figure 4.53 Snapshots taken during the 80ns multiscale simulation of PGA20-
co-C18PGA80 with DXMP. A: 5ns (with acetone shown), B: 5ns, C: 30ns, D: 
50ns, E: 80ns (with acetone shown), F: 80ns. DXMP (red/blue/white), PGA 
(white), C18 chains (yellow), acetone (blue). Water and CG virtual sites not 
shown for clarity. 
Experimental data suggests that at this specific degree of 
polymerisation (30mer) PGA20-co-C18PGA80 should display the best 
encapsulation efficiency when compared with PGA100 and C18PGA100. Our 
aim was to test if our multiscale simulations could also match this experimental 
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trend. PGA20-co-C18PGA80 was simulated in exactly the same conditions as 
PGA100 except two polymer chains were used instead of three inside the 
acetone drop. 
PGA20-co-C18PGA80 differs from PGA100 by having less hydroxyl 
groups and long hydrophobic acyl chains that extended away from the polymer 
in acetone (Figure 4.53C).  The polymer is less soluble in water and the result 
is that the C18 chains on the polymer were able to interact with DXMP 
molecules near the surface of the shrinking acetone drop. More drugs ended up 
positioned at the surface of the shrinking acetone drop and so this polymer was 
able to encapsulate more DXMP molecules in total when compared with 
PGA100. 
Towards the end of the simulation the polymer chains were more 
exposed to the surrounding water and so the C18 chains become more buried in 
the emerging nanoparticle (Figure 4.53D-F). However, due to the degree of 
side-chain functionalisation of this polymer there was insufficient PGA 
backbone to shield the hydrophobic C18 chains fully from the surrounding 
water. This left some C18 chains exposed to interact with DXMP molecules at 
the surface (Figure 4.53F). Considering the orientation of the DXMP molecules 
was such that the hydrophobic steroid part of the molecule faces the 
nanoparticle surface, these C18 chains can now make strong interactions with 
DXMP as it is drawn onto the nanoparticle surface. These strong interactions 
could affect the release of DXMP from these nanoparticles. 
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4.3 Simulation of C18PGA100 nanoprecipitation in 
the presence of DXMP 
The experimental data on C18 functionalised PGA with DXMP shows 
that PGA20-co-C18PGA80 is the optimal polymer. The reasons for this are 
unclear but the most striking result from the experiments studies on PGA is 
that C18PGA100 displays a marked decrease in encapsulation efficiency when 
compared with PGA20-co-C18PGA80. This result suggests that the increase in 
hydrophobicity and elimination of free hydroxyl groups from the polymer 
influences its ability to encapsulate DXMP. Our aim here was to simulate 
C18PGA100 nanoprecipitation to gain an insight into this experimental trend. 
 
Figure 4.54 Snapshots taken during the 80ns multiscale simulation of 
C18PGA100 with DXMP. A: 5ns (with acetone shown), B: 5ns, C: 30ns, D: 
50ns, E: 80ns (with acetone shown), F: 80ns. DXMP (red/blue/white), PGA 
(white), C18 chains (yellow), acetone (blue). Water and CG virtual sites not 
shown for clarity. 
The simulations for C18PGA100 were similar to the simulations with 
PGA20-co-C18PGA80. DXMP maintains a similar orientation at the surface of 
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the acetone drop and the final aggregated nanoparticle had C18 chains exposed 
that interact with DXMP (Figure 4.54). This was expected as C18PGA100 is a 
very similar polymer to PGA20-co-C18PGA80. 
The surface of the nascent nanoparticle (Figure 4.54F) appeared to 
contain more exposed C18 chains. Compared with PGA20-co-C18PGA80 there 
are more C18 chains, but as only the same number can be buried, into the core 
of the nanoparticle upon aggregation there were a greater number of exposed 
chains. These exposed C18 chains could play a role in increasing interactions 
ZLWK ';03¶V K\GURSKRELF VWHURLG ULQJV Increasing the acylation of PGA 
changes the packing of the chains in the nanoparticle and could change its 
ability to interact with DXMP. A more hydrophobic polymer should pack its 
C18 chains tighter in the nanoparticle reducing interactions with drug 
molecules. 
 
4.4 Model validation through resolution 
transformation 
To assess the accuracy of our multiscale simulations it would be 
desirable to compare with equivalent simulations run with a fully atomistic 
force field. By converting the CG solvent to atomistic solvent and removing 
the CG virtual sites, we created fully atomistic systems for a pure AAMD 
simulation. 
Our aim was to perform AA simulations on snapshots from the 80ns 
multiscale simulation. This would allow comparison of the multiscale force 
field with an atomistic force field. The full simulation system is too large to be 
studied at the atomistic level, therefore subsections from the 80ns multiscale 
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nanoprecipitation simulation, centred on the nascent nanoparticle, were 
extracted at three time points (30, 50, and 80ns). These subsections were 
simulated using an atomistic and multiscale force field separately and the 
behaviour of the polymer and drug molecules was examined. 
These subsections are still in an active state of acetone dispersion. As 
such the comparison simulations were limited to 5ns of molecular dynamics. 
This is because we only wanted to analyse the behaviour of the molecules at 
this time point and not the dynamics of the system over time. Longer 
simulations would result in dispersion of the acetone drop especially at the 
30ns time point. 
Our goal was that the dynamics in both simulations should be as similar 
as possible. Two particular features of the simulations that seemed to be 
important for influencing encapsulation efficiency were the degree of 
compaction of the emerging nascent nanoparticle, and the orientational 
preferences of the drug molecules. We evaluated the former by comparing the 
total radius of gyration (Rg) of the polymer cluster in atomistic versus 
multiscale representations, and the latter using the orientational metric 
described in the Methods.  
Our analysis (Figure 4.55) showed that we were able to replicate both 
features very well using the multiscale force field. For the compaction of the 
nanoparticle the greatest variation in the polymer Rg was seen at the 30ns 
timepoint when the acetone drop is largest. This is due to the solubility of the 
polymer in acetone causing variations in the cluster size. Whilst the fluctuation 
of the Rg was large it is similar for both force fields used. Notaby for PGA20-
co-C18PGA80 at the 30ns time point a decrease in Rg was seen. This is 
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presumably due to the dispersion of acetone during the 5ns simulation that 
effects the compaction of the nanoparticle. However, the changes in Rg that 
were seen in the atomistic simulation are matched with the multiscale 
representation. 
 
 
Figure 4.55 Analysis for PGA100 (top) PGA20-co-C18PGA80 (bottom) with 
DXMP. Left: Two snapshots from the end of the 5ns simulations. DXMP 
(multi), PGA (white with C18 chains yellow). Graphs for the total radius of 
gyration of the polymer cluster (middle) and the orientation of DXMP in 
relation to the centre of mass of the polymer chains (right). Atomistic (red), 
multiscale (green). 
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The orientation of DXMP also fluctuates during the 5ns simulations. 
This was mostly seen at the 50ns and 80ns time points. As DXMP begins to 
interact with the surface of the polymer cluster its orientation can change more 
drastically then when it is positioned at the surface of the acetone drop. Drug 
molecules can lay flat on the surface of the nanoparticle and this will reduce 
WKHǻGLVWDQFH REVHUYHG+RZHYHUZKLOVW FKDQJHV DUH VHHQ WKH\were similar 
with both force fields used. 
The greatest differences between the simulations was seen at the start of 
the simulations when the simulation is still equilibrating to the resolution 
transformation of the solvent. Replacing large spheres with small atomistic 
molecules requires the solute molecules to reorientate around the atomistic 
solvent. Whilst the CG molecules lack any polarity the atomistic molecules 
they were replaced with do. The interactions with the atomistic solute can be 
different depending on the orientation of the atomistic solvent molecules close 
by. With this in mind it is important to consider the orientation of DXMP 
towards the end of the simulations and it is at this point the two simulations are 
predominately in good agreement. 
Resolution transfomation of the C18PGA100 simulation was not 
SHUIRUPHG GXH WR WKH SRO\PHU¶V VLPLODULW\ WR PGA20-co-C18PGA80. Both of 
these polymers have the same CG interactions with the CG solvent as they 
possess the same virtual sites. 
 
4.5 Encapsulation Efficiency and Drug Loading 
Experimentally, PGA20-co-C18PGA80 nanoparticles have shown the 
highest DXMP loading (DL) and encapsulation efficiency (EE)11. With PGA100 
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and C18PGA100 showing similar lower values for DL and EE. Our simulation 
results were in qualitative agreement with this trend: after running triplicates of 
both simulations we found an increase in EE and DL for PGA20-co-C18PGA80 
over the other two polymers simulated (Table 4.1).  
Acylation (%) Encapsulation Efficiency (%) Drug Loading (%) 
0 5.93 +/- 0.25 44.76 +/- 1.05 
80  8.73 +/- 0.25 46.60 +/- 0.71 
100 6.07 +/- 0.09 34.16 +/- 0.35 
                    ൌ ୑ୟୱୱ୭୤ୢ୰୳୥୧୬୬ୟ୬୭୮ୟ୰୲୧ୡ୪ୣ୘୭୲ୟ୪୫ୟୱୱ୭୤ୢ୰୳୥୳ୱୣୢ                
                            ൌ ୑ୟୱୱ୭୤ୢ୰୳୥୧୬୬ୟ୬୭୮ୟ୰୲୧ୡ୪ୣ୘୭୲ୟ୪୫ୟୱୱ୭୤୬ୟ୬୭୮ୟ୰୲୧ୡ୪ୣ                           
Table 4.1 Encapsulation efficiency and drug loading for the three polymer 
systems is calculated for triplicate repeats. Data is obtained from the final 
snapshot of the simulation. 
A direct comparison of these values to the experimental data, whilst 
possible, was not considered due to multiple reasons. The size of our 
nanoprecipitation simulation is incredibly small compared to real life 
experiment. Experimentally nanoparticles formed are roughly 150 nm in 
diameter. The nanoparticles produced by simulation are ~4 nm in diameter, 
roughly 30 times smaller than those made experimentally. Therefore the 
addition a single drug molecule has a much more profound effect on the drug 
loading as this is based on the total weight of the nanoparticle. 
Additionally the volume of water in the simulation has to be fixed. 
Experimentally the volume ratio between acetone and water is much larger. 
This affects the encapsulation efficiency because it is dependent on the total 
mass of drug present in the solvent. As such the drug loading values are likely 
a better metric for comparison with experimental values. 
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We found the simulation values for EE were lower than those found 
experimentally. EE is dependent on the total drug that the nanoparticle can 
hold. In our simulations a large majority of the nanoparticle surface was 
covered in drug molecules. Additionally the simulations were only run for 80ns 
and additional drug may bind to the nanoparticles if the simulations were 
longer. A much larger particle with a larger surface area should be able to bind 
more drug at the same concentration as there is more room for drug to interact 
with the surface of the nanoparticle. Whilst the EE for PGA100 is quite similar 
to experimental data (5.93% vs. ~8% from experiment), the other polymers 
show large differences from experimental values. 
DL is the opposite, simulation values are larger than those found 
experimentally. Again this could be due to the size of the simulated 
nanoparticle. DL is dependent on the mass of drugs present in the nanoparticle 
and the mass of the nanoparticle itself. If the majority of DXMP binds to the 
surface of the polymer nanoparticle then for a small nanoparticle the drug 
loading is large. However, for a large polymer size with predominately surface 
bound DXMP the drug loading decreases as the weight of the polymer has 
increased significantly over the amount of drug encapsulated. A larger sized 
particle has a lower surface area to volume ratio so for an equivalent amount of 
polymer there would be less drug binding for a larger particle. 
For these reasons it is difficult to compare our small scale simulations 
directly with experimental data. We decided instead to focus on the comparison 
of the EE and DL between different polymers which is in good agreement. 
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4.6 Testing Drug Binding Affinity 
As discussed in the Methods, some DXMP molecules do not strongly 
interact with the surface of the polymer nanoparticle. However, these drugs 
were still counted as encapsulated by the nanoparticle based on a subsequent 
simulation in pure water. 
The polymer nanoparticle, including DXMP and acetone molecules 
near the surface of the particle, was placed in a new periodic box filled with 
water. Experimentally once the particles are formed they are eventually washed 
in pure water to remove any drug that is not fully encapsulated. This simulation 
attempts to mimic this process in order to ascertain how DXMP interact with 
the nanoparticle during washing (Figure 4.56). 
For PGA100 a drug was chosen that made minimal contacts with the 
polymer nanoparticle at the end of the 80ns nanoprecipitation simulation. 
During the subsequent 20ns ³ZDVKLQJ´VLPXODWLRQ WKHGUXJTXLFNO\EULQJV LWV
hydrophobic steroidal backbone in greater contact with the polymer whilst 
keeping its hydrophilic phosphate group exposed to the surrounding water. 
Additionally the polymer appears to cluster around the drug molecule to make 
stronger contact. 
The same was true for PGA20-co-C18PGA80 with DXMP. Figure 4.56F 
shows that C18 chains in yellow move to make interactions with the 
hydrophobic steroid part of DXMP. The hydrophobic C18 chains of this 
polymer appeared to make stronger interactions with the drug when compared 
with PGA100. This could result in a better drug release profile for this polymer 
over PGA100 as drugs are held more tightly by the nanoparticle. 
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A drug delivery system aims to release drug over a prolonged period of 
time rather than burst release. From this simulation it was seen that PGA100 is 
more likely to show a burst release of DXMP as it made less interaction with 
the drug than PGA20-co-C18PGA80. With PGA20-co-C18PGA80 the polymer 
moved to make strong hydrophobic interactions with the drug whilst the more 
hydrophilic parts of the polymer were still interacting with the hydrophilic part 
of the drug. 
 
 
Figure 4.56 Snapshots taken during a 20ns pure water simulation of the final 
nascent nanoparticles from the 80ns nanoprecipitation simulation of PGA100 
(A,B,C) and PGA20-co-C18PGA80 (D,E,F) with A and D being the start, B and 
E middle and C and F the end of the simulation. PGA (white), C18 chains 
(yellow) and DXMP (multi). For clarity only a single drug molecule with no 
CG solvent or virtual sites are shown. 
 
4.7 The Importance of Acetone Dispersion 
The general fit of the experimental trends observed for drug 
incorporation by the simulations provides mechanistic insight as to why 
PGA20-co-C18PGA80 is the most effective polymer at encapsulating DXMP. 
A B C 
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From our simulations we observed that DXMP preferentially interacts with the 
acetone water interface, resulting in multiple molecules positioning at the 
surface of the shrinking acetone drop. As the drop reduces in size this brings 
the drug molecules towards the surface of the aggregating polymer chains. This 
drives the interaction of DXMP with the polymer nanoparticle. 
One advantage of using a computational model is that it can be quickly 
adjusted to test new hypotheses. To further assess the effect of acetone 
dispersion on drug loading and encapsulation efficiency we ran two 
simulations. The first involved PGA20-co-C18PGA80 with DXMP in pure water 
without acetone. The polymer and drug molar ratios were kept the same as in 
the original multiscale simulation with acetone and the polymer chains started 
in a similar configuration as they did for the 80ns nanoprecipitation simulation. 
We found a 23% reduction in DL and 43% decrease in EE when compared to 
the original simulations using an acetone droplet. 
The second simulation tested the effect of the rate of acetone dispersion 
by adjusting the diffusion constant of acetone in water. When acetone disperses 
at a faster rate we found a 47% reduction in drug loading and a 69% reduction 
in encapsulation efficiency when compared with the original simulations. 
These results, albeit difficult to reproduce experimentally, confirm our 
initial findings that acetone plays a major role in bringing drug molecules close 
to the surface of the polymer. When the dispersion of an acetone drop is not 
present or artificially sped up, the encapsulation of drug within the polymer 
nanoparticle is reduced. DXMP benefits from having interactions with both the 
acetone and water and this allows drug molecules to be drawn towards the 
polymer as the acetone drop shrinks, increasing encapsulation efficiency and 
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loading. This behaviour may be unique to DXMP and when using 
nanoprecipitation to form a drug delivery system it is important to not only 
consider the drug-SRO\PHU LQWHUDFWLRQV LQYROYHG EXW WKH GUXJ¶V VROXELOLW\ LQ
both solvents used. 
The positioning of DXMP at the acetone drop surface could also 
explain why this drug is encapsulated better than cytarabine by PGA and its 
derivatives experimentally11. DXMP is amphiphilic (logP = 1.56) and can 
interact favourably with both the organic and aqueous phases in the system. 
However, cytarabine is neutral with a log P of -2.8 and as such may not be able 
adopt this orientation on the acetone surface and hence will not be pulled into 
the surface of the aggregating nanoparticle. 
An 80ns nanoprecipitation simulation of PGA100 with cytarabine 
confirmed this hypothesis. Using experimental conditions similar to 
simulations with DXMP, PGA100 had low EE and DL with cytarabine. Our 
simulations also showed that cytarabine does not interact with the acetone drop 
as hypothesised reducing its encapsulation within PGA100. For cytarabine, drug 
encapsulation is reliant on drug diffusing towards the surface of the polymer 
nanoparticle (Figure 4.57). 
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Figure 4.57 Snapshot taken at the end of a simulation containing three chains 
of PGA100 with cytarabine. PGA100 (white), cytarabine (multi). CG solvent and 
virtual sites are not shown for clarity. 
When designing future drug delivery systems it is important to consider 
the interactions between the drug and solvent. For acetone in water an 
amphiphilic drug that interacts with both solvents appears to exhibit increased 
EE and DL. This phenomenon appears to be independent of the polymer used. 
 
4.8 Explanation for the Experimental Trend 
The dispersion of acetone is consistent in all three systems yet we see 
differences in encapsulation efficiency i.e. the amount of drug that reaches the 
surface of the polymer nanoparticle. We analysed the interaction of the 
polymer chains with DXMP over the course of the 80ns simulations (Figure 
4.58). Specifically we looked within the 1.2 nm cut-off for intermolecular 
interactions used in the simulations. This ensured we only consider drug 
molecules that are interacting specifically with the polymer. 
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Figure 4.58 Number of DXMP molecules within 1.2 nm of the polymer chains 
is analysed for all three polymers over the 80ns simulations. Error bars are 
included for the standard error of the mean from triplicate repeats. PGA100 
(red), PGA20-co-C18PGA80 (blue), C18PGA100 (green). 
As the acetone drop dispersed during the simulation, DXMP molecules 
were brought within the 1.2 nm cut-off as they interacted with the polymer 
chains inside. At first there was a consistent increase for all three polymers 
over the first 20ns. However after 20ns PGA20-co-C18PGA80 was able to 
interact with more drug molecules than the other two polymers. More DXMP 
molecules are present at the acetone drop surface when it contains PGA20-co-
C18PGA80 polymer chains, indicating an increased affinity for the drug. By 
50ns acetone had dispersed enough to allow all the DXMP molecules that were 
present at the acetone drop surface to interact with the polymer nanoparticle. 
For the rest of the simulation there was little change in the number of DXMP 
within the 1.2nm cut-off. 
However, it is noteworthy that for PGA20-co-C18PGA80 there was a 
sharp rise in the number of drug molecules interacting with the nanoparticle. 
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This is due to a cluster of drug molecules binding to the surface of the 
nanoparticle (Figure 4.59). 
 
Figure 4.59 Snapshots taken from a PGA20-co-C18PGA80 multiscale 
simulation with DXMP. (A-E) A drug cluster binds to the surface of the 
polymer nanoparticle. (F) A drug cluster in solution formed during the 80ns 
simulation. 
Visual analysis revealed the cluster interacts initially with other drug 
molecules on the surface. Interaction with the C18 chains of the polymer was 
only observed after the drug molecules re-orientate across the surface of the 
particle. Whilst this may be a chance occurrence it was not observed for the 
other two polymers. 
This result suggests that the number of drugs encapsulated within these 
polymers may potentially increase during longer simulations. Drug molecules 
diffusing in the surrounding water may collide with the formed nanoparticle 
and become encapsulated. It is not realistic to test these events with the model 
due to the slow speed of the simulation. As the total simulation time is kept 
constant for all the polymers tested, the comparison between them is still fair. 
A B C
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The difference in the number of DXMP interacting with the three 
different polymer chains occurred during the 20-50ns time frame. This is a key 
point in nanoprecipitation where acetone begins to disperse revealing the 
aggregating polymer chains inside the acetone drop. 
A number of factors are involved in how many drugs reach the surface 
of the acetone drop and were subsequently encapsulated in the polymer 
nanoparticle. The solubility of the polymer chains in both solvents affected the 
rate of polymer aggregation. A more aggregated polymer had fewer 
interactions with DXMP molecules surrounding the acetone drop. 
Additionally, the functional groups on the polymer played a role as the 
C18 chains on PGA20-co-C18PGA80 and C18PGA100 made stronger 
hydrophobic interactions with DXMP. These C18 chains were in an extended 
conformation in acetone but when exposed to water they became buried into 
the nanoparticle. When buried, the interactions with surrounding DXMP 
molecules were decreased resulting in less DXMP bound to the nascent 
nanoparticle (Figure 4.60). 
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Figure 4.60 Snapshots taken at the around the 20ns time point of the 
nanoprecipitation simulations. PGA100 (A,D), PGA20-co-C18PGA80 (B,E), 
C18PGA100 (C,F). Acetone is shown on the top row of snapshots to indicate the 
size of the acetone drop. PGA (white) and C18 chains (yellow). Water is not 
shown for clarity. 
A polymer needs to maintain good solubility in both solvents to ensure 
it is in an extended, un-aggregated state for as long as possible. This guarantees 
maximum interaction with surrounding DXMP molecules before the polymer 
fully aggregates into a nanoparticle. However, hydrophobic moieties that 
reduce the solubility of the polymer are still required. C18 chains formed 
stronger interactions with DXMP than the PGA backbone in the simulation. 
Whilst hydroxyl groups may be necessary for the solubility of the polymer they 
do not seem to form strong interactions with the drug molecules. A balance of 
hydrophobic and hydrophilic moieties is required to ensure optimal interactions 
with surrounding DXMP molecules. 
To analyse this further the total radius of gyration (Rg) for the polymer 
clusters was calculated during the 10-50ns time period where acetone disperses 
and water begins to interact with the polymer chains (Figure 4.61).  
A B C 
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In acetone the polymers were relatively soluble and so the total Rg was 
large and fluctuated. However, as acetone dispersed, the polymer was exposed 
to water and this triggered the aggregation of the polymer chains. PGA100 was 
the most soluble of the three polymers in both acetone and water and so 
maintained a large total Rg during this time period. The total Rg for PGA20-co-
C18PGA80 and C18PGA100 was lower due a decrease in solubility arising from 
the acylation of PGA. However, the total Rg was higher for PGA20-co-
C18PGA80 as it contains 20% more hydrophilic hydroxyl groups than 
C18PGA100. This allowed PGA20-co-C18PGA80 to maintain a more extended 
conformation during the simulation than C18PGA100 during this crucial time 
period. 
 
Figure 4.61 The radius of gyration of the all the polymers in each system over 
the 10-50ns time period of the 80ns multiscale simulation. Error bars are 
included for the standard error of the mean from triplicate repeats. PGA100 
(red), PGA20-co-C18PGA80 (blue), C18PGA100 (green). 
Overall PGA20-co-C18PGA80 was able to interact with more DXMP 
molecules in the surrounding water. This pulled more DXMP onto the acetone 
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drop surface which subsequently increased drug loading with this particular 
polymer. 
Whilst PGA100 had the largest total Rg, indicating it interacted the most 
with surrounding DXMP molecules, it lacks the hydrophobic C18 chains that 
are required for strong interactions with DXMP. 
 
4.9 Conclusion 
The results from this chapter on polymer drug compatibility are in 
agreement with contact angle measurements on similar PGA polymers by 
Orafai et al.40 A PGA60-co-C8PGA40 polymer showed the lowest surface free 
energy when compared with PGA100 and C8PGA100 polymers. It was 
hypothesised that this due to a balance of polar and nonpolar components in the 
polymer. 
The balance of polymer polarity/hydrophilicity was also proposed from 
experimental data by Kallinteri et al.12 However, they suggested that hydroxyl 
JURXSV RQ 3*$PD\ SOD\ D UROH LQ LQWHUDFWLQJ ZLWK WKH ';03¶V SKRVSKDWH
groups forming hydrogen bonds. This is an assumption that drug-polymer 
interactions drive encapsulation. Our simulations revealed that whilst DXMP 
PD\IRUPK\GURJHQERQGVZLWK3*$¶VK\GUR[\OJURXSVLWLVWKHVROXELOWLHVRI
the drug and polymer molecules in the two solvents used that affects the 
encapsulation efficiency of this particular polymer-based drug delivery system. 
Our simulations have revealed intricate processes that affect drug 
encapsulation. Molecular dynamics has provided a unique insight into 
nanoprecipitation. Whilst drug-polymer interactions are important, solubility of 
the solutes in both solvents is also significant. Changes to the polymer may 
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enhance drug-polymer interactions they may also affect polymer solubility. 
However, this could have the opposite effect on encapsulation efficiency than 
intended. For this reason carrier and drug solubility should also be considered 
when optimising a drug delivery system. 
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Chapter 5 
Incorporation of DXMP into 
PGA Nanoparticles: Atomistic 
Model 
 
The simulation of nanoprecipitation, including the dispersion of 
acetone, requires a large amount of molecules to interact simultaneously. 
Specifically the amount of solvent is vast, slowing down the speed of the 
simulation significantly. To overcome this, solvent molecules were coarse-
grained and a multiscale model was used to enable AA solute molecules to 
interact with CG solvent molecules. 
However, it has always been the case that a fully atomistic MD 
simulation is the most realistic MD model possible. An AA model is also more 
accurate than the multiscale model because it does not require the mixing of 
two force fields. AA force fields are well optimised and widely used in the 
field of computational modelling. CG models have several caveats, the most 
important being the loss of detailed electrostatic interactions and long-range 
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electrostatics. This was a major obstacle in optimising the multiscale model 
used in the previous chapter. 
Previously AA simulations were used as reference simulations often at 
small scales due to their computationally demanding nature. Resolution 
transformation on small subsections of the multiscale nanoprecipitation 
simulation enabled comparison of the multiscale force field with an AA force 
field. However, these simulations are not ideal as only a small subsection of the 
entire simulation box was analysed. Preferably the entire system would be 
simulated for a realistic comparison between the two force fields. 
Whilst we were confident in the results obtained with the multiscale 
force field in the previous chapter based on the resolution transformation, we 
were interested in the dynamics of an entirely atomistic simulation of 
nanoprecipitation. Without an atomistic reference simulation of the entire 
simulation it is difficult to be 100% sure of the accuracy of the multiscale 
model. 
Our results so far have also shown that solvent plays a large role in 
encapsulation efficiency and drug loading for a polymer drug delivery system. 
Acetone dispersion rate and its interaction with both the polymer and drug 
affected how the polymer and drug interact. As we have simplified the acetone 
in our multiscale simulation using CG acetone, we were interested in 
simulating nanoprecipitation using atomistic solvent. 
Our aim with this simulation was to analyse every aspect of it and 
compare it with our previous work. Through comparison we should be able to 
see faults in the multiscale model and address them in an updated force field. 
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5.1 Acetone Dispersion 
We previous calculated that an 80ns fully atomistic simulation of 
PGA20-co-C18PGA80 in the presence of DXMP would contain over 20 million 
atoms. On our computational resources available this would take around 6 
months to run including queuing time. As such we wanted to ensure that the 
simulation was as good as possible before it was run. This involved ensuring 
every aspect of the model was as close as possible to experimental conditions. 
Based on the results from the multiscale model we knew that the 
dispersion of acetone would have a profound effect on the simulation. 
Therefore we decided to analyse the rate of atomistic acetone dispersion using 
an AA force field again to ensure accuracy in relation to experimental 
conditions. 
We previously optimised the dispersion of CG acetone in CG water 
using AA acetone obtained from the Automated Topology Database (ATB) 
version 1.0. At the time this topology was considered sufficient for our needs. 
However, recently this acetone topology has been updated and this has altered 
the diffusion constant of AA acetone in AA water. 
Experimentally the diffusion constant for acetone in water at various 
temperatures and molar fractions was determined by Tyn et al. in 1975. Our 
aim was to simulate the diffusion of acetone in a box of water and compare the 
diffusion constant with these experimental results. 
Whilst AMBER and OPLS provide acetone topologies, the GROMOS 
force field does not and so the ATB was used to obtain one. Our original 
acetone model was obtained from version 1.0 of the ATB compatible with the 
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GROMOS 53A6 force field. This united atom topology contained neutral 
methyl atoms and had a +/-0.450 charge on the central carbonyl group. 
 
Figure 5.62 Chemical structure of acetone showing methyl groups and central 
carbonyl group. 
Other acetone models available from the literature include WS 
(Weerasinghe and Smith), Perera, Vlugt and TraPPE (Transferable Potentials 
for Phase Equilibria) models. The WS model optimised using Kirkwood-Buff 
(KB) integrals has shown good performance over a range of acetone molar 
ratios. The KB theory relates the structure of a solution to its thermodynamic 
properties. KB integrals using the radial distribution function from a solvent 
mixture can create a topology for a molecule through optimisation against 
experimental data. 
The WS parameters for acetone differ from the ATB v1.0 acetone 
topology used previously as the charge on the central carbonyl is increased to 
+/- 0.565. There are also differences in the sigma and epsilon values that define 
the Lennard Jones potential for the carbon, oxygen and methyl united atoms. 
Additionally the bonded parameters of the model slightly differ. 
 
į-0.450 
į+0.450 
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5.1.1 Molecular Dynamics Optimisation 
To determine the optimal acetone topology we compared the ATB 
models and the WS model to determine which matched the experimental 
values from Tyn et al. closest. 
Mixtures of acetone and water at two molar ratios: 0.024 and 0.28 were 
created. These ratios were chosen due to the experimental data available. The 
molecules were first allowed to mix fully, then a production MD simulation of 
1ns was used to analyse the acetone diffusion constant in SPC/E water. As the 
diffusion constant varies with molar ratio we wanted to ensure that our acetone 
topology would have a diffusion constant similar to the experimental values at 
these two molar ratios. 
 Exp. ATB 
v1.0 
ATB 
v1.2 
ATB 
v2.0 
WS WS_RM 
Diffusion Constant 
(1x10-5 cm2/s) 
0.650 2.263 0.477 1.461 0.934 0.655 
Oxygen Charge n/a -0.450 -0.652 -0.568 -0.565 
 
-0.626 
Carbon Charge n/a +0.450 +0.652 +0.734 
 
+0.565 
 
+0.626 
Table 5.1 Summary of the atomistic acetone models tested and compared with 
experimental data for the diffusion constant of acetone in water at a molar ratio 
of 0.28. 
At a 0.28 molar ratio the diffusion constant of acetone experimentally is 
0.650x10-5 cm2/s. The original WS model produced a diffusion constant of 
0.934x10-5 cm2/s, this was adjusted to 0.655x10-5 cm2/s by increasing the 
charge on the carbonyl of acetone to +/-0.626. The other bonded parameters of 
the WS model were left unchanged but this slight increase in the polarity of the 
molecule changed its diffusion constant to match the experimental data. 
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This new model, named WS_RM henceforth, was tested with a 0.024 
molar ratio acetone-water mixture. This molar ratio is closer to the ratio used in 
the nanoprecipitation simulation (0.002). At this molar ratio the diffusion 
constant using the WS_RM model was 1.088x10-5 cm2/s which is in good 
agreement with the experimental value of 1.140 x10-5 cm2/s. 
Our results show that the latest ATB parameters were unable to 
generate the dynamics required to match the experimental diffusion constant of 
acetone in water. The original version 1.0 ATB and version 2.0 acetone 
parameters resulted in diffusion constants that were vastly different to the 
experimental value.  
Version 1.2 has a carbonyl charge that is similar to our optimised 
WS_RM model. But other parameters in the topology result in a decrease in the 
diffusion constant with respect to the experimental data. 
The ATB acetone model may be more suited to other simulations that 
do not involve its dispersion in water. However, for nanoprecipitation we 
require the most accurate dispersion of acetone in water and so we have chosen 
to use the WS_RM model. 
 
5.2 Fully Atomistic Simulation of PGA20-co-
C18PGA80 nanoprecipitation in the presence of 
DXMP 
The WS_RM model for acetone differs from the original ATB v1.0 
acetone model to which the multiscale force field was parameterised. 
Compared to the multiscale model, the dispersion of acetone using WS_RM is 
faster. The time taken for full dispersion of acetone during nanoprecipitation is 
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almost halved with a full nanoparticle forming around 20-30ns into the 
simulation. 
This difference between the models means that this fully atomistic 
simulation will not be identical to the multiscale simulations due to the change 
in acetone dispersion. A decrease in the drug loading and encapsulation 
efficiency is expected based on previous results on faster dispersing acetone. 
However, the increased dispersion speed of acetone is advantageous as the total 
simulation time required for nanoprecipitation is greatly reduced. The total 
required time required to run the simulation was reduced to ~3 months. 
The fully atomistic simulation was created using identical 
concentrations to the previous multiscale simulations. We chose to simulate 
PGA20-co-C18PGA80 as this polymer showed the highest encapsulation 
efficiency and drug loading using the multiscale force field and also 
experimentally. Unfortunately due to time constraints we were unable to 
simulate nanoprecipitation with the other two polymers using a fully atomistic 
force field. 
With the new WS_RM acetone topology the acetone drop dispersed 
into to the surrounding water at around double the speed. This caused faster 
aggregation of the polymer chains during the simulation. At 10ns almost all of 
the C18 chains had collapsed onto the surface of the nanoparticle and full 
aggregation into a nanoparticle occurred at around 20ns into the simulation 
(Figure 5.63). 
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Figure 5.63 Snapshots taken during the 50ns atomistic simulation of PGA20-co-
C18PGA80 with DXMP. A: 2ns, B: 10ns, C: 20ns, D: 30ns, E: 40ns , F: 50ns. 
DXMP (red/blue/white), PGA (white), C18 chains (yellow), acetone (blue). 
Water and acetone not shown for clarity. 
Faster polymer aggregation reduced the interactions the polymer can 
make with surrounding drug molecules; something which was observed in the 
multiscale simulations. Still, C18 chains were still exposed on the surface of 
the polymer cluster. Similarly to the multiscale simulation these chains became 
buried into the polymer upon full exposure to water towards the end of the 
simulation. 
Drug molecules that start close to the polymer chains at the beginning 
of the simulation formed strong interactions as the polymer quickly aggregates. 
Later in the simulation drug molecules bound to the surface of the nanoparticle 
by chance interaction whilst diffusing through the solvent. The expected 
orientation of the drug molecules was consistent with the multiscale 
simulations. Drug molecules lay flat on the surface of the nanoparticle with the 
charged phosphate group exposed to surrounding water and counter ions. As 
A B C 
D F E 
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the simulation progressed the polymer chains rearranged to form tighter 
contacts with drugs at the nanoparticle surface. This buried some drug 
molecules slightly deeper into the nanoparticle. 
This process of the nanoparticle adapting to DXMP was also seen in 
multiscale simulations of polymer/drug nanoparticles in pure water after the 
80ns multiscale simulation. The steroid part of DXMP is hydrophobic enough 
to promote stronger interactions with the polymer once it has interacted with 
the polymer nanoparticle surface initially (Figure 5.64). 
 
Figure 5.64 Snapshot taken at the end of the 50ns atomistic nanoprecipitation 
simulation. Some drug molecules are buried into the nanoparticle whilst others 
rest on the surface. 
This highlights a potential flaw in the multiscale model. Interactions 
between the polymer nanoparticle and drug molecules may be reduced due to 
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the force field. An increase in the relative dielectric constant used for the 
multiscale simulation could be reducing the electrostatic interactions between 
these molecules. Whilst the orientation of the drug molecules is correct DXMP 
was unable to bury itself into the nanoparticle in the multiscale simulations. 
Another reason could be due to the difference in the dispersion of 
acetone. Acetone maintains a droplet shape during the multiscale simulation 
but in the atomistic simulation acetone this does not happen. For the atomistic 
simulation this reduces the amount of acetone present at the surface of the 
nanoparticle, resulting in a more aqueous environment at the exterior of the 
nanoparticles compared with the multiscale model. This causes the 
hydrophobic steroid backbone of DXMP to become buried into the 
hydrophobic nanoparticle (Figure 5.65B). 
 
Figure 5.65 The location of acetone at the start (A) and end (B) of the 50ns 
fully atomistic nanoprecipitation simulation. 
Furthermore acetone could be preventing further DXMP molecules 
from interacting with the surface of the polymer nanoparticle if they happen to 
drift close by. As acetone shields the hydrophobic surface of the nanoparticle 
further drug encapsulation could be reduced. 
A B
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([SHULPHQWDOO\ QDQRSDUWLFOHV DUH OHIW WR µKDUGHQ¶ RYHUQLJKW DIWHU WKH\
form, allowing acetone in the water to evaporate. This could allow drug 
molecules to make stronger contacts with the nanoparticle. However, we are 
unable to test this in our simulation due to time constraints. 
 
5.3 Encapsulation Efficiency and Drug Loading 
As expected the increased speed of acetone dispersion had an impact on 
encapsulation efficiency. As with our previous experiments on faster dispersing 
acetone using the multiscale force field (section 4.7), a decrease in both drug 
loading and encapsulation efficiency was seen. This was due to the decreased 
interaction between DXMP and acetone and faster aggregation of the polymer 
chains. 
When acetone dispersed at a slower rate, as in the multiscale force field, 
the surface of the drop was present for longer allowing more drug molecules to 
interact with it. The acetone drop appeared to dissolve into the surrounding 
water instead of all the acetone molecules dispersing equally. This was due to 
strong interactions between the CG acetone beads holding them together. The 
result is that acetone remained as a drop for a longer time which allowed 
DXMP molecules to interact with its surface. 
At a faster acetone dispersion rate using the WS_RM model, the 
acetone drop surface was less prevalent (Figure 5.66). DXMP was unable to 
interact with an acetone drop and therefore drugs were not brought onto the 
surface of the polymer as acetone dispersed. 
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Figure 5.66 The dispersion of atomistic acetone over 50ns during the fully 
atomistic nanoprecipitation simulation. 
In our fully atomistic simulation we found that 12 DXMP molecules 
were encapsulated by PGA20-co-C18PGA80 after 50ns. This translates to an EE 
of 2.4% and a DL of 24.7%. When compared with the multiscale simulation of 
PGA20-co-C18PGA80 with DXMP the EE has dropped by roughly a third and 
DL has halved. It should be noted this data is from a single simulation as 
repeats were not feasible due to time constraints. 
This result reaffirms our previous understanding that acetone dispersion 
rate has a major role in the EE and DL for DXMP with PGA20-co-C18PGA80. 
Our results indicate that a slower dispersing solvent may increase drug loading 
for this polymer drug delivery system. This could be tested experimentally by 
using a solvent with a lower diffusion rate in water than acetone. If amphiphilic 
DXMP is still able to interact with this solvent then the slower dispersing 
solvent will allow for a greater amount of drug molecules to interact with the 
solvent drop before it fully disperses. 
 
5.4 Sodium Ion Interactions 
In the multiscale force field there are no electrostatic interactions 
between the CG solvent and the atomistic molecules in the system. As a 
consequence tKH LQWHUDFWLRQ EHWZHHQ VRGLXP FRXQWHU LRQV DQG ';03¶V
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phosphate group was strong. This caused almost all of the drugs to interact 
strongly with at least one sodium counter ion in solution during the 80ns 
multiscale simulation. Although electrostatics were decreased by increasing the 
relative dielectric constant, drugs that were unable to pair with a counter ion 
buried their charged phosphate groups into the polymer nanoparticle as the 
only other source of counter charge. 
 
Figure 5.67 (A) A large cluster of DXMP molecules forms with sodium 
counter ions for the phosphate charge. (B) Phosphate groups on DXMP 
molecules encapsulated by PGA20-co-C18PGA80 interact with surrounding 
ions. 
In the fully atomistic system solvent molecules have electrostatic 
interactions with the solute molecules. Whilst the interaction of sodium counter 
ions with the phosphate groups on DXMP was still observed, it was less 
pronounced. In addition we were able to observe that clusters of DXMP 
formed with counter ions. These clusters were also observed during the 
multiscale simulation. The use of particle mesh Ewald allowed for long range 
electrostatics between DXMP and the sodium ions resulting in presumably 
more realistic behaviour between these molecules. 
A B
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This is difficult to replicate in the multiscale model as long range 
electrostatics were not used, instead a short range 1.2 nm shifted potential was 
used. Whilst PME could be used it is likely not the solution as the primary 
problem was a lack of electrostatic interactions between the solute and solvent. 
In bulk water the sodium counter ions were the only major counter charge for 
DXMP and so they bound tightly when CG solvent is used. 
The phosphate group of DXMP is water soluble due to its phosphate 
group making hydrogen bonds with water. Dexamethasone is far less water 
soluble than DXMP as it has a hydroxyl group in place of the charged 
phosphate found on DXMP. When sodium forms strong electrostatic 
interactions with DXMP a salt forms that decreases interactions with the polar 
water molecules. This could promote its aggregation with other drug molecules 
that have also formed sodium salts (Figure 5.67A). 
 
5.5 Drug Cluster Binding to the Polymer 
Nanoparticle 
As with the multiscale simulations, DXMP clusters formed relatively 
quickly during the nanoprecipitation simulation in bulk water. Around 25ns 
into the atomistic simulation we observed a single drug cluster merging with 
the surface of the nascent polymer nanoparticle (Figure 5.68). 
As the drug cluster contains several drugs, the binding of this cluster 
contributed about half of the overall encapsulated drug found in the 
nanoparticle at the end of the simulation. 
Once the nanoparticle had formed, drug encapsulation occurred due to 
chance interactions with DXMP molecules diffusing through the bulk water. 
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When these drug molecules formed a cluster, the surface area to interact with 
the polymer nanoparticle increased. This might have increased the chances of 
drug being encapsulated. 
 
Figure 5.68 The process of a DXMP cluster merging with the surface of the 
polymer nanoparticle is shown over 2ns A-E. F: Close-up of where the drug 
bound to the surface of the polymer (drug shown with liquorice representation 
for clarity). 
In Figure 5.68F it can be seen that DXMP preferentially bound to the 
yellow C18 chains of the polymer. These hydrophobic chains make strong 
interactions with the hydrophobic steroid rings on DXMP. The C18 chains can 
be seen to reach out and interact with the drug cluster (Figure 5.68B). The 
cluster was then brought onto the surface of the nanoparticle and broken up. 
The drug molecules then moved across the nanoparticle surface where they 
found optimal interactions predominately with the C18 chains on the polymer. 
Unfortunately we were only able to run a single fully atomistic 
simulation of nanoprecipitation so we were unable to confirm the probability of 
these clusters binding to the polymer nanoparticle.  
A B C
D FE
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5.6 Conclusion 
This simulation and the multiscale simulations in the previous chapter 
have shown that not only is drug-polymer compatibility important, but also 
interactions with solvent. An ideal solvent will ensure high solubility for the 
polymer and form good interactions with the drug to promote encapsulation. 
Slow diffusion of the polymer solvent into the counter solvent may increase the 
amount of drug that is brought onto the polymer nanoparticle surface and 
subsequently encapsulated. When optimising nanoparticle formation for a drug 
delivery system not only does the polymer need to be optimised through trial 
and error but the solvents used for nanoprecipitation should also be adjusted. 
The atomistic simulation described in this chapter has shown that when 
acetone diffuses in accordance with experimental data, fewer drug molecules 
were drawn onto the polymer surface. This results in the majority of drug-
polymer interactions occurring once the nanoparticle had already formed. This 
suggests that drug-polymer interactions may be more prevalent than first 
thought. 
During the simulation drug clusters were able to interact with the 
nascent nanoparticle. These drug clusters break up on contact with the 
nanoparticle and individual drug molecules embed into the nanoparticle 
surface. This atomistic simulation showed that C18 chains facilitated this 
interaction. 
The multiscale simulations also showed drug cluster interaction with an 
extant PGA20-co-C18PGA80 nanoparticle. However, DXMP did not interact 
with C18 chains but DXMP molecules already bound to the surface of the 
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nanoparticles. The atomistic simulation using a more accurate acetone 
dispersion rate revealed that drug loading in the multiscale simulations was 
artificially increased. This suggests that drug-polymer interactions rather than 
drug-drug interactions are most likely to facilitate the interaction with 
surrounding drug clusters. 
This may explain why we have not observed drug cluster binding to 
PGA100 or C18PGA100. PGA100 lacks C18 chains and may be unable to interact 
strongly enough with nearby drug clusters present in solution. C18PGA100 may 
lack the correct packing of the polymer in order for it to be mobile enough to 
extend its C18 chains out into the surrounding solution. This was shown in the 
multiscale simulations in the previous chapter where C18PGA100 forms a very 
tight nanoparticle compared to the other two polymers simulated. Additionally 
this hypothesis could explain the reduction in encapsulation efficiency and 
drug loading with these polymers. As they are less likely to bind DXMP 
clusters their overall drug loading of DXMP is reduced compared with PGA20-
co-C18PGA80. 
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Chapter 6 
Incorporation of DXMP into 
PGA Nanoparticles: Updated 
Multiscale Model 
 
The fully atomistic simulation described in the previous chapter 
unveiled some new interactions between DXMP and PGA20-co-C18PGA80. 
Most notably the change in diffusion rate of acetone affected the encapsulation 
efficiency of the polymer. This faster dispersing acetone is believed to be a 
more accurate representation of experimental conditions as it is based on 
experimentally determined diffusion constants of acetone in water. 
Whilst the accuracy of the AA simulation is superlative, the time taken 
for the simulation was extremely long. In order to use a nanoprecipitation 
model to aid in the experimental creation of polymer-based drug delivery 
systems the simulations must be relatively quick. Our initial 80ns multiscale 
nanoprecipitation simulations took around five days using the fastest available 
computational resources at the time. The shorter fully atomistic simulation 
(50ns) took around three months to complete. Whilst this simulation offers the 
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most relative accuracy it is too slow for our needs. Fully atomistic simulations 
may serve a purpose in analysing some experimental results but they cannot 
achieve rapid results. 
A computational model needs to be able to quickly ascertain the 
compatibility of a drug-polymer pairing. This includes running multiple 
simulations to check for errors in the simulation. Our multiscale model is ideal 
for this, as although it has a slight decrease in accuracy it is significantly faster 
than fully atomistic simulations. 
We have established that acetone should be dispersing at a faster rate 
than previously thought; at 50ns the simulations are completed in roughly three 
days. Triplicate repeats of a simulation are completed quicker and results 
obtained faster. 
The original multiscale simulation described in Chapter 4 was 
optimised vis-a-YLVDWRPLVWLF³JROGVWDQGDUG´VLPXODWLRQVRIVPDOOVXEV\VWHPV
However, with the completion of the fully atomistic simulation we have access 
to a full scale reference simulation. 
Our aim at this stage was to attempt to replicate the dynamics observed 
in the fully atomistic simulation using the multiscale force field. If we can 
optimise the multiscale force field for the nanoprecipitation PGA20-co-
C18PGA80 with DXMP, these optimisations should hopefully work for the 
other two polymers. Overall this allows for another detailed analysis of the 
experimental data and may reveal new explanations for the experimental trend. 
It should be noted that when attempting to perfectly match two things 
that are inherently different it is highly non-trivial. CG acetone is a simple 
sphere compared to the united AA acetone model that contains partial charges 
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and four separate atoms. As such we are merely attempting to reach the best 
possible match for the multiscale simulation as an exact replica is likely to be 
impossible. 
For clarity, in this chapter we will refer to the original multiscale force 
field used in Chapter 4 as MS1 and the updated force field used for this chapter 
as MS2. 
 
6.1 Optimisation 
6.1.1 Acetone Dispersion 
In the original multiscale force field (MS1), the CG acetone diffusion 
constant was matched with the diffusion constant of AA acetone using a 
topology obtained from the ATB. The new acetone topology, WS_RM, was 
created to match the experimental diffusion constant of acetone in water at two 
different molar ratios. As such this topology was considered superior to the 
previous AA topology and resulted in faster dispersion of the acetone drop 
during the nanoprecipitation simulation. 
As with the original optimisation we wanted to match the diffusion 
constant and mean squared diffusion over time using CG acetone in CG water. 
Adjusting the non-bonded interactions between these two CG molecules 
enables adjustment of the diffusion constant of acetone in water. 
Using the same 5ns simulation of a small sphere of acetone dispersing 
in water, we calculated the mean squared displacement (MSD) of acetone. The 
AA WS_RM acetone topology changes the MSD of AA acetone to 1.3456x10-5 
cm2/s. This value was matched using CG acetone to a reach an MSD of 
1.3758x10-5 cm2/s. 
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Figure 6.69 Plots for the mean squared displacement of acetone in water using 
various force fields. Original ATB AA (cyan), original multiscale (MS1) 
(purple), MARTINI CG (blue), WS_RM AA (green), new multiscale (MS2) 
(red). 
Using MS1 the MSD over time for acetone in water was larger than 
with the updated multiscale force field (MS2). The overall diffusion constant 
for the 5ns simulation was also larger. However, we know that for our larger 
scale nanoprecipitation simulation this acetone dispersed into water at a faster 
rate. With MS1 the diffusion constant was larger (2.213x10-5 cm2/s) but 
acetone dispersed into water over a longer time frame (60-80ns). 
The diffusion constant indicates that on average acetone using MS1 
diffuses faster than with MS2. However, the time taken for the acetone drop to 
disperse in water was shorter with MS2. This is due to the behaviour of the 
acetone drop in the two different force fields. Using MS1 acetone dissolves 
into water whereas with MS2 the acetone drop disperses equally and does not 
remain as a spherical droplet (Figure 6.70).  
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Figure 6.70 The dispersion of acetone differs between the original MS1 force 
field (left) and the atomistic force field WS_RM (right). Acetone is shown as a 
single sphere in both images for comparison. 
CG acetone beads have a smoother surface than the atomistic acetone 
and this promotes faster dynamics. To match the atomistic acetone model using 
CG acetone it was necessary to increase the interaction between these beads to 
retard the diffusion/dispersion of the beads. Whilst this decreased the diffusion 
constant to ensure that acetone dispersed evenly and did not remain as a 
droplet, the interaction with solvent was also increased. 
For a 5ns simulation this worked as is seen in Figure 6.69, however by 
increasing intermolecular interactions for acetone the chance of the solvent 
freezing is drastically increased. The MARTINI force field has been 
documented as having a propensity for freezing, specifically when the water is 
at 290K +/- 5K. This is due to relatively strong interaction between water 
molecules sometimes generating a nucleation point for water to freeze. When 
using a shift potential there are no long-range electrostatics in the simulation to 
prevent freezing. 
To slow the overall MSD of acetone in water the short range 
interactions between the CG molecules were increased but this results in 
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acetone were not suitable for our nanoprecipitation simulation. 
To prevent freezing, the MARTINI force field uses antifreeze particles. 
These particles have extremely high attractive interactions with the solvent to 
prevent clustering into a nucleus from which the solvent can freeze. Attempts 
were made to introduce an antifreeze particle for acetone without success. 
Additionally the complication of having an unrealistic particle in the system 
was undesirable. 
 
Figure 6.71 The MSD of acetone in water during 50ns of nanoprecipitation 
simulation time. Original multiscale (blue), fully atomistic (red), optimised 
multiscale (green). 
Consequently the diffusion of acetone for the new multiscale force field 
was optimised based on a direct comparison of the MSD of acetone during the 
fully atomistic simulation (Figure 6.71). The initial Lennard-Jones epsilon and 
sigma parameters were based on the results from the smaller 5ns simulation 
and then tested on a 50ns nanoprecipitation simulation. These parameters were 
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further optimised until they were able to reasonably matched acetone 
dispersion in the fully atomistic simulation. 
 
6.1.2 PGA20-co-C18PGA80 Radius of Gyration 
Additionally the radius of gyration for the two polymer chains in the 
simulation was optimised. The interaction between PGA20-co-C18PGA80 and 
CG acetone was adjusted such that the aggregation of the polymer chains 
matched the fully atomistic simulation (Figure 6.72). 
The attraction of the polymer to CG acetone was increased to retard the 
aggregation of the polymer chains. This allowed the Rg over time to match the 
fully atomistic simulation from polymer chains starting in similar 
configurations. Whilst the initial drop in Rg is steeper with the MS2 force field 
the Rg when the polymer nanoparticle forms is slightly larger.  
 
Figure 6.72 The total radius of gyration for a two polymer cluster is analysed 
over a 50ns nanoprecipitation simulations. Fully AA (green), MS2 (red). 
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Upon analysing the simulation we found that acetone was being 
retained around the polymer nanoparticle which lubricated the chains reducing 
nanoparticle density. 
Although the MSD over time was matched against the fully atomistic 
simulation, the dispersion of acetone using the MS2 force field is still slightly 
different. This may be a flaw in using CG solvent molecules. The CG 
interactions between the virtual sites on the atomistic polymer and the CG 
acetone prevented correct aggregation of the polymer chains during the 
simulation. The interaction with acetone had to be increased to correct the 
radius of gyration but this resulted in incorrect acetone dispersion (Figure 6.73Figure  
6.73). 
Acetone remained as a droplet due to stronger interactions with the 
polymer chains than the surrounding water. It is possible to correct this and 
prevent clustering of acetone around the polymer chains however the overall 
dispersion of acetone becomes too quick. Full dispersion of the acetone drop 
occurred over a short time frame and this is unreasonable if we want to match 
the atomistic simulation. As explained at the start of this chapter it may be 
impossible to perfectly match the AA dynamics of nanoprecipitation. 
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6.2 Simulation of PGA20-co-C18PGA80 
nanoprecipitation in the presence of DXMP 
 Visual analysis revealed that despite the flaws in the MS2 force field; 
the nanoprecipitation of PGA20-co-C18PGA80 was very similar to the fully 
atomistic simulation (Figure 6.74). The polymer nanoparticle aggregates over a 
similar time frame to the atomistic simulation. Compared with MS1, polymer 
chains aggregated earlier in the simulation using MS2 due to faster dispersing 
acetone. 
Drug loading was fairly similar also with the MS2 simulation binding 
15 drugs molecules, an increase of 3 over the atomistic simulation. This 
equates to a 0.6% increase in EE and 4.3% increase in drug loading. Repeats 
would need to be performed to confirm these values. 
Whilst the number of drugs encapsulated in the simulation was similar, 
the interaction between the polymer and drug molecules was different. Firstly 
the drugs appeared to bind less tightly to the nanoparticle than in the atomistic 
simulation. The orientation of the drug was similar, but drugs were not buried 
into the nanoparticle. This could be explained by the layer of acetone that 
remained around the nanoparticle (Figure 6.75). Acetone surrounded the 
nanoparticle solvating drug molecules at the surface. This prevented them from 
binding tightly to the nanoparticle and burying their hydrophobic steroid rings. 
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Figure 6.75 Snapshots taken at the end of the nanoprecipitation simulation of 
PGA20-co-C18PGA80 with DXMP using the MS2 force field (left) and 
atomistic force field (right). Acetone surrounding the polymer is shown for 
comparison. 
Additionally drugs appear to initially bind the nanoparticle in the 
incorrect orientation (Figure 6.76). The negative charge on the phosphate group 
of DXMP buried into the nanoparticle if the drug was unable to partner with a 
sodium counter ion. Efforts were made to prevent this in the MS1 force field 
such as increasing the relative dielectric constant and those are unchanged with 
MS2. However, the presence of the acetone drop in the MS1 simulations 
prevented drug from reaching the polymer nanoparticle before the drug 
partnered with a counter ion.  
Acetone dispersed faster with MS2, so there was still somewhat of an 
acetone drop around the polymer chains but it was not enough to prevent drug 
molecules from interacting with the polymer at early stages in the simulation 
before the drug found a counter ion. If a counter ion was able to interact with 
the phosphate group of DXMP the orientation of the drug was reversed (Figure 
6.76). 
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Figure 6.76 The binding of DXMP to PGA20-co-C18PGA80 during the MS2 
simulation (left). If DXMP binds an ion the orientation of the drug molecule is 
reversed (right).  
 
Figure 6.77 Snapshots taken during the 50ns MS2 simulation of PGA20-co-
C18PGA80 with DXMP salt. A: 2ns, B: 10ns, C: 20ns, D: 30ns, E: 40ns, F: 
50ns. DXMP (red/blue/white), PGA (white). Water and acetone not shown for 
clarity. 
Whilst counter ions were able to reverse the orientation of DXMP and 
the encapsulation efficiency is comparable to the atomistic simulation, the way 
the drug interacts with the nanoparticle was different. As we wanted to match 
A B C 
D F E 
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the atomistic dynamics as closely as possible we decided that starting the 
simulation with DXMP as a disodium salt would correct this erroneous 
binding. This involved adding DXMP to the simulation box with two counter 
ions in close proximity to the phosphate group of the drug. This contrast with 
the normal method where counter ions are introduced randomly throughout the 
simulation box by replacing water beads. 
Starting DXMP as a salt prevented the drug from burying its negative 
charge into the nanoparticle during the simulation (Figure 6.77). The diffusion 
constant of DXMP was unchanged when it was present as a salt. This new 
model is named MS2_salt hereafter. 
DXMP bound in the correct orientation to the polymer but the large 
amount of acetone surrounding the nanoparticle prevented the drugs from 
being buried into the particle as they were in the fully atomsitic simulation. 
 To check this hypothesis, a 10ns ³ZDVK´VLPXODWLRQLQSXUH&*ZDWHU
was run where acetone surrounding the polymer was removed.  In this 
simulation the drug molecules were able to bind tighter to the nanoparticle 
(Figure 6.78). 
 
Figure 6.78 Snapshots taken from the 10ns wash simulation in pure CG water 
at the start (left) and end (right) of the simulation using the MS2 force field. 
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 Additionally the radius of gyration of the polymer cluster changed due 
to the removal of acetone. During the first 100 ps of the simulation the Rg 
decreases and by the end of the 10ns ³ZDVK´VLPXODWLRQWKH5g matched closely 
with the Rg obtained at the end of the fully atomistic simulation (Figure 6.79). 
 
Figure 6.79 The radius of gyration (Rg) for the PGA20-co-C18PGA80 
nanoparticle during a 10ns wash simulation (blue) is overlaid with the Rg from 
the last 10ns of the MS2 simulation (red) and fully atomistic simulation 
(green). 
 The presence of acetone at the surface of the polymer nanoparticle was 
affecting its compaction and interaction with DXMP molecules at the surface. 
The removal of acetone alleviated these problems and allowed the model to 
behave similarly to the fully atomistic simulation. 
 
6.3 Simulation of C18PGA100 nanoprecipitation in 
the presence of DXMP (MS2_salt) 
 The simulation for C18PGA100 is similar to that of PGA20-co-
C18PGA80. DXMP was present as a disodium salt again to correct its 
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orientation. Again drug molecules were unable to form tight interactions with 
the polymer due to a layer of acetone that surrounded the nanoparticle at the 
end of the simulation. Upon removal of acetone these drugs will form tighter 
interactions and so we considered these drugs encapsulated within the 
nanoparticle. 
 
Figure 6.80 Snapshots taken during the 50ns MS2 simulation of C18PGA100 
with DXMP salt. A: 2ns, B: 10ns, C: 20ns, D: 30ns, E: 40ns, F: 50ns. DXMP 
(red/blue/white), PGA (white). Water and acetone not shown for clarity. 
 In Figure 6.80D we observed a few DXMP molecules interacting with 
the layer of acetone that coated the polymer. This acetone could artificially 
increase the encapsulation of DXMP in this model compared with the atomistic 
simulation. In the atomistic simulation acetone dispersed evenly (Figure 6.73Figure 6.73) 
therefore DXMP was able to directly interact with the nanoparticle surface. As 
DXMP preferentially interacts at the acetone water interface, a layer of acetone 
around the polymer chains attracts more drug molecules to the nascent 
nanoparticle. 
A B C 
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 20ns into the simulation the nanoparticle appeared more compacted 
than PGA20-co-C18PGA80 at this time point. The increased hydrophobicity of 
this polymer and decreased solubility in acetone may cause tighter compaction 
and increased density of the C18PGA100 nanoparticle. This could reduce the 
ability for DXMP molecules to interact with the surface of C18PGA100. 
 
6.4 Simulation of PGA100 nanoprecipitation in the 
presence of DXMP (MS2_salt) 
 
Figure 6.81 Snapshots taken during the 50ns MS2 simulation of PGA100 with 
DXMP salt. A: 2ns, B: 10ns, C: 20ns, D: 30ns, E: 40ns, F: 50ns. DXMP 
(red/blue/white), PGA (white). Water and acetone not shown for clarity. 
For PGA100 the radius of gyration of the polymer during the simulation 
was different than with the other two polymers tested. This can be seen visually 
in Figure 6.81. With the PGA20-co-C18PGA80 and C18PGA100 the polymer 
chains fully aggregated within 10ns. However for PGA100 full aggregation of 
the polymer chains into a nanoparticle did not occur until 40ns into the 
simulation. This was due to the reduction in hydrophobicity for this polymer 
A B C 
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when compared with the acylated versions of PGA. The hydroxyl groups on 
PGA kept the polymer chains in an extended conformation for a longer 
duration during nanoprecipitation. 
DXMP was able to bind the polymer in the correct orientation due to 
the presence of the counter ion bound to its charged phosphate group. The 
increased solubility of this polymer reduced the nanoparticle density and forms 
nooks throughout the nanoparticle surface. This could aid in binding DXMP at 
the surface of the nascent nanoparticle. 
 
6.5 Drug Loading and Encapsulation Efficiency 
Polymer Model No. DXMP 
bound 
Encapsulation 
Efficiency (%) 
Drug Loading 
(%) 
PGA20-co-C18PGA80 AA 12 2.4 24.70 
 MS2 15 3 29.08 
                             MS2_salt 18 3.6 32.98 
C18PGA100  MS2 25 5 40.60 
 MS2_salt 19 3.8 34.19 
PGA100  MS2 25 5 40.60 
 MS2_salt 14 2.8 27.68 
Table 6.1 The encapsulation efficiency and drug loading for three polymers 
with DXMP was analysed using different models. 
For the new MS2 force field we were unable to run triplicate repeats 
due to time constraints. However, we were able to compare the effect of 
starting DXMP as a disodium salt as opposed to free drug with counter ions. 
For C18PGA100 and PGA100 there was a marked decrease in drug loading when 
DXMP started as a salt. This is because the phosphate group of DXMP is less 
attracted to the polymer as it did not need to bury its negative charge as it is 
countered by two sodium ions. The electrostatic attraction of DXMP to the 
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polymer chains was increased in the absence of a counter ion for its phosphate 
group. However, for PGA20-co-C18PGA80 we saw little change when DXMP 
started as a salt. Therefore this hypothesis would need to be tested with repeat 
simulations. 
All of the MS2 simulations had higher DL and EE than the fully 
atomistic simulation. This is likely due to the layer of acetone that surround the 
nanoparticle as it forms. DXMP was drawn to the acetone and this artificially 
increased the number of drug molecules that interact with the nanoparticle 
compared with the atomistic simulation where acetone did not form layer 
around the polymer chains. 
Compared with the results of the original MS1 simulations we were 
unable to perfectly match the experimental trend for the polymers. Obviously 
this would need to be tested with triplicate repeats. Nonetheless, the acylated 
polymers PGA20-co-C18PGA80 and C18PGA100 were able to encapsulate more 
drug than PGA100 when starting DXMP as a salt. Despite PGA100 sustaining a 
considerably larger radius of gyration throughout the simulation the lack of 
C18 chains on the polymer appear to reduce its encapsulation efficiency with 
DXMP. 
 The lack of disparity between PGA20-co-C18PGA80 and C18PGA100 
may be due to the presence of acetone around the polymer during the 
simulation. This acetone layer was similar for both polymers and so similar 
amounts of drug interact with these two polymers. Correction of acetone 
dispersion to perfectly match the atomistic simulation may yield more accurate 
drug loading results. 
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Additionally differences between the acylated polymers are less 
pronounced due to the faster aggregation of the polymer chains. As acetone 
dispersed faster when compared with the original MS1 model it is unlikely that 
we will observe differences in the polymers radius of gyration that could affect 
encapsulation of DXMP. By having polymer at a concentration much higher 
than experimental conditions the aggregation of the polymer chains was very 
fast. Therefore we would expect to see little difference in the encapsulation of 
DXMP between these two polymers. 
 
6.6 Conclusion 
 In the updated multiscale force field MS2 we were able to closely 
match the diffusion constant for acetone in water based on the diffusion 
constant obtained from the fully atomistic simulation of PGA20-co-C18PGA80 
with DXMP. We also match the radius of gyration of PGA20-co-C18PGA80 
during nanoprecipitation. However, we still observed a layer of acetone coating 
the polymer chains as they aggregated. This may be a problem with the use of a 
CG solvent model as it was very difficult to match the AA acetone dynamics 
perfectly. 
 Additionally DXMP was prone to binding the nanoparticle in an 
incorrect orientation so an updated model where DXMP started as a salt bound 
to two counter ions was used. This corrected the orientation of DXMP during 
the simulation yet the levels of DL and EE using the MS2 force field were 
higher than for the atomistic simulation. This was due to the layer of acetone 
that surrounded the polymer cluster during nanoprecipitation. DXMP interacts 
with this acetone increasing the amount of drug molecules drawn onto the 
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surface of the aggregating nanoparticle. Subsequent simulations in pure CG 
water with the acetone removed revealed that DXMP will bind the polymer 
similarly to the atomistic simulation. 
Whilst we have improved certain aspects of the simulation the MS2 
force field is still not perfect. We were able to show that levels of DL and EE 
do decrease compared with the MS1 force field due to the faster dispersion of 
acetone. Unfortunately we are unable to match the dispersion of AA acetone in 
AA water using a CG model. This has proven the most difficult optimisation 
and will need further work in the future. 
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Chapter 7 
Conclusions and Future Work 
 
 In this thesis a computational model to simulate the nanoprecipitation 
of PGA with DXMP was presented. The conception of the model and use of a 
multiscale force field was discussed. DPD and other coarse-grained simulation 
techniques were considered less accurate than a multiscale model that allowed 
for atomistic drug-polymer interactions. 
 The multiscale force field was optimised via comparison with atomistic 
simulations. Metrics were designed to ensure the dynamics in the multiscale 
simulation matched the atomistic simulation. The dispersion of acetone into 
water was of particular importance due to its solubilising effect on both drug 
and polymer molecules in the model. 
 After simulating three polymers the drug loading and encapsulation 
efficiency data matched an experimentally determined trend. The 
hydrophobicity of the polymer and its solubility in acetone affected its radius 
of gyration. This was found to influence its attraction to drug molecules 
surrounding the acetone drop. 
It would be useful to explore the effect of PGA acylation in more depth. 
Whilst the experimental trend is matched for three polymers we would have 
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more confidence in the multiscale model created if more polymers were tested. 
For example experimental data exists for a 40% acylated polymer. Additionally 
simulating a 70% or 90% acylated polymer would help determine the optimal 
C18 acylated polymer for DXMP. 
 Our initial hypothesis is that hydroxyl groups on the polymer influence 
its solubility in acetone and water. Other functional groups that would help 
increase the solubility of the polymer without effecting its hydrophobic 
interactions with DXMP could also be beneficial. PGA has been functionalised 
experimentally with amino acids in the past. A copolymer with amino acid 
groups and C18 chains could increase encapsulation efficiency with DXMP. 
However, the packing of the polymer nanoparticle may change due to steric 
effects of large amino acid groups. 
 The length of the acyl chain was not tested by simulation. 
Experimentally varying the length of the acyl chain had profound effects on the 
encapsulation of DXMP within nanoparticles. A computational model offers an 
easy method to explore these modifications to PGA and will also provide a 
molecular level understanding of how a change in acyl chain length affects 
polymer dynamics, solubility and interactions with DXMP. 
$Q LQFUHDVH LQ FKDLQ OHQJWK LQFUHDVHV WKH SRO\PHU¶V K\GURSKRELFLW\
These longer chains may be able to interact with more drug molecules at the 
surface of the acetone drop. However, more hydrophilic groups may be 
required to balance the polymers solubility in acetone and water. Hydroxyl 
groups may be insufficient to maintain optimal compaction of the polymer. 
Again an amino acid may be a useful hydrophilic group to add to the polymer 
to balance its hydrophobicity with longer hydrophobic acyl chains. 
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 When acetone disperses into water at a faster rate the loading of DXMP 
within a PGA20-co-C18PGA80 nanoparticle decreased. This suggests that a 
slower dispersing solvent may be able to increase the encapsulation efficiency 
of this particular polymer drug mixture. The model could be used to test new 
solvents that are slower at dispersing in water than acetone. Any potential 
candidates should be subsequently tested experimentally.  
 The atomistic simulation of PGA20-co-C18PGA80 with DXMP revealed 
that the dispersion of acetone in our original multiscale model (MS1) was not 
accurate with regards to experimentally determined diffusion constants of 
acetone in water. However, atomistic simulations were very slow and due to 
limited computational resources we were only able to run a single simulation 
for this thesis. It would be useful to have atomistic simulations of the other two 
polymers tested: PGA100 and C18PGA100 so that the multiscale force field for 
these polymers can also be optimised. 
 For the update multiscale force field, MS2, we corrected the dispersion 
of acetone and the aggregation of PGA20-co-C18PGA80 using the atomistic 
simulation as a reference. Additionally to correct the orientation of DXMP 
during nanoprecipitation, using the atomistic simulation as a reference, the 
drug was started as a disodium salt. Whilst this ensured DXMP bound in the 
correct orientation it is not accurate to experimental conditions. Additionally 
we were unable to perfectly match the atomistic dispersion of acetone in water 
using a CG model. The overall dispersion of acetone had to be slowed but also 
disperse more evenly without remaining as a droplet. To achieve this strong 
interactions between the CG acetone beads themselves and CG water were 
required. However, this caused CG acetone to freeze at 300 kelvin. It may be 
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SRVVLEOH WR XVH ³DQWLIUHH]H´ SDUWLFOHV WKDW KDYH EHHQ XVHG LQ WKH 0$57,1,
force field to prevent the freezing of acetone. Correcting this flaw in the MS2 
force field will bring it in line with the dynamics of the atomistic simulation. 
The DL and EE values obtained using the MS2 force field did not 
match the experimental trend as well as the MS1 model. This is likely due to a 
lack of repeats and further optimisation for the MS2 force field using PGA100 
and C18PGA100 is required. Having the atomistic simulation of PGA20-co-
C18PGA80 with DXMP helped in optimising MS2 for this polymer, but 
resolution transformation could be used in the future with the PGA100 and 
C18PGA100 MS2 simulations to improve the force field for these polymers. 
 
When optimising the multiscale force field a consistent problem was 
the large charge on DXMP. This charge meant that the system required counter 
ions and a careful adjustment of the relative dielectric constant for the 
simulation. This problem has also been observed by Wassenaar et al. when 
using a multiscale force field with charged protein side chains. They were 
unable to match the potential of mean force (PMF) between charged amino 
acids when compared with an atomistic force field. 
The likely cause of this disparity is the lack of polarity of CG water. 
Converting four mobile polar water molecules into a neutral bead has profound 
implications on charged moieties using a multiscale force field. However, 
Wassenaar et al. found that even polarisable CG water models such as BMW 
and MARTINI PW were unable to match the PMF between charged amino 
acids produced using AA SPC/E. The PMF for a sodium and chloride ion was 
different to SPC/E for all CG water models tested. 
185 
 
We have also observed inaccurate electrostatic interactions in our own 
multiscale simulations. The interaction of the sodium counter ions with the 
phosphate group of DXMP was exaggerated. In the atomistic simulation using 
PME with AA water, DXMP had weaker interactions with the counter ions in 
the system. 
Therefore the simulation of neutral drug molecules is expected to be 
more accurate with the multiscale force field. Not only are counter ions not 
required for neutral drug molecules but the relative dielectric constant of the 
simulation can be substantially decreased from the large value used for DXMP. 
The ideal relative dielectric constant (İr) for atomistic interactions is 1 as this 
ensures accurate electrostatics between the atomistic molecules in the system. 
:HKDGWRXVHDQİr of 6 for our multiscale simulations to reduce the strength of 
electrostatic interactions with the charged phosphate group of DXMP. 
+RZHYHU LI WKHV\VWHPFRQWDLQVDOOQHXWUDOPROHFXOHV WKHİr could be set to a 
much lower value. The optimisation of neutral molecules is likely much faster 
and easier than for charged ones. 
 
 In theory a fully CG model of nanoprecipitation is also possible if the 
CG interactions are adjusted such that the dynamics match a fully atomistic 
reference simulation such as the one completed for PGA20-co-C18PGA80 with 
DXMP. A CG model has many advantages over a multiscale force field, the 
most important being the possibility to simulate much larger systems. CG 
simulations can be run with a time step around 20 times longer than multiscale 
and AA simulations. A larger time step drastically reduces the amount of 
equations that must be computed for a simulation. 
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 Large scale simulations of nanoprecipitation could provide insight into 
that formation of nanoparticles closer in size to those formed experimentally. 
The particles formed in our multiscale and AA simulations were around 30 
times smaller than those formed experimentally. Larger particles could reveal 
new ways in which DXMP binds to PGA and its derivatives. 
 Our initial simulations found the MARTINI force field unable to 
accurately simulate nanoprecipitation of PGA with DXMP. As such a fully CG 
simulation would require re-parameterisation of the MARTINI force field in a 
similar manner to how the multiscale CG interactions were optimised. The 
fully atomistic simulation could be used as the ideal reference to which a new 
CG force field could be optimised. 
However, it is likely that the CG force field created may be specific to 
the polymer it is optimised for. Whilst the optimisation may be quick due to the 
decreased time to run CG simulations, the lack of atomistic detail makes 
analysis difficult. It is probable that drug-polymer interactions would be 
inferior in a CG simulation. Furthermore CG drug molecules are difficult to 
create with no established method. Usually the CG beads on the molecule must 
be tightly constrained which often reduces flexibility such that the drug 
becomes a rigid block of connected CG beads. 
 Ideally the removal of water would be the best way to speed up the 
simulation of nanoprecipitation. The majority of the model is comprised of 
water and so the bulk of simulation time is spent on interactions between water 
molecules. An implicit solvent model may be possible however this would 
likely result in inaccurate acetone dispersion. A key conclusion from this work 
has been that the dispersion of acetone has a major impact on the encapsulation 
187 
 
of DXMP into PGA polymers. We were unable to match the dispersion of AA 
acetone using CG acetone in CG water so it is likely that it will be more 
difficult using implicit water. 
 
 In the literature there is little focus on how nanoparticles form but 
rather how drug molecules are encapsulated into preformed particles. Our 
results have demonstrated that the formation of nanoparticles influences their 
encapsulation efficiency. However, the majority of DXMP bound to the 
nanoparticle was on the surface. This indicates that it is possible for preformed 
nanoparticles to achieve similar encapsulation efficiency to nanoparticles that 
are formed in the presence of drug molecules. 
 This difference in encapsulation efficiency between forming and pre-
formed particles was analysed by Woodhead et al. in the introduction26. The 
advantage of simulating with preformed particles is that there is no need to 
simulate the dispersion of acetone in water that is a big limitation to the 
nanoprecipitation simulations in this thesis. However, in order to achieve the 
correct polymer entanglement, nanoprecipitation using an acetone drop must be 
performed. One method would involve running a multiscale simulation of 
nanoprecipitation in the absence of drug at a large scale. This would form a 
polymer nanoparticle which could, when stripped of it's virtual sites, be used 
for fully atomistic simulations. AA nanoparticles in pure water could be 
simulated with AA drug molecules at a relevant concentration to observe their 
interactions. 
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 We have also considered that the nanoprecipitation simulation we have 
designed may not be completely accurate compared to how it occurs 
experimentally. In our simulations acetone starts as a drop surrounded by 
water. However, we know that the acetone can diffuse quickly in water so it is 
unrealistic to assume that a droplet could stay intact as it enters the water such 
that it can become surrounded by it. 
 
Figure 7.82 An alternative model for nanoprecipitation where the aqueous and 
organic phases are separated into planes and allowed to mix during the 
simulation. 
A more realistic simulation could involve simulating two planes of 
solvent mixing with each other. As the acetone drop makes contact with the 
water it is likely that it disperses into the water in this way as opposed to a 
droplet dispersing in all directions. In addition to being potentially more 
Water + Drug 
Acetone + 
Polymer 
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accurate, this model may also require less water than our nanoprecipitation 
model. 
One limitation of this model is in dealing with boundary conditions. 
Normal xyz boundary conditions would allow for water to diffuse into acetone 
through the y boundary. This results in acetone diffusing not only with water 
below but also through the boundary above. To prevent mixing of solvent 
across the y boundary it is possible to use the walls feature in GROMACS. 
This allows the construction of a wall of Lennard-Jones particles that prevent 
the movement of particles across the y boundary. 
 
This thesis has focused heavily on nanoprecipitation and the formation 
of nanoparticles. Whilst this provides understanding of this complicated 
process there are other techniques that can be used to aid in developing 
polymer-based drug delivery systems. These techniques also help address the 
inability for MD to help understand drug released from nanoparticles. As drug 
release occurs over a long time frame we are currently unable to observe this 
using conventional MD. 
The first is the free energy of binding of the drug to polymer 
nanoparticle. This technique is traditionally used for drug molecules bound 
within an active site of a protein. However, it is possible to apply techniques 
such as MM-PBSA (Molecular Mechanics Poisson Boltzmann Surface Area) 
to calculate the free energy of binding DXMP to a nanoparticle. 
 GMXPBSA52 allows for the calculation of free energies using 
GROMACS and could be used on the nanoparticles formed in this thesis. Our 
initial studies are not presented in this thesis as the results were inconclusive 
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but there is potential to use free energy of binding to indicate the relative 
strength of drug-polymer interactions in a drug delivery system. 
 Similarly umbrella sampling could be used to obtain the free energy 
profile for drug release from a nanoparticle. Using steered MD in a similar 
manner to Maiti et al.32 it is possible to remove single DXMP molecules from 
PGA nanoparticles formed using the multiscale force field. Umbrella sampling 
can be used to calculate the potential of mean force for that particular delivery 
system. 
 Not only is this an interesting method to compare the drug-polymer 
interactions between different polymers, but it can also give an indication of 
the drug release profile for a particular delivery system. DXMP molecules that 
have a lower free energy barrier from the umbrella sampling form weaker 
interactions with the nanoparticle and should be more readily released in 
solution. 
 The advantage of this technique is that it gives an insight into drug-
polymer interactions without need to simulate nanoprecipitation. However, to 
form the drug delivery systems nanoprecipitation will have to be run initially. 
Our studies in this area were inconclusive due to the variation in the 
drug-polymer interactions at the surface of the polymer. Umbrella sampling 
requires multiple simulations to be run with a large amount of optimisation. 
Some drugs were bound more tightly than others and so to gain an accurate 
representation of the drug-polymer interactions multiple DXMP molecules 
would need to be analysed. 
It would be beneficial to automate the process of umbrella sampling for 
all the drugs bound to a particular nanoparticle. The larger the sample size the 
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more accurate the comparison between polymers as it is likely the free energy 
barrier could be quite similar if drugs are bound in similar positions on the 
nanoparticle. This is especially true for drugs that are bound to the surface of 
WKHSRO\PHU$³ZDVK´VLPXODWLRQLQSXUHZDWHUFRXOGHQVXUHGUXJPROHFXOHV
form optimal interactions with the nanoparticle before umbrella sampling is 
performed. 
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Appendix 
 
WS_RM Acetone Topology 
[ moleculetype ] 
; Name   nrexcl 
AON      3 
[ atoms ] 
;  nr  type  resnr  resid  atom  cgnr  charge    mass    total_charge 
    1   CHA    1     AON     C1    1    0.000  15.0350      ;  0.000 
    2   CAC    1     AON     C2    2    0.626  12.0110  
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    3   OAC    1     AON     O1    2   -0.626  15.9994      ;  0.000 
    4   CHA    1     AON     C3    3    0.000  15.0350      ;  0.000 
; total charge of the molecule:   0.000 
[ bonds ] 
;  ai   aj  funct   c0         c1 
    1    2    2   0.1507   7.1500e+06 
    2    3    2   0.1222   1.6600e+07 
    2    4    2   0.1507   7.1500e+06 
[ pairs ] 
;  ai   aj  funct  ;  all 1-4 pairs but the ones excluded in GROMOS itp 
[ angles ] 
;  ai   aj   ak  funct   angle     fc 
    1    2    3    2    121.44   730.00 
    1    2    4    2    117.12   670.00 
    3    2    4    2    121.44   730.00 
[ dihedrals ] 
; GROMOS improper dihedrals 
;  ai   aj   ak   al  funct   angle     fc 
    2    3    4    1    2      0.00   167.36 
 
Multiscale DXMP.gro 
Gromacs Runs On Most of All Computer Systems 
   68 
    1DXM     C7    1   1.266   0.954   1.154 
    1DXM     H4    2   1.349   0.946   1.223 
    1DXM     H5    3   1.190   0.882   1.183 
    1DXM     H6    4   1.224   1.053   1.162 
    1DXM     C5    5   1.425   1.026   0.970 
    1DXM     C6    6   1.318   0.922   1.010 
    1DXM    C11    7   1.206   0.930   0.896 
    1DXM     F1    8   1.277   0.917   0.777 
    1DXM     C4    9   1.554   1.005   0.992 
    1DXM     H2   10   1.627   1.081   0.966 
    1DXM     C1   11   1.609   0.875   1.043 
    1DXM     O1   12   1.725   0.861   1.080 
    1DXM     C2   13   1.509   0.762   1.040 
    1DXM     H1   14   1.548   0.662   1.054 
    1DXM     C3   15   1.381   0.783   1.020 
    1DXM     H3   16   1.311   0.701   1.018 
    1DXM     C8   17   1.380   1.155   0.900 
    1DXM     H7   18   1.395   1.142   0.793 
    1DXM     H8   19   1.443   1.238   0.932 
    1DXM     C9   20   1.232   1.189   0.926 
    1DXM     H9   21   1.205   1.277   0.867 
    1DXM    H10   22   1.219   1.217   1.030 
    1DXM    C10   23   1.136   1.073   0.890 
    1DXM    H12   24   1.108   1.084   0.785 
    1DXM    C13   25   1.006   1.083   0.974 
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    1DXM    H16   26   1.032   1.078   1.080 
    1DXM    C14   27   0.907   0.969   0.947 
    1DXM    H22   28   0.879   0.970   0.841 
    1DXM    C15   29   0.971   0.833   0.979 
    1DXM    H14   30   0.999   0.828   1.084 
    1DXM    H15   31   0.902   0.752   0.958 
    1DXM    C12   32   1.095   0.817   0.886 
    1DXM    H13   33   1.057   0.829   0.783 
    1DXM     O2   34   1.154   0.687   0.897 
    1DXM    H11   35   1.080   0.625   0.874 
    1DXM    C16   36   0.919   1.208   0.952 
    1DXM    H17   37   0.913   1.231   0.846 
    1DXM    H18   38   0.959   1.296   1.002 
    1DXM    C17   39   0.779   1.170   1.007 
    1DXM    H23   40   0.766   1.214   1.106 
    1DXM    C18   41   0.665   1.223   0.917 
    1DXM    H19   42   0.673   1.331   0.910 
    1DXM    H20   43   0.567   1.199   0.957 
    1DXM    H21   44   0.673   1.182   0.817 
    1DXM    C19   45   0.781   1.012   1.027 
    1DXM    C20   46   0.653   0.939   0.974 
    1DXM     O4   47   0.634   0.920   0.855 
    1DXM     O3   48   0.805   0.978   1.165 
    1DXM    H24   49   0.741   1.033   1.216 
    1DXM    C21   50   0.552   0.887   1.081 
    1DXM    H25   51   0.517   0.971   1.142 
    1DXM    H26   52   0.606   0.819   1.148 
    1DXM     O5   53   0.445   0.812   1.021 
    1DXM     P1   54   0.308   0.906   0.979 
    1DXM     O8   55   0.192   0.822   0.897 
    1DXM     O6   56   0.376   1.045   0.907 
    1DXM     O7   57   0.268   0.979   1.128 
    1DXC     AD   58   1.609   0.874   1.042 
    1DXC     BD   59   1.322   0.886   1.061 
    1DXC     CD   60   1.346   1.123   0.932 
    1DXC     DD   61   1.218   0.964   0.842 
    1DXC     ED   62   0.842   1.171   0.962 
    1DXC     FD   63   1.081   0.770   0.918 
    1DXC     GD   64   0.828   0.985   1.058 
    1DXC     HD   65   0.615   0.916   0.959 
    1DXC     ID   66   0.316   0.912   0.985 
   1.96400   1.96400   1.96400 
 
Multiscale DXMP.itp 
[ moleculetype ] 
; Name   nrexcl 
DXM     3 
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[ atoms ] 
;  nr  type  resnr  resid  atom  cgnr  charge    mass    total_charge 
    1     C    1     DXM     C7    1   -0.192  12.0110  
    2    HC    1     DXM     H4    1    0.064   1.0080  
    3    HC    1     DXM     H5    1    0.064   1.0080  
    4    HC    1     DXM     H6    1    0.064   1.0080      ;  0.000 
    5     C    1     DXM     C5    2    0.028  12.0110  
    6   CH0    1     DXM     C6    2    0.017  12.0110  
    7   CH0    1     DXM    C11    2    0.150  12.0110  
    8     F    1     DXM     F1    2   -0.179  18.9984      ;  0.016 
    9     C    1     DXM     C4    3   -0.114  12.0110  
   10    HC    1     DXM     H2    3    0.064   1.0080      ; -0.050 
   11     C    1     DXM     C1    4    0.189  12.0110  
   12     O    1     DXM     O1    4   -0.249  15.9994      ; -0.060 
   13     C    1     DXM     C2    5   -0.107  12.0110  
   14    HC    1     DXM     H1    5    0.068   1.0080      ; -0.039 
   15     C    1     DXM     C3    6   -0.054  12.0110  
   16    HC    1     DXM     H3    6    0.100   1.0080      ;  0.046 
   17     C    1     DXM     C8    7   -0.122  12.0110  
   18    HC    1     DXM     H7    7    0.061   1.0080  
   19    HC    1     DXM     H8    7    0.061   1.0080      ;  0.000 
   20     C    1     DXM     C9    8   -0.112  12.0110  
   21    HC    1     DXM     H9    8    0.056   1.0080  
   22    HC    1     DXM    H10    8    0.056   1.0080      ;  0.000 
   23     C    1     DXM    C10    9   -0.055  12.0110  
   24    HC    1     DXM    H12    9    0.055   1.0080      ;  0.000 
   25     C    1     DXM    C13   10   -0.047  12.0110  
   26    HC    1     DXM    H16   10    0.047   1.0080      ;  0.000 
   27     C    1     DXM    C14   11   -0.049  12.0110  
   28    HC    1     DXM    H22   11    0.049   1.0080      ;  0.000 
   29     C    1     DXM    C15   12   -0.124  12.0110  
   30    HC    1     DXM    H14   12    0.062   1.0080  
   31    HC    1     DXM    H15   12    0.062   1.0080      ;  0.000 
   32     C    1     DXM    C12   13    0.060  12.0110  
   33    HC    1     DXM    H13   13    0.054   1.0080      ;  0.114 
   34    OA    1     DXM     O2   14   -0.306  15.9994  
   35     H    1     DXM    H11   14    0.192   1.0080      ; -0.114 
   36     C    1     DXM    C16   15   -0.112  12.0110  
   37    HC    1     DXM    H17   15    0.056   1.0080  
   38    HC    1     DXM    H18   15    0.056   1.0080      ;  0.000 
   39     C    1     DXM    C17   16   -0.047  12.0110  
   40    HC    1     DXM    H23   16    0.047   1.0080      ;  0.000 
   41     C    1     DXM    C18   17   -0.192  12.0110  
   42    HC    1     DXM    H19   17    0.064   1.0080  
   43    HC    1     DXM    H20   17    0.064   1.0080  
   44    HC    1     DXM    H21   17    0.064   1.0080      ;  0.000 
   45   CH0    1     DXM    C19   18    0.108  12.0110  
   46     C    1     DXM    C20   18    0.188  12.0110  
   47     O    1     DXM     O4   18   -0.249  15.9994      ;  0.047 
   48    OA    1     DXM     O3   19   -0.309  15.9994  
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   49     H    1     DXM    H24   19    0.187   1.0080      ; -0.122 
   50     C    1     DXM    C21   20    0.230  12.0110  
   51    HC    1     DXM    H25   20    0.066   1.0080  
   52    HC    1     DXM    H26   20    0.066   1.0080      ;  0.140 
   53    OA    1     DXM     O5   21   -0.559  15.9994  
   54     P    1     DXM     P1   21    0.921  30.9738  
   55    OM    1     DXM     O8   21   -0.854  15.9994      ;  0.329 
   56    OM    1     DXM     O6   21   -0.854  15.9994  
   57    OM    1     DXM     O7   21   -0.854  15.9994  
   58   AD  1  DXC   AD   22  0 
   59   BD  1  DXC   BD   23  0 
   60   CD  1  DXC   CD   24  0 
   61   DD  1  DXC   DD   25  0 
   62   ED  1  DXC   ED   26  0 
   63   FD  1  DXC   FD   27  0 
   64   GD  1  DXC   GD   28  0 
   65   HD  1  DXC   HD   29  0 
   66   ID  1  DXC   ID   30  0 
 
[ bonds ] 
;  ai   aj  funct   c0         c1 
    1    2    2   0.1090   1.2300e+07 
    1    3    2   0.1090   1.2300e+07 
    1    4    2   0.1090   1.2300e+07 
    1    6    2   0.1530   7.1500e+06 
    5    6    2   0.1530   7.1500e+06 
    5    9    2   0.1330   1.1800e+07 
    5   17    2   0.1530   7.1500e+06 
    6    7    2   0.1570   2.7500e+06 
    6   15    2   0.1530   7.1500e+06 
    7    8    2   0.1360   4.7700e+06 
    7   23    2   0.1570   2.7500e+06 
    7   32    2   0.1570   2.7500e+06 
    9   10    2   0.1090   1.2300e+07 
    9   11    2   0.1520   5.4300e+06 
   11   12    2   0.1230   1.6600e+07 
   11   13    2   0.1520   5.4300e+06 
   13   14    2   0.1090   1.2300e+07 
   13   15    2   0.1330   1.1800e+07 
   15   16    2   0.1090   1.2300e+07 
   17   18    2   0.1090   1.2300e+07 
   17   19    2   0.1090   1.2300e+07 
   17   20    2   0.1530   7.1500e+06 
   20   21    2   0.1090   1.2300e+07 
   20   22    2   0.1090   1.2300e+07 
   20   23    2   0.1530   7.1500e+06 
   23   24    2   0.1090   1.2300e+07 
   23   25    2   0.1530   7.1500e+06 
   25   26    2   0.1090   1.2300e+07 
   25   27    2   0.1530   7.1500e+06 
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   25   36    2   0.1530   7.1500e+06 
   27   28    2   0.1090   1.2300e+07 
   27   29    2   0.1530   7.1500e+06 
   27   45    2   0.1530   7.1500e+06 
   29   30    2   0.1090   1.2300e+07 
   29   31    2   0.1090   1.2300e+07 
   29   32    2   0.1530   7.1500e+06 
   32   33    2   0.1100   1.2100e+07 
   32   34    2   0.1435   6.1000e+06 
   34   35    2   0.1000   1.5700e+07 
   36   37    2   0.1090   1.2300e+07 
   36   38    2   0.1090   1.2300e+07 
   36   39    2   0.1530   7.1500e+06 
   39   40    2   0.1090   1.2300e+07 
   39   41    2   0.1530   7.1500e+06 
   39   45    2   0.1570   2.7500e+06 
   41   42    2   0.1090   1.2300e+07 
   41   43    2   0.1090   1.2300e+07 
   41   44    2   0.1090   1.2300e+07 
   45   46    2   0.1570   2.7500e+06 
   45   48    2   0.1435   6.1000e+06 
   46   47    2   0.1230   1.6600e+07 
   46   50    2   0.1530   7.1500e+06 
   48   49    2   0.1000   1.5700e+07 
   50   51    2   0.1090   1.2300e+07 
   50   52    2   0.1090   1.2300e+07 
   50   53    2   0.1360   1.0200e+07 
   53   54    2   0.1760   1.2900e+06 
   54   55    2   0.1530   3.5700e+06 
   54   56    2   0.1530   3.5700e+06 
   54   57    2   0.1530   3.5700e+06 
[ pairs ] 
;  ai   aj  funct  ;  all 1-4 pairs but the ones excluded in GROMOS itp 
    1    8    1 
    1    9    1 
    1   13    1 
    1   16    1 
    1   17    1 
    1   23    1 
    1   32    1 
    2    5    1 
    2    7    1 
    2   15    1 
    3    5    1 
    3    7    1 
    3   15    1 
    4    5    1 
    4    7    1 
    4   15    1 
    5    8    1 
203 
 
    5   12    1 
    5   13    1 
    5   16    1 
    5   21    1 
    5   22    1 
    5   23    1 
    5   32    1 
    6   10    1 
    6   11    1 
    6   14    1 
    6   18    1 
    6   19    1 
    6   20    1 
    6   24    1 
    6   25    1 
    6   29    1 
    6   33    1 
    6   34    1 
    7    9    1 
    7   13    1 
    7   16    1 
    7   17    1 
    7   21    1 
    7   22    1 
    7   26    1 
    7   27    1 
    7   30    1 
    7   31    1 
    7   35    1 
    7   36    1 
    8   15    1 
    8   20    1 
    8   24    1 
    8   25    1 
    8   29    1 
    8   33    1 
    8   34    1 
    9   14    1 
    9   15    1 
    9   18    1 
    9   19    1 
    9   20    1 
   10   12    1 
   10   13    1 
   10   17    1 
   11   16    1 
   11   17    1 
   12   14    1 
   12   15    1 
   14   16    1 
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   15   17    1 
   15   23    1 
   15   32    1 
   17   24    1 
   17   25    1 
   18   21    1 
   18   22    1 
   18   23    1 
   19   21    1 
   19   22    1 
   19   23    1 
   20   26    1 
   20   27    1 
   20   32    1 
   20   36    1 
   21   24    1 
   21   25    1 
   22   24    1 
   22   25    1 
   23   28    1 
   23   29    1 
   23   33    1 
   23   34    1 
   23   37    1 
   23   38    1 
   23   39    1 
   23   45    1 
   24   26    1 
   24   27    1 
   24   32    1 
   24   36    1 
   25   30    1 
   25   31    1 
   25   32    1 
   25   40    1 
   25   41    1 
   25   46    1 
   25   48    1 
   26   28    1 
   26   29    1 
   26   37    1 
   26   38    1 
   26   39    1 
   26   45    1 
   27   33    1 
   27   34    1 
   27   37    1 
   27   38    1 
   27   40    1 
   27   41    1 
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   27   47    1 
   27   49    1 
   27   50    1 
   28   30    1 
   28   31    1 
   28   32    1 
   28   36    1 
   28   39    1 
   28   46    1 
   28   48    1 
   29   35    1 
   29   36    1 
   29   39    1 
   29   46    1 
   29   48    1 
   30   33    1 
   30   34    1 
   30   45    1 
   31   33    1 
   31   34    1 
   31   45    1 
   32   45    1 
   33   35    1 
   36   42    1 
   36   43    1 
   36   44    1 
   36   46    1 
   36   48    1 
   37   40    1 
   37   41    1 
   37   45    1 
   38   40    1 
   38   41    1 
   38   45    1 
   39   47    1 
   39   49    1 
   39   50    1 
   40   42    1 
   40   43    1 
   40   44    1 
   40   46    1 
   40   48    1 
   41   46    1 
   41   48    1 
   42   45    1 
   43   45    1 
   44   45    1 
   45   51    1 
   45   52    1 
   45   53    1 
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   46   49    1 
   46   54    1 
   47   48    1 
   47   51    1 
   47   52    1 
   47   53    1 
   48   50    1 
   50   55    1 
   50   56    1 
   50   57    1 
   51   54    1 
   52   54    1 
 
[ angles ] 
;  ai   aj   ak  funct   angle     fc 
    2    1    3    2    107.00   987.00 
    2    1    4    2    107.00   987.00 
    2    1    6    2    109.00   842.00 
    3    1    4    2    107.00   987.00 
    3    1    6    2    109.00   842.00 
    4    1    6    2    114.00   928.00 
    6    5    9    2    120.00   560.00 
    6    5   17    2    120.00   560.00 
    9    5   17    2    120.00   560.00 
    1    6    5    2    109.50   285.00 
    1    6    7    2    111.00   530.00 
    1    6   15    2    109.50   285.00 
    5    6    7    2    109.50   285.00 
    5    6   15    2    109.50   285.00 
    7    6   15    2    111.00   530.00 
    6    7    8    2    104.00   490.00 
    6    7   23    2    111.00   530.00 
    6    7   32    2    120.00   560.00 
    8    7   23    2    106.75   503.00 
    8    7   32    2    104.00   490.00 
   23    7   32    2    109.50   285.00 
    5    9   10    2    120.00   505.00 
    5    9   11    2    125.00   750.00 
   10    9   11    2    120.00   505.00 
    9   11   12    2    125.00   750.00 
    9   11   13    2    111.00   530.00 
   12   11   13    2    125.00   750.00 
   11   13   14    2    120.00   505.00 
   11   13   15    2    120.00   560.00 
   14   13   15    2    120.00   505.00 
    6   15   13    2    125.00   750.00 
    6   15   16    2    114.00   928.00 
   13   15   16    2    120.00   505.00 
    5   17   18    2    109.00   842.00 
    5   17   19    2    109.00   842.00 
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    5   17   20    2    111.00   530.00 
   18   17   19    2    107.00   987.00 
   18   17   20    2    109.00   842.00 
   19   17   20    2    109.00   842.00 
   17   20   21    2    109.00   842.00 
   17   20   22    2    109.00   842.00 
   17   20   23    2    111.00   530.00 
   21   20   22    2    107.00   987.00 
   21   20   23    2    109.00   842.00 
   22   20   23    2    109.00   842.00 
    7   23   20    2    111.00   530.00 
    7   23   24    2    109.00   842.00 
    7   23   25    2    111.00   530.00 
   20   23   24    2    109.00   842.00 
   20   23   25    2    109.50   285.00 
   24   23   25    2    109.00   842.00 
   23   25   26    2    109.00   842.00 
   23   25   27    2    111.00   530.00 
   23   25   36    2    120.00   560.00 
   26   25   27    2    109.00   842.00 
   26   25   36    2    109.00   842.00 
   27   25   36    2    101.00   821.00 
   25   27   28    2    109.00   842.00 
   25   27   29    2    111.00   530.00 
   25   27   45    2    101.00   821.00 
   28   27   29    2    109.00   842.00 
   28   27   45    2    109.00   842.00 
   29   27   45    2    120.00   560.00 
   27   29   30    2    109.00   842.00 
   27   29   31    2    109.00   842.00 
   27   29   32    2    109.50   285.00 
   30   29   31    2    107.00   987.00 
   30   29   32    2    114.00   928.00 
   31   29   32    2    109.00   842.00 
    7   32   29    2    120.00   560.00 
    7   32   33    2    103.00   420.00 
    7   32   34    2    111.00   530.00 
   29   32   33    2    109.00   842.00 
   29   32   34    2    111.00   530.00 
   33   32   34    2    110.00   739.00 
   32   34   35    2    108.53   443.00 
   25   36   37    2    109.00   842.00 
   25   36   38    2    114.00   928.00 
   25   36   39    2    109.50   285.00 
   37   36   38    2    107.00   987.00 
   37   36   39    2    109.00   842.00 
   38   36   39    2    109.00   842.00 
   36   39   40    2    109.00   842.00 
   36   39   41    2    111.00   530.00 
   36   39   45    2    109.50   285.00 
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   40   39   41    2    109.00   842.00 
   40   39   45    2    109.00   842.00 
   41   39   45    2    111.00   530.00 
   39   41   42    2    109.00   842.00 
   39   41   43    2    114.00   928.00 
   39   41   44    2    109.00   842.00 
   42   41   43    2    107.00   987.00 
   42   41   44    2    107.00   987.00 
   43   41   44    2    107.00   987.00 
   27   45   39    2    101.00   821.00 
   27   45   46    2    111.00   530.00 
   27   45   48    2    109.50   320.00 
   39   45   46    2    111.00   530.00 
   39   45   48    2    111.00   530.00 
   46   45   48    2    110.30   524.00 
   45   46   47    2    121.00   685.00 
   45   46   50    2    120.00   560.00 
   47   46   50    2    121.00   685.00 
   45   48   49    2    108.53   443.00 
   46   50   51    2    109.00   842.00 
   46   50   52    2    109.00   842.00 
   46   50   53    2    111.00   530.00 
   51   50   52    2    107.00   987.00 
   51   50   53    2    110.00   739.00 
   52   50   53    2    110.00   739.00 
   50   53   54    2    120.00   530.00 
   53   54   55    2    103.00   420.00 
   53   54   56    2    103.00   420.00 
   53   54   57    2    103.00   420.00 
   55   54   56    2    109.60   450.00 
   55   54   57    2    120.00   780.00 
   56   54   57    2    109.60   450.00 
 
[ dihedrals ] 
; GROMOS improper dihedrals 
;  ai   aj   ak   al  funct   angle     fc 
   11    9   12   13    2      0.00   167.36 
   13   11   14   15    2      0.00   167.36 
   15    6   13   16    2      0.00   167.36 
    9    5   10   11    2      0.00   167.36 
    5    6    9   17    2      0.00   167.36 
   46   45   47   50    2      0.00   167.36 
[ dihedrals ] 
;  ai   aj   ak   al  funct    ph0      cp     mult 
    2    1    6   15    1      0.00     3.77    3 
    9    5    6   15    1      0.00     1.00    6 
    6    5    9   11    1    180.00     1.53    2 
    9    5   17   20    1      0.00     1.00    6 
   15    6    7   23    1      0.00     3.77    3 
    5    6   15   13    1      0.00     1.00    6 
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    6    7   23   20    1      0.00     3.77    3 
    6    7   32   34    1      0.00     3.77    3 
    5    9   11   13    1    180.00     1.53    2 
   12   11   13   15    1    180.00     5.86    2 
   11   13   15    6    1    180.00     1.53    2 
    5   17   20   23    1      0.00     3.77    3 
   17   20   23    7    1    180.00     1.00    3 
   20   23   25   27    1      0.00     3.77    3 
   23   25   27   29    1      0.00     3.77    3 
   23   25   36   39    1      0.00     3.77    3 
   25   27   29   32    1      0.00     3.77    3 
   25   27   45   39    1      0.00     3.77    3 
   27   29   32    7    1      0.00     3.77    3 
    7   32   34   35    1      0.00     1.26    3 
   25   36   39   41    1    180.00     1.00    3 
   36   39   41   42    1      0.00     3.77    3 
   36   39   45   27    1    180.00     1.00    3 
   27   45   46   47    1      0.00     1.00    6 
   27   45   48   49    1      0.00     1.26    3 
   45   46   50   53    1    180.00     1.00    6 
   46   50   53   54    1    180.00     1.00    3 
   50   53   54   56    1      0.00     1.05    3 
 
[ virtual_sitesn ] 
58 2 12 9 13 14 10 11 
59 2 15 6 1 2 3 4 16 
60 2 5 17 20 18 19 21 22 
61 2 23 7 8 24  
62 2 25 36 39 41 26 37 38 42 43 44 40  
63 2 32 29 34 33 30 31 35 
64 2 27 45 48 28 49 
65 2 51 52 47 46 50 
66 2 53 54 55 56 57 
 
grompp.mdp for Multiscale Simulations 
integrator               = md 
dt                       = 0.002 
nsteps                   = 25000000 
 
nstxout                  = 0 
nstvout                  = 0 
nstfout                  = 0 
nstlog                   = 0 
nstenergy                = 0 
nstxtcout                = 100000 
 
nstlist                  = 5 
rlist                    = 1.4 
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coulombtype              = shift 
rcoulomb_switch          = 0.0 
rcoulomb                 = 1.2 
epsilon_r                = 6 
vdw_type                 = shift 
rvdw_switch              = 0.9 
rvdw                     = 1.2 
 
tcoupl                   = v-rescale 
tc-grps                  = PGA STR STe PGs PCG AON DXM DXC  W  NA 
tau_t                    = 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
ref_t                    = 310 310 310 310 310 310 310 310 310 310 
;Pcoupl                   = berendsen 
Pcoupltype               = isotropic 
tau_p                    = 5.0 
compressibility          = 1e-5 
ref_p                    = 1.0 
 
constraints   = hbonds 
 
MS2 force field 
[ defaults ] 
1 1 
 
[ atomtypes ] 
;name  at.num      mass        charge   ptype     c6          c12 
    O    8  15.9994       0.000     A  0.0022619536  1e-06 
   OA    8  15.9994       0.000     A  0.0022619536  1.505529e-06 
   OM    8  15.9994       0.000     A  0.0022619536  7.4149321e-07 
   OE    8  15.9994       0.000     A  0.0022619536  1.21e-06 
    C    6  12.011        0.000     A  0.0023406244  4.937284e-06 
  CH0    6  12.011        0.000     A  0.0023970816  0.0002053489 
  CH1    6  13.019        0.000     A  0.00606841    9.70225e-05 
  CH2    6  14.027        0.000     A  0.0074684164  3.3965584e-05 
  CH3    6  0.000         0.000     A  0.0096138025  2.6646244e-05 
   HC    1  1.0080        0.000     A  8.464e-05     1.5129e-08 
    F    9  18.9984       0.000     A  0.0011778624  7.6073284e-07 
    P   15   30.9738       0.000     A  0.01473796    2.2193521e-05 
    H    1  1.0080        0.000     A  0.0           0.0 
  NA+   11   22.9898         0.000     A  7.2063121e-05  2.1025e-08 
   AX    0  0.000        0.000     V  0.0          0.0  
   BX    0  0.000         0.000     V  0.0          0.0  
   CX    0  0.000        0.000     V  0.0          0.0  
   DX    0  0.000        0.000     V  0.0           0.0 
   EX    0  0.000        0.000     V  0.0          0.0  
   FX    0  0.000        0.000     V  0.0           0.0 
   GX    0  0.000        0.000     V  0.0          0.0  
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   HX    0  0.000         0.000     V  0.0          0.0  
   IX    0  0.000        0.000     V  0.0          0.0  
   JX    0  0.000        0.000     V  0.0           0.0 
   KX    0  0.000        0.000     V  0.0          0.0  
   LX    0  0.000        0.000     V  0.0           0.0     
   AD    0  0.000        0.000     V  0.0          0.0  
   BD    0  0.000         0.000     V  0.0          0.0  
   CD    0  0.000        0.000     V  0.0          0.0  
   DD    0  0.000        0.000     V  0.0           0.0  
   ED    0  0.000        0.000     V  0.0           0.0  
   FD    0  0.000        0.000     V  0.0           0.0  
   GD    0  0.000        0.000     V  0.0           0.0  
   HD    0  0.000        0.000     V  0.0           0.0  
   ID    0  0.000        0.000     V  0.0           0.0  
P4  72.0 0.000 A 0.0 0.0 
Na  72.0 0.000 A 0.0 0.0 
 
[ nonbond_params ] 
      OM        O  1  0.0022619536   8.611e-07 
      OA        O  1  0.0022619536  1.38651e-06 
      OA       OM  1  0.0022619536  2.258907e-06 
      OE        O  1  0.0022619536     1.1e-06 
      OE       OM  1  0.0022619536  9.4721e-07 
      OE       OA  1  0.0022619536  1.505529e-06 
       C        O  1  0.0023009528   2.222e-06 
       C       OM  1  0.0023009528  1.9133642e-06 
       C       OA  1  0.0023009528  2.4442e-06 
       C       OE  1  0.0023009528  2.4442e-06 
     CH0        O  1  0.0023285376   1.433e-05 
     CH0       OM  1  0.0023285376  1.2339563e-05 
     CH0       OA  1  0.0023285376  1.5763e-05 
     CH0       OE  1  0.0023285376  1.5763e-05 
     CH0        C  1  0.0023686848  3.184126e-05 
     CH1        O  1  0.003704924    9.85e-06 
     CH1       OM  1  0.003704924  8.481835e-06 
     CH1       OA  1  0.003704924  1.0835e-05 
     CH1       OE  1  0.003704924  1.0835e-05 
     CH1        C  1  0.003768802  2.18867e-05 
     CH1      CH0  1  0.003813984  0.0001411505 
     CH2        O  1  0.0041101352   5.828e-06 
     CH2       OM  1  0.0041101352  5.0184908e-06 
     CH2       OA  1  0.0041101352  6.4108e-06 
     CH2       OE  1  0.0041101352  6.4108e-06 
     CH2        C  1  0.0041809996  1.2949816e-05 
     CH2      CH0  1  0.0042311232  8.351524e-05 
     CH2      CH1  1  0.006732118  5.74058e-05 
     CH3        O  1  0.004663258   5.162e-06 
     CH3       OM  1  0.004663258  4.4449982e-06 
     CH3       OA  1  0.004663258  5.6782e-06 
     CH3       OE  1  0.004663258  5.6782e-06 
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     CH3        C  1  0.004743659  1.1469964e-05 
     CH3      CH0  1  0.004800528  7.397146e-05 
     CH3      CH1  1  0.007638095  5.08457e-05 
     CH3      CH2  1  0.008473481  3.0084136e-05 
      HC        O  1  0.000437552    1.23e-07 
      HC       OM  1  0.000437552  1.059153e-07 
      HC       OA  1  0.000437552   1.353e-07 
      HC       OE  1  0.000437552   1.353e-07 
      HC        C  1  0.000445096  2.73306e-07 
      HC      CH0  1  0.000450432  1.76259e-06 
      HC      CH1  1  0.00071668  1.21155e-06 
      HC      CH2  1  0.000795064  7.16844e-07 
      HC      CH3  1  0.00090206  6.34926e-07 
       H        O  1           0           0 
       H       OM  1           0           0 
       H       OA  1           0           0 
       H       OE  1           0           0 
       H        C  1           0           0 
       H      CH0  1           0           0 
       H      CH1  1           0           0 
       H      CH2  1           0           0 
       H      CH3  1           0           0 
       H       HC  1           0           0 
       P        O  1  0.005773784  5.32343e-06 
       P       OM  1  0.005773784  1.4453348e-05 
       P       OA  1  0.005773784  5.780397e-06 
       P       OE  1  0.005773784  5.780397e-06 
       P        C  1  0.005873332  1.0467842e-05 
       P      CH0  1  0.005943744  6.750863e-05 
       P      CH1  1  0.00945706  4.640335e-05 
       P      CH2  1  0.010491388  2.7455708e-05 
       P      CH3  1  0.01190327  2.4318182e-05 
       P       HC  1  0.00111688  5.79453e-07 
       P        H  1           0           0 
       F        O  1  0.0016322592   8.722e-07 
       F       OM  1  0.0016322592  7.5105142e-07 
       F       OA  1  0.0016322592  1.505529e-06 
       F       OE  1  0.0016322592  9.5942e-07 
       F        C  1  0.0016604016  1.9380284e-06 
       F      CH0  1  0.0016803072  1.2498626e-05 
       F      CH1  1  0.002673528  8.59117e-06 
       F      CH2  1  0.0029659344  5.0831816e-06 
       F      CH3  1  0.003365076  4.5022964e-06 
       F       HC  1  0.000315744  1.072806e-07 
       F        H  1           0           0 
       F        P  1  0.004166448  5.780397e-06 
     NA+        O  1  0.00040373684  1.6385e-07 
     NA+       OM  1  0.00040373684  4.4486e-07 
     NA+       OA  1  0.00040373684  1.77915e-07 
     NA+       OE  1  0.00040373684  1.77915e-07 
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     NA+        C  1  0.00041069782  3.2219e-07 
     NA+      CH0  1  0.00041562144  2.07785e-06 
     NA+      CH1  1  0.0006612931  1.42825e-06 
     NA+      CH2  1  0.00073361938  8.4506e-07 
     NA+      CH3  1  0.00083234645  7.4849e-07 
     NA+       HC  1  7.80988e-05  1.7835e-08 
     NA+        H  1           0           0 
     NA+        P  1  0.0010305646  6.83095e-07 
     NA+        F  1  0.00029134248  1.77915e-07 
   
;solvent 
  P4  Na  1  0.20002E-00  0.21514E-02 
  Na  Na  1  0.24145E-00  0.26027E-02 
  P4  P4  1  0.21558E-00  0.23238E-02 
  NA+   Na 1 0.17246E-00  0.18590E-02  
  NA+ P4 1 0.24145E-00  0.26027E-02 
 
;polymer 
  P4  AX  1  0.13366E-00  0.14408E-02 
  P4  BX  1  0.11642E-00  0.12549E-02 
  P4  CX  1  0.86233E-01  0.92953E-03 
  P4  DX  1  0.11642E-00  0.12549E-02 
  P4  EX  1  0.13366E-00  0.14408E-02 
  P4  FX  1  0.13366E-00  0.14408E-02 
  P4  GX  1  0.11642E-00  0.12549E-02 
  P4  HX  1  0.86233E-01  0.92953E-03 
  P4  IX  1  0.86233E-01  0.92953E-03 
  P4  JX  1  0.86233E-01  0.92953E-03 
  P4  KX  1  0.86233E-01  0.92953E-03 
  P4  LX  1  0.86233E-01  0.92953E-03    
   
  Na AX  1  0.17246E-00  0.18590E-02 
  Na  BX  1  0.17246E-00  0.18590E-02 
  Na  CX  1  0.15091E-00  0.16267E-02 
  Na  DX  1  0.17246E-00  0.18590E-02 
  Na EX  1  0.15091E-00  0.16267E-02 
  Na FX  1  0.15091E-00  0.16267E-02 
  Na  GX  1  0.15091E-00  0.16267E-02 
  Na  HX  1  0.15091E-00  0.16267E-02    
  Na  IX  1  0.15091E-00  0.16267E-02 
  Na JX  1  0.15091E-00  0.16267E-02 
  Na  KX  1  0.15091E-00  0.16267E-02 
  Na  LX  1  0.15091E-00  0.16267E-02 
   
;drug  
  P4  AD  1  0.86233E-01  0.92953E-03 
  P4  BD  1  0.86233E-01  0.92953E-03 
  P4  CD  1  0.86233E-01  0.92953E-03 
  P4  DD  1  0.86233E-01  0.92953E-03  
  P4  ED  1  0.86233E-01  0.92953E-03 
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  P4  FD  1  0.86233E-01  0.92953E-03 
  P4  GD  1  0.86233E-01  0.92953E-03 
  P4  HD  1  0.11642E-00  0.12549E-02 
  P4  ID  1  0.24145E-00  0.26027E-02 
   
  Na  AD  1  0.13366E-00  0.14408E-02 
  Na  BD  1  0.13366E-00  0.14408E-02 
  Na  CD  1  0.13366E-00  0.14408E-02 
  Na  DD  1  0.13366E-00  0.14408E-02 
  Na  ED  1  0.13366E-00  0.14408E-02 
  Na  FD  1  0.15091E-00  0.16267E-02 
  Na  GD  1  0.15091E-00  0.16267E-02 
  Na  HD  1  0.15091E-00  0.16267E-02 
  Na  ID  1  0.13366E-00  0.14408E-02 
 
[ pairtypes ] 
; i    j func          c6           c12 
       O        O  1  0.0022619536  7.4149321e-07 
      OM        O  1  0.0022619536  7.4149321e-07 
      OM       OM  1  0.0022619536  7.4149321e-07 
      OA        O  1  0.0022619536  9.687375e-07 
      OA       OM  1  0.0022619536  9.687375e-07 
      OA       OA  1  0.0022619536  1.265625e-06 
      OE        O  1  0.0022619536  9.687375e-07 
      OE       OM  1  0.0022619536  9.687375e-07 
      OE       OA  1  0.0022619536  1.265625e-06 
      OE       OE  1  0.0022619536  1.265625e-06 
       C        O  1  0.0023009528  1.5818407e-06 
       C       OM  1  0.0023009528  1.5818407e-06 
       C       OA  1  0.0023009528  2.066625e-06 
       C       OE  1  0.0023009528  2.066625e-06 
       C        C  1  0.0023406244  3.374569e-06 
     CH0        O  1  0.0023009528  1.5818407e-06 
     CH0       OM  1  0.0023009528  1.5818407e-06 
     CH0       OA  1  0.0023009528  2.066625e-06 
     CH0       OE  1  0.0023009528  2.066625e-06 
     CH0        C  1  0.0023406244  3.374569e-06 
     CH0      CH0  1  0.0023406244  3.374569e-06 
     CH1        O  1  0.0025663376  1.6645063e-06 
     CH1       OM  1  0.0025663376  1.6645063e-06 
     CH1       OA  1  0.0025663376  2.174625e-06 
     CH1       OE  1  0.0025663376  2.174625e-06 
     CH1        C  1  0.0026105848  3.550921e-06 
     CH1      CH0  1  0.0026105848  3.550921e-06 
     CH1      CH1  1  0.0029116816  3.736489e-06 
     CH2        O  1  0.0032687988  1.8751283e-06 
     CH2       OM  1  0.0032687988  1.8751283e-06 
     CH2       OA  1  0.0032687988  2.4497959e-06 
     CH2       OE  1  0.0032687988  2.4497959e-06 
     CH2        C  1  0.0033251574  4.0002446e-06 
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     CH2      CH0  1  0.0033251574  4.0002446e-06 
     CH2      CH1  1  0.0037086708  4.2092938e-06 
     CH2      CH2  1  0.0047238129  4.7419261e-06 
     CH3        O  1  0.0039370168  2.1146739e-06 
     CH3       OM  1  0.0039370168  2.1146739e-06 
     CH3       OA  1  0.0039370168  2.7627548e-06 
     CH3       OE  1  0.0039370168  2.7627548e-06 
     CH3        C  1  0.0040048964  4.5112715e-06 
     CH3      CH0  1  0.0040048964  4.5112715e-06 
     CH3      CH1  1  0.0044668088  4.7470266e-06 
     CH3      CH2  1  0.0056894694  5.347702e-06 
     CH3      CH3  1  0.0068525284  6.0308652e-06 
      HC        O  1  0.000437552  1.059153e-07 
      HC       OM  1  0.000437552  1.059153e-07 
      HC       OA  1  0.000437552  1.38375e-07 
      HC       OE  1  0.000437552  1.38375e-07 
      HC        C  1  0.000445096  2.25951e-07 
      HC      CH0  1  0.000445096  2.25951e-07 
      HC      CH1  1  0.000496432  2.37759e-07 
      HC      CH2  1  0.000632316  2.6784436e-07 
      HC      CH3  1  0.000761576  3.0206119e-07 
      HC       HC  1   8.464e-05  1.5129e-08 
       H        O  1           0           0 
       H       OM  1           0           0 
       H       OA  1           0           0 
       H       OE  1           0           0 
       H        C  1           0           0 
       H      CH0  1           0           0 
       H      CH1  1           0           0 
       H      CH2  1           0           0 
       H      CH3  1           0           0 
       H       HC  1           0           0 
       H        H  1           0           0 
       P        O  1  0.005773784  4.0566421e-06 
       P       OM  1  0.005773784  4.0566421e-06 
       P       OA  1  0.005773784  5.299875e-06 
       P       OE  1  0.005773784  5.299875e-06 
       P        C  1  0.005873332  8.654107e-06 
       P      CH0  1  0.005873332  8.654107e-06 
       P      CH1  1  0.006550744  9.106363e-06 
       P      CH2  1  0.008343822  1.0258657e-05 
       P      CH3  1  0.010049492  1.1569189e-05 
       P       HC  1  0.00111688  5.79453e-07 
       P        H  1           0           0 
       P        P  1  0.01473796  2.2193521e-05 
       F        O  1  0.0016322592  7.5105142e-07 
       F       OM  1  0.0016322592  7.5105142e-07 
       F       OA  1  0.0016322592  9.81225e-07 
       F       OE  1  0.0016322592  9.81225e-07 
       F        C  1  0.0016604016  1.6022314e-06 
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       F      CH0  1  0.0016604016  1.6022314e-06 
       F      CH1  1  0.0018519072  1.6859626e-06 
       F      CH2  1  0.0023588136  1.8992996e-06 
       F      CH3  1  0.0028410096  2.1419331e-06 
       F       HC  1  0.000315744  1.072806e-07 
       F        H  1           0           0 
       F        P  1  0.004166448  4.1089342e-06 
       F        F  1  0.0011778624  7.6073284e-07 
     NA+        O  1  0.00040373684  1.248595e-07 
     NA+       OM  1  0.00040373684  1.248595e-07 
     NA+       OA  1  0.00040373684  1.63125e-07 
     NA+       OE  1  0.00040373684  1.63125e-07 
     NA+        C  1  0.00041069782  2.66365e-07 
     NA+      CH0  1  0.00041069782  2.66365e-07 
     NA+      CH1  1  0.00045806644  2.80285e-07 
     NA+      CH2  1  0.00058344897  3.1575148e-07 
     NA+      CH3  1  0.00070271942  3.5608839e-07 
     NA+       HC  1  7.80988e-05  1.7835e-08 
     NA+        H  1           0           0 
     NA+        P  1  0.0010305646  6.83095e-07 
     NA+        F  1  0.00029134248  1.26469e-07 
 
#include "dxmpsalt.itp" 
#include "hyb80c18.itp" 
 
;;;;;; ACETONE 
 
[ moleculetype ] 
; molname   nrexcl 
  AON  1 
 
[ atoms ] 
;id  type  resnr  residu  atom  cgnr  charge 
 1  Na  1  AON  Na  1  0 
 
;;;;;; SODIUM 
 
[ moleculetype ] 
; Name   nrexcl 
NA       1 
 
[ atoms ] 
;  nr  type  resnr  resid  atom  cgnr  charge    mass    total_charge 
    1   NA+    1      NA    NA   1      1     
 
;;;;;; WATER (representing 4 H2O molecules) 
 
[ moleculetype ] 
; molname   nrexcl 
  W       1 
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[ atoms ] 
;id  type  resnr  residu  atom  cgnr  charge 
 1  P4  1  W  W  1  0 
